GO Terms |
Score |
Description |
GO:0008150 |
82.92% |
biological_process |
GO:0009987 |
80.84% |
cellular process |
GO:0008152 |
79.39% |
metabolic process |
GO:0071704 |
78.71% |
organic substance metabolic process |
GO:0044237 |
78.57% |
cellular metabolic process |
GO:0044238 |
76.04% |
primary metabolic process |
GO:0044281 |
73.95% |
small molecule metabolic process |
GO:0019752 |
73.17% |
carboxylic acid metabolic process |
GO:0006082 |
72.81% |
organic acid metabolic process |
GO:0043436 |
72.29% |
oxoacid metabolic process |
GO:0065007 |
70.25% |
biological regulation |
GO:1901575 |
68.69% |
organic substance catabolic process |
GO:0009056 |
68.62% |
catabolic process |
GO:0006629 |
68.18% |
lipid metabolic process |
GO:0032787 |
67.88% |
monocarboxylic acid metabolic process |
GO:0044248 |
67.77% |
cellular catabolic process |
GO:0055114 |
67.75% |
oxidation-reduction process |
GO:0044255 |
67.52% |
cellular lipid metabolic process |
GO:0065008 |
67.11% |
regulation of biological quality |
GO:0044282 |
66.84% |
small molecule catabolic process |
GO:0046395 |
66.52% |
carboxylic acid catabolic process |
GO:0016054 |
66.37% |
organic acid catabolic process |
GO:0006631 |
65.12% |
fatty acid metabolic process |
GO:0016042 |
64.54% |
lipid catabolic process |
GO:0042592 |
64.37% |
homeostatic process |
GO:0044242 |
64.08% |
cellular lipid catabolic process |
GO:0072329 |
63.74% |
monocarboxylic acid catabolic process |
GO:0048878 |
63.69% |
chemical homeostasis |
GO:0030258 |
63.63% |
lipid modification |
GO:0055088 |
62.89% |
lipid homeostasis |
GO:0009062 |
62.60% |
fatty acid catabolic process |
GO:0034440 |
62.53% |
lipid oxidation |
GO:0019395 |
62.51% |
fatty acid oxidation |
GO:0006635 |
61.98% |
fatty acid beta-oxidation |
GO:0009058 |
50.25% |
biosynthetic process |
GO:0044249 |
49.50% |
cellular biosynthetic process |
GO:0000038 |
40.89% |
very long-chain fatty acid metabolic process |
GO:0017144 |
34.16% |
drug metabolic process |
GO:0006091 |
33.45% |
generation of precursor metabolites and energy |
GO:0051186 |
32.26% |
cofactor metabolic process |
GO:0051188 |
31.85% |
cofactor biosynthetic process |
GO:0016999 |
31.51% |
antibiotic metabolic process |
GO:0072593 |
29.05% |
reactive oxygen species metabolic process |
GO:1901568 |
28.88% |
fatty acid derivative metabolic process |
GO:0006690 |
28.29% |
icosanoid metabolic process |
GO:0017000 |
28.28% |
antibiotic biosynthetic process |
GO:1903409 |
27.93% |
reactive oxygen species biosynthetic process |
GO:0033559 |
27.90% |
unsaturated fatty acid metabolic process |
GO:0042743 |
27.63% |
hydrogen peroxide metabolic process |
GO:0006692 |
27.52% |
prostanoid metabolic process |
GO:0006693 |
27.52% |
prostaglandin metabolic process |
GO:0032502 |
27.20% |
developmental process |
GO:0022414 |
26.23% |
reproductive process |
GO:0003006 |
25.31% |
developmental process involved in reproduction |
GO:0048609 |
24.04% |
multicellular organismal reproductive process |
GO:0007276 |
23.21% |
gamete generation |
GO:0050789 |
23.17% |
regulation of biological process |
GO:0050794 |
22.47% |
regulation of cellular process |
GO:0007283 |
22.17% |
spermatogenesis |
GO:0048232 |
22.14% |
male gamete generation |
GO:0071840 |
21.47% |
cellular component organization or biogenesis |
GO:0016043 |
21.42% |
cellular component organization |
GO:0048518 |
21.03% |
positive regulation of biological process |
GO:0048522 |
20.23% |
positive regulation of cellular process |
GO:0048583 |
18.80% |
regulation of response to stimulus |
GO:0006996 |
18.52% |
organelle organization |
GO:0010941 |
17.94% |
regulation of cell death |
GO:0080134 |
17.89% |
regulation of response to stress |
GO:0048584 |
17.43% |
positive regulation of response to stimulus |
GO:1901576 |
17.19% |
organic substance biosynthetic process |
GO:0010817 |
17.12% |
regulation of hormone levels |
GO:0010942 |
16.84% |
positive regulation of cell death |
GO:0042446 |
16.71% |
hormone biosynthetic process |
GO:0042445 |
16.48% |
hormone metabolic process |
GO:1902882 |
16.09% |
regulation of response to oxidative stress |
GO:0006807 |
15.10% |
nitrogen compound metabolic process |
GO:1902884 |
14.88% |
positive regulation of response to oxidative stress |
GO:0050896 |
14.24% |
response to stimulus |
GO:0048285 |
14.23% |
organelle fission |
GO:0044283 |
13.69% |
small molecule biosynthetic process |
GO:1901564 |
13.21% |
organonitrogen compound metabolic process |
GO:0001676 |
13.20% |
long-chain fatty acid metabolic process |
GO:0016053 |
13.03% |
organic acid biosynthetic process |
GO:0043170 |
13.02% |
macromolecule metabolic process |
GO:0046394 |
12.98% |
carboxylic acid biosynthetic process |
GO:0055092 |
12.93% |
sterol homeostasis |
GO:0042632 |
12.90% |
cholesterol homeostasis |
GO:0044550 |
12.56% |
secondary metabolite biosynthetic process |
GO:0019748 |
12.34% |
secondary metabolic process |
GO:0006950 |
12.30% |
response to stress |
GO:0044260 |
11.84% |
cellular macromolecule metabolic process |
GO:0034641 |
11.50% |
cellular nitrogen compound metabolic process |
GO:1901360 |
11.41% |
organic cyclic compound metabolic process |
GO:0009605 |
11.24% |
response to external stimulus |
GO:0051704 |
11.23% |
multi-organism process |
GO:0046483 |
11.09% |
heterocycle metabolic process |
GO:0019538 |
10.93% |
protein metabolic process |
GO:0006725 |
10.84% |
cellular aromatic compound metabolic process |
GO:0044267 |
10.63% |
cellular protein metabolic process |
GO:0043412 |
10.38% |
macromolecule modification |
GO:0009607 |
10.34% |
response to biotic stimulus |
GO:0043207 |
10.31% |
response to external biotic stimulus |
GO:0006520 |
10.26% |
cellular amino acid metabolic process |
GO:0051707 |
10.16% |
response to other organism |
GO:0006464 |
9.69% |
cellular protein modification process |
GO:0006139 |
9.67% |
nucleobase-containing compound metabolic process |
GO:0036211 |
9.64% |
protein modification process |
GO:0006793 |
9.59% |
phosphorus metabolic process |
GO:0044271 |
9.45% |
cellular nitrogen compound biosynthetic process |
GO:0016070 |
9.41% |
RNA metabolic process |
GO:0072330 |
9.41% |
monocarboxylic acid biosynthetic process |
GO:1901605 |
9.25% |
alpha-amino acid metabolic process |
GO:1901362 |
9.14% |
organic cyclic compound biosynthetic process |
GO:1901566 |
8.99% |
organonitrogen compound biosynthetic process |
GO:0090304 |
8.95% |
nucleic acid metabolic process |
GO:0006796 |
8.82% |
phosphate-containing compound metabolic process |
GO:0019438 |
8.50% |
aromatic compound biosynthetic process |
GO:0018130 |
8.49% |
heterocycle biosynthetic process |
GO:0048856 |
8.31% |
anatomical structure development |
GO:0009059 |
8.29% |
macromolecule biosynthetic process |
GO:0048869 |
8.24% |
cellular developmental process |
GO:0009611 |
8.11% |
response to wounding |
GO:0005975 |
8.02% |
carbohydrate metabolic process |
GO:0042221 |
7.95% |
response to chemical |
GO:0034660 |
7.86% |
ncRNA metabolic process |
GO:0043603 |
7.84% |
cellular amide metabolic process |
GO:0019222 |
7.74% |
regulation of metabolic process |
GO:0032501 |
7.72% |
multicellular organismal process |
GO:0034645 |
7.71% |
cellular macromolecule biosynthetic process |
GO:0022607 |
7.57% |
cellular component assembly |
GO:0006399 |
7.57% |
tRNA metabolic process |
GO:0009225 |
7.56% |
nucleotide-sugar metabolic process |
GO:1901135 |
7.40% |
carbohydrate derivative metabolic process |
GO:0019637 |
7.19% |
organophosphate metabolic process |
GO:0051716 |
7.11% |
cellular response to stimulus |
GO:1901565 |
7.09% |
organonitrogen compound catabolic process |
GO:0051179 |
7.08% |
localization |
GO:0009620 |
7.08% |
response to fungus |
GO:1901607 |
7.08% |
alpha-amino acid biosynthetic process |
GO:0006396 |
7.03% |
RNA processing |
GO:0008652 |
6.95% |
cellular amino acid biosynthetic process |
GO:0010468 |
6.91% |
regulation of gene expression |
GO:0043604 |
6.90% |
amide biosynthetic process |
GO:0031323 |
6.88% |
regulation of cellular metabolic process |
GO:0010033 |
6.81% |
response to organic substance |
GO:0009889 |
6.78% |
regulation of biosynthetic process |
GO:1901700 |
6.74% |
response to oxygen-containing compound |
GO:0006518 |
6.72% |
peptide metabolic process |
GO:0055086 |
6.70% |
nucleobase-containing small molecule metabolic process |
GO:0009064 |
6.67% |
glutamine family amino acid metabolic process |
GO:0042398 |
6.65% |
cellular modified amino acid biosynthetic process |
GO:0006575 |
6.63% |
cellular modified amino acid metabolic process |
GO:0008610 |
6.63% |
lipid biosynthetic process |
GO:0034654 |
6.62% |
nucleobase-containing compound biosynthetic process |
GO:0016310 |
6.60% |
phosphorylation |
GO:0006508 |
6.60% |
proteolysis |
GO:0070085 |
6.60% |
glycosylation |
GO:0006486 |
6.58% |
protein glycosylation |
GO:0060255 |
6.57% |
regulation of macromolecule metabolic process |
GO:0032259 |
6.57% |
methylation |
GO:0043039 |
6.54% |
tRNA aminoacylation |
GO:0033554 |
6.51% |
cellular response to stress |
GO:0009628 |
6.50% |
response to abiotic stimulus |
GO:0030154 |
6.47% |
cell differentiation |
GO:0043038 |
6.46% |
amino acid activation |
GO:0043413 |
6.45% |
macromolecule glycosylation |
GO:0031326 |
6.45% |
regulation of cellular biosynthetic process |
GO:0009072 |
6.44% |
aromatic amino acid family metabolic process |
GO:0006732 |
6.43% |
coenzyme metabolic process |
GO:0080090 |
6.41% |
regulation of primary metabolic process |
GO:0009653 |
6.38% |
anatomical structure morphogenesis |
GO:0051234 |
6.36% |
establishment of localization |
GO:0006810 |
6.35% |
transport |
GO:0018193 |
6.35% |
peptidyl-amino acid modification |
GO:0009063 |
6.30% |
cellular amino acid catabolic process |
GO:0050793 |
6.28% |
regulation of developmental process |
GO:0015980 |
6.27% |
energy derivation by oxidation of organic compounds |
GO:0009108 |
6.26% |
coenzyme biosynthetic process |
GO:0034470 |
6.26% |
ncRNA processing |
GO:0006418 |
6.24% |
tRNA aminoacylation for protein translation |
GO:1901606 |
6.19% |
alpha-amino acid catabolic process |
GO:0043933 |
6.17% |
protein-containing complex subunit organization |
GO:2000112 |
6.17% |
regulation of cellular macromolecule biosynthetic process |
GO:0065003 |
6.15% |
protein-containing complex assembly |
GO:1901137 |
6.14% |
carbohydrate derivative biosynthetic process |
GO:0043648 |
6.09% |
dicarboxylic acid metabolic process |
GO:0090407 |
6.09% |
organophosphate biosynthetic process |
GO:0051171 |
6.05% |
regulation of nitrogen compound metabolic process |
GO:1901615 |
6.02% |
organic hydroxy compound metabolic process |
GO:0010556 |
6.01% |
regulation of macromolecule biosynthetic process |
GO:0051128 |
6.00% |
regulation of cellular component organization |
GO:0006790 |
5.95% |
sulfur compound metabolic process |
GO:0009226 |
5.92% |
nucleotide-sugar biosynthetic process |
GO:0032989 |
5.91% |
cellular component morphogenesis |
GO:0007165 |
5.89% |
signal transduction |
GO:0008033 |
5.82% |
tRNA processing |
GO:0006040 |
5.80% |
amino sugar metabolic process |
GO:0006468 |
5.77% |
protein phosphorylation |
GO:0043043 |
5.77% |
peptide biosynthetic process |
GO:0005996 |
5.76% |
monosaccharide metabolic process |
GO:0006412 |
5.73% |
translation |
GO:0009057 |
5.70% |
macromolecule catabolic process |
GO:0044265 |
5.68% |
cellular macromolecule catabolic process |
GO:1901617 |
5.66% |
organic hydroxy compound biosynthetic process |
GO:0048519 |
5.65% |
negative regulation of biological process |
GO:0009451 |
5.64% |
RNA modification |
GO:0006952 |
5.62% |
defense response |
GO:0051252 |
5.61% |
regulation of RNA metabolic process |
GO:0006576 |
5.60% |
cellular biogenic amine metabolic process |
GO:0097164 |
5.58% |
ammonium ion metabolic process |
GO:0044262 |
5.57% |
cellular carbohydrate metabolic process |
GO:0009893 |
5.55% |
positive regulation of metabolic process |
GO:0048513 |
5.55% |
animal organ development |
GO:0019318 |
5.55% |
hexose metabolic process |
GO:0016071 |
5.52% |
mRNA metabolic process |
GO:0033036 |
5.48% |
macromolecule localization |
GO:0046349 |
5.47% |
amino sugar biosynthetic process |
GO:0016192 |
5.45% |
vesicle-mediated transport |
GO:0006541 |
5.45% |
glutamine metabolic process |
GO:0051641 |
5.44% |
cellular localization |
GO:0008104 |
5.44% |
protein localization |
GO:0051239 |
5.42% |
regulation of multicellular organismal process |
GO:0007275 |
5.40% |
multicellular organism development |
GO:0007154 |
5.39% |
cell communication |
GO:0007010 |
5.39% |
cytoskeleton organization |
GO:0009725 |
5.37% |
response to hormone |
GO:0006720 |
5.34% |
isoprenoid metabolic process |
GO:0019219 |
5.33% |
regulation of nucleobase-containing compound metabolic process |
GO:0032543 |
5.33% |
mitochondrial translation |
GO:0006259 |
5.32% |
DNA metabolic process |
GO:0010035 |
5.32% |
response to inorganic substance |
GO:0000902 |
5.28% |
cell morphogenesis |
GO:0006066 |
5.27% |
alcohol metabolic process |
GO:1901361 |
5.25% |
organic cyclic compound catabolic process |
GO:0019439 |
5.25% |
aromatic compound catabolic process |
GO:0070887 |
5.24% |
cellular response to chemical stimulus |
GO:0062012 |
5.24% |
regulation of small molecule metabolic process |
GO:0006355 |
5.22% |
regulation of transcription, DNA-templated |
GO:0006721 |
5.19% |
terpenoid metabolic process |
GO:0030163 |
5.17% |
protein catabolic process |
GO:0071702 |
5.16% |
organic substance transport |
GO:0048646 |
5.15% |
anatomical structure formation involved in morphogenesis |
GO:0022402 |
5.15% |
cell cycle process |
GO:0000959 |
5.14% |
mitochondrial RNA metabolic process |
GO:0009719 |
5.12% |
response to endogenous stimulus |
GO:0007049 |
5.12% |
cell cycle |
GO:0010608 |
5.11% |
posttranscriptional regulation of gene expression |
GO:0042180 |
5.10% |
cellular ketone metabolic process |
GO:1903506 |
5.10% |
regulation of nucleic acid-templated transcription |
GO:0044270 |
5.10% |
cellular nitrogen compound catabolic process |
GO:0006112 |
5.10% |
energy reserve metabolic process |
GO:0009066 |
5.09% |
aspartate family amino acid metabolic process |
GO:0051246 |
5.08% |
regulation of protein metabolic process |
GO:0001101 |
5.08% |
response to acid chemical |
GO:0016485 |
5.07% |
protein processing |
GO:0008299 |
5.06% |
isoprenoid biosynthetic process |
GO:0048523 |
5.06% |
negative regulation of cellular process |
GO:0044106 |
5.05% |
cellular amine metabolic process |
GO:0022412 |
5.04% |
cellular process involved in reproduction in multicellular organism |
GO:0048589 |
5.03% |
developmental growth |
GO:0040007 |
5.02% |
growth |
GO:0032446 |
4.99% |
protein modification by small protein conjugation |
GO:2001141 |
4.99% |
regulation of RNA biosynthetic process |
GO:0006744 |
4.98% |
ubiquinone biosynthetic process |
GO:0046165 |
4.98% |
alcohol biosynthetic process |
GO:0071705 |
4.97% |
nitrogen compound transport |
GO:2000026 |
4.96% |
regulation of multicellular organismal development |
GO:0006397 |
4.96% |
mRNA processing |
GO:0006047 |
4.96% |
UDP-N-acetylglucosamine metabolic process |
GO:0016114 |
4.95% |
terpenoid biosynthetic process |
GO:1901663 |
4.95% |
quinone biosynthetic process |
GO:0018195 |
4.95% |
peptidyl-arginine modification |
GO:0048468 |
4.95% |
cell development |
GO:0009314 |
4.94% |
response to radiation |
GO:0007017 |
4.94% |
microtubule-based process |
GO:0009416 |
4.93% |
response to light stimulus |
GO:0046700 |
4.93% |
heterocycle catabolic process |
GO:0032268 |
4.92% |
regulation of cellular protein metabolic process |
GO:0009308 |
4.92% |
amine metabolic process |
GO:0048608 |
4.90% |
reproductive structure development |
GO:0043414 |
4.90% |
macromolecule methylation |
GO:0044272 |
4.90% |
sulfur compound biosynthetic process |
GO:0008380 |
4.89% |
RNA splicing |
GO:0042181 |
4.89% |
ketone biosynthetic process |
GO:0006325 |
4.89% |
chromatin organization |
GO:0006733 |
4.88% |
oxidoreduction coenzyme metabolic process |
GO:0033993 |
4.87% |
response to lipid |
GO:0000226 |
4.85% |
microtubule cytoskeleton organization |
GO:0001505 |
4.85% |
regulation of neurotransmitter levels |
GO:0007610 |
4.83% |
behavior |
GO:0003008 |
4.83% |
system process |
GO:1901698 |
4.83% |
response to nitrogen compound |
GO:0044087 |
4.83% |
regulation of cellular component biogenesis |
GO:0031325 |
4.82% |
positive regulation of cellular metabolic process |
GO:0000096 |
4.81% |
sulfur amino acid metabolic process |
GO:0046148 |
4.81% |
pigment biosynthetic process |
GO:0022900 |
4.80% |
electron transport chain |
GO:0070647 |
4.80% |
protein modification by small protein conjugation or removal |
GO:0009067 |
4.79% |
aspartate family amino acid biosynthetic process |
GO:0016049 |
4.78% |
cell growth |
GO:0006081 |
4.77% |
cellular aldehyde metabolic process |
GO:0006743 |
4.74% |
ubiquinone metabolic process |
GO:0034622 |
4.73% |
cellular protein-containing complex assembly |
GO:0009991 |
4.72% |
response to extracellular stimulus |
GO:0006955 |
4.72% |
immune response |
GO:0051604 |
4.71% |
protein maturation |
GO:0006400 |
4.71% |
tRNA modification |
GO:0098542 |
4.70% |
defense response to other organism |
GO:0051603 |
4.68% |
proteolysis involved in cellular protein catabolic process |
GO:0009555 |
4.67% |
pollen development |
GO:0006928 |
4.67% |
movement of cell or subcellular component |
GO:0035556 |
4.65% |
intracellular signal transduction |
GO:0009309 |
4.65% |
amine biosynthetic process |
GO:0051726 |
4.64% |
regulation of cell cycle |
GO:0010604 |
4.64% |
positive regulation of macromolecule metabolic process |
GO:0006487 |
4.63% |
protein N-linked glycosylation |
GO:0042133 |
4.63% |
neurotransmitter metabolic process |
GO:0007166 |
4.63% |
cell surface receptor signaling pathway |
GO:0006739 |
4.62% |
NADP metabolic process |
GO:0006974 |
4.62% |
cellular response to DNA damage stimulus |
GO:0042401 |
4.61% |
cellular biogenic amine biosynthetic process |
GO:0006979 |
4.61% |
response to oxidative stress |
GO:0006766 |
4.60% |
vitamin metabolic process |
GO:0002376 |
4.60% |
immune system process |
GO:0016311 |
4.59% |
dephosphorylation |
GO:0051321 |
4.59% |
meiotic cell cycle |
GO:0034248 |
4.59% |
regulation of cellular amide metabolic process |
GO:0060560 |
4.58% |
developmental growth involved in morphogenesis |
GO:0009790 |
4.58% |
embryo development |
GO:0006281 |
4.57% |
DNA repair |
GO:0010038 |
4.56% |
response to metal ion |
GO:0006536 |
4.54% |
glutamate metabolic process |
GO:0009826 |
4.54% |
unidimensional cell growth |
GO:0006644 |
4.54% |
phospholipid metabolic process |
GO:1903046 |
4.53% |
meiotic cell cycle process |
GO:0040008 |
4.52% |
regulation of growth |
GO:0010243 |
4.52% |
response to organonitrogen compound |
GO:0009617 |
4.52% |
response to bacterium |
GO:0006570 |
4.52% |
tyrosine metabolic process |
GO:0022904 |
4.51% |
respiratory electron transport chain |
GO:0022603 |
4.51% |
regulation of anatomical structure morphogenesis |
GO:0031667 |
4.51% |
response to nutrient levels |
GO:0009892 |
4.50% |
negative regulation of metabolic process |
GO:0032774 |
4.50% |
RNA biosynthetic process |
GO:0006767 |
4.50% |
water-soluble vitamin metabolic process |
GO:0009117 |
4.49% |
nucleotide metabolic process |
GO:0050877 |
4.49% |
nervous system process |
GO:0050667 |
4.49% |
homocysteine metabolic process |
GO:0070727 |
4.48% |
cellular macromolecule localization |
GO:0015833 |
4.48% |
peptide transport |
GO:0009074 |
4.48% |
aromatic amino acid family catabolic process |
GO:0016052 |
4.47% |
carbohydrate catabolic process |
GO:0072350 |
4.47% |
tricarboxylic acid metabolic process |
GO:0010628 |
4.47% |
positive regulation of gene expression |
GO:0061024 |
4.45% |
membrane organization |
GO:0051173 |
4.44% |
positive regulation of nitrogen compound metabolic process |
GO:0010605 |
4.44% |
negative regulation of macromolecule metabolic process |
GO:0016567 |
4.43% |
protein ubiquitination |
GO:0031328 |
4.42% |
positive regulation of cellular biosynthetic process |
GO:0006753 |
4.42% |
nucleoside phosphate metabolic process |
GO:0006760 |
4.41% |
folic acid-containing compound metabolic process |
GO:0044042 |
4.40% |
glucan metabolic process |
GO:0042440 |
4.40% |
pigment metabolic process |
GO:0040011 |
4.39% |
locomotion |
GO:0042558 |
4.39% |
pteridine-containing compound metabolic process |
GO:0006073 |
4.39% |
cellular glucan metabolic process |
GO:0009110 |
4.39% |
vitamin biosynthetic process |
GO:0042493 |
4.38% |
response to drug |
GO:0042364 |
4.38% |
water-soluble vitamin biosynthetic process |
GO:0014070 |
4.37% |
response to organic cyclic compound |
GO:0009791 |
4.37% |
post-embryonic development |
GO:0048731 |
4.37% |
system development |
GO:0043632 |
4.37% |
modification-dependent macromolecule catabolic process |
GO:0042742 |
4.36% |
defense response to bacterium |
GO:0006970 |
4.36% |
response to osmotic stress |
GO:0000910 |
4.36% |
cytokinesis |
GO:0009894 |
4.35% |
regulation of catabolic process |
GO:0019751 |
4.35% |
polyol metabolic process |
GO:0009081 |
4.35% |
branched-chain amino acid metabolic process |
GO:0023052 |
4.35% |
signaling |
GO:0008219 |
4.35% |
cell death |
GO:0019941 |
4.32% |
modification-dependent protein catabolic process |
GO:0042430 |
4.32% |
indole-containing compound metabolic process |
GO:0042886 |
4.32% |
amide transport |
GO:0009891 |
4.31% |
positive regulation of biosynthetic process |
GO:0032879 |
4.31% |
regulation of localization |
GO:0097305 |
4.31% |
response to alcohol |
GO:0061982 |
4.30% |
meiosis I cell cycle process |
GO:0000904 |
4.30% |
cell morphogenesis involved in differentiation |
GO:0030030 |
4.29% |
cell projection organization |
GO:0033043 |
4.28% |
regulation of organelle organization |
GO:0048229 |
4.28% |
gametophyte development |
GO:0034613 |
4.28% |
cellular protein localization |
GO:0045184 |
4.28% |
establishment of protein localization |
GO:0006417 |
4.27% |
regulation of translation |
GO:0009266 |
4.27% |
response to temperature stimulus |
GO:0016569 |
4.26% |
covalent chromatin modification |
GO:0015031 |
4.25% |
protein transport |
GO:0006740 |
4.25% |
NADPH regeneration |
GO:0043161 |
4.25% |
proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:0008654 |
4.24% |
phospholipid biosynthetic process |
GO:0006109 |
4.24% |
regulation of carbohydrate metabolic process |
GO:0051094 |
4.24% |
positive regulation of developmental process |
GO:0046173 |
4.22% |
polyol biosynthetic process |
GO:0007005 |
4.22% |
mitochondrion organization |
GO:0048511 |
4.22% |
rhythmic process |
GO:0050790 |
4.20% |
regulation of catalytic activity |
GO:0031329 |
4.20% |
regulation of cellular catabolic process |
GO:0006120 |
4.20% |
mitochondrial electron transport, NADH to ubiquinone |
GO:0051156 |
4.19% |
glucose 6-phosphate metabolic process |
GO:0006413 |
4.19% |
translational initiation |
GO:0070925 |
4.19% |
organelle assembly |
GO:0045595 |
4.18% |
regulation of cell differentiation |
GO:0046903 |
4.18% |
secretion |
GO:0046907 |
4.17% |
intracellular transport |
GO:0005977 |
4.17% |
glycogen metabolic process |
GO:0010498 |
4.14% |
proteasomal protein catabolic process |
GO:0045087 |
4.14% |
innate immune response |
GO:0016570 |
4.11% |
histone modification |
GO:0010675 |
4.09% |
regulation of cellular carbohydrate metabolic process |
GO:0010646 |
4.09% |
regulation of cell communication |
GO:0046777 |
4.08% |
protein autophosphorylation |
GO:0042737 |
4.08% |
drug catabolic process |
GO:1901661 |
4.08% |
quinone metabolic process |
GO:0012501 |
4.08% |
programmed cell death |
GO:0006006 |
4.07% |
glucose metabolic process |
GO:0009084 |
4.07% |
glutamine family amino acid biosynthetic process |
GO:0006414 |
4.07% |
translational elongation |
GO:0071310 |
4.06% |
cellular response to organic substance |
GO:0007267 |
4.06% |
cell-cell signaling |
GO:0065009 |
4.05% |
regulation of molecular function |
GO:0010906 |
4.04% |
regulation of glucose metabolic process |
GO:0010629 |
4.04% |
negative regulation of gene expression |
GO:0006099 |
4.03% |
tricarboxylic acid cycle |
GO:0042136 |
4.02% |
neurotransmitter biosynthetic process |
GO:0023051 |
4.02% |
regulation of signaling |
GO:0009636 |
4.01% |
response to toxic substance |
GO:0006470 |
4.00% |
protein dephosphorylation |
GO:0010257 |
3.99% |
NADH dehydrogenase complex assembly |
GO:0006558 |
3.98% |
L-phenylalanine metabolic process |
GO:0007281 |
3.98% |
germ cell development |
GO:0009073 |
3.98% |
aromatic amino acid family biosynthetic process |
GO:0006595 |
3.97% |
polyamine metabolic process |
GO:0015931 |
3.97% |
nucleobase-containing compound transport |
GO:0000963 |
3.96% |
mitochondrial RNA processing |
GO:0050658 |
3.96% |
RNA transport |
GO:0009737 |
3.96% |
response to abscisic acid |
GO:0032981 |
3.96% |
mitochondrial respiratory chain complex I assembly |
GO:1902221 |
3.95% |
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process |
GO:0005976 |
3.95% |
polysaccharide metabolic process |
GO:0002183 |
3.94% |
cytoplasmic translational initiation |
GO:0043067 |
3.93% |
regulation of programmed cell death |
GO:1901071 |
3.92% |
glucosamine-containing compound metabolic process |
GO:0048870 |
3.91% |
cell motility |
GO:0140053 |
3.91% |
mitochondrial gene expression |
GO:0044264 |
3.91% |
cellular polysaccharide metabolic process |
GO:0006596 |
3.90% |
polyamine biosynthetic process |
GO:0009065 |
3.90% |
glutamine family amino acid catabolic process |
GO:0006551 |
3.89% |
leucine metabolic process |
GO:0006534 |
3.88% |
cysteine metabolic process |
GO:0018209 |
3.88% |
peptidyl-serine modification |
GO:0051236 |
3.85% |
establishment of RNA localization |
GO:0006643 |
3.85% |
membrane lipid metabolic process |
GO:0071496 |
3.84% |
cellular response to external stimulus |
GO:0048638 |
3.84% |
regulation of developmental growth |
GO:0010557 |
3.84% |
positive regulation of macromolecule biosynthetic process |
GO:0051130 |
3.84% |
positive regulation of cellular component organization |
GO:0031668 |
3.83% |
cellular response to extracellular stimulus |
GO:0050657 |
3.83% |
nucleic acid transport |
GO:0006493 |
3.82% |
protein O-linked glycosylation |
GO:0006805 |
3.82% |
xenobiotic metabolic process |
GO:0071941 |
3.81% |
nitrogen cycle metabolic process |
GO:0000377 |
3.80% |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
GO:0006479 |
3.80% |
protein methylation |
GO:0008213 |
3.80% |
protein alkylation |
GO:0000375 |
3.80% |
RNA splicing, via transesterification reactions |
GO:0099120 |
3.79% |
socially cooperative development |
GO:0097435 |
3.79% |
supramolecular fiber organization |
GO:0090567 |
3.79% |
reproductive shoot system development |
GO:0006909 |
3.79% |
phagocytosis |
GO:0120036 |
3.79% |
plasma membrane bounded cell projection organization |
GO:1990830 |
3.79% |
cellular response to leukemia inhibitory factor |
GO:0043647 |
3.78% |
inositol phosphate metabolic process |
GO:0009408 |
3.78% |
response to heat |
GO:0016051 |
3.78% |
carbohydrate biosynthetic process |
GO:0042981 |
3.78% |
regulation of apoptotic process |
GO:0006730 |
3.77% |
one-carbon metabolic process |
GO:0051049 |
3.77% |
regulation of transport |
GO:0006401 |
3.77% |
RNA catabolic process |
GO:0006525 |
3.76% |
arginine metabolic process |
GO:0048588 |
3.75% |
developmental cell growth |
GO:0140352 |
3.75% |
export from cell |
GO:0009888 |
3.74% |
tissue development |
GO:0031669 |
3.73% |
cellular response to nutrient levels |
GO:0051276 |
3.73% |
chromosome organization |
GO:0031123 |
3.72% |
RNA 3'-end processing |
GO:0033108 |
3.72% |
mitochondrial respiratory chain complex assembly |
GO:0044273 |
3.71% |
sulfur compound catabolic process |
GO:0009966 |
3.70% |
regulation of signal transduction |
GO:0001539 |
3.70% |
cilium or flagellum-dependent cell motility |
GO:0006108 |
3.70% |
malate metabolic process |
GO:0072521 |
3.70% |
purine-containing compound metabolic process |
GO:0006457 |
3.69% |
protein folding |
GO:0018958 |
3.69% |
phenol-containing compound metabolic process |
GO:0006511 |
3.69% |
ubiquitin-dependent protein catabolic process |
GO:0031324 |
3.69% |
negative regulation of cellular metabolic process |
GO:0034599 |
3.68% |
cellular response to oxidative stress |
GO:0051253 |
3.68% |
negative regulation of RNA metabolic process |
GO:0009792 |
3.67% |
embryo development ending in birth or egg hatching |
GO:0009651 |
3.67% |
response to salt stress |
GO:0009311 |
3.67% |
oligosaccharide metabolic process |
GO:0051172 |
3.67% |
negative regulation of nitrogen compound metabolic process |
GO:0022604 |
3.67% |
regulation of cell morphogenesis |
GO:0051240 |
3.66% |
positive regulation of multicellular organismal process |
GO:0007274 |
3.66% |
neuromuscular synaptic transmission |
GO:0006002 |
3.65% |
fructose 6-phosphate metabolic process |
GO:0006555 |
3.64% |
methionine metabolic process |
GO:0030435 |
3.64% |
sporulation resulting in formation of a cellular spore |
GO:0006260 |
3.64% |
DNA replication |
GO:0009812 |
3.63% |
flavonoid metabolic process |
GO:0006357 |
3.63% |
regulation of transcription by RNA polymerase II |
GO:0022411 |
3.63% |
cellular component disassembly |
GO:0043255 |
3.63% |
regulation of carbohydrate biosynthetic process |
GO:0080135 |
3.63% |
regulation of cellular response to stress |
GO:0043062 |
3.62% |
extracellular structure organization |
GO:0007623 |
3.62% |
circadian rhythm |
GO:0042559 |
3.62% |
pteridine-containing compound biosynthetic process |
GO:1990823 |
3.62% |
response to leukemia inhibitory factor |
GO:0046486 |
3.62% |
glycerolipid metabolic process |
GO:0006650 |
3.62% |
glycerophospholipid metabolic process |
GO:0032940 |
3.62% |
secretion by cell |
GO:0007051 |
3.61% |
spindle organization |
GO:0018205 |
3.61% |
peptidyl-lysine modification |
GO:0007292 |
3.61% |
female gamete generation |
GO:0051703 |
3.61% |
intraspecies interaction between organisms |
GO:0051301 |
3.61% |
cell division |
GO:0010927 |
3.60% |
cellular component assembly involved in morphogenesis |
GO:0045333 |
3.60% |
cellular respiration |
GO:0042594 |
3.60% |
response to starvation |
GO:0045935 |
3.59% |
positive regulation of nucleobase-containing compound metabolic process |
GO:0043094 |
3.59% |
cellular metabolic compound salvage |
GO:0009404 |
3.59% |
toxin metabolic process |
GO:0006405 |
3.59% |
RNA export from nucleus |
GO:0060285 |
3.58% |
cilium-dependent cell motility |
GO:0046467 |
3.58% |
membrane lipid biosynthetic process |
GO:0009860 |
3.57% |
pollen tube growth |
GO:0045934 |
3.56% |
negative regulation of nucleobase-containing compound metabolic process |
GO:0006568 |
3.56% |
tryptophan metabolic process |
GO:0021700 |
3.56% |
developmental maturation |
GO:0009932 |
3.56% |
cell tip growth |
GO:0030198 |
3.56% |
extracellular matrix organization |
GO:0006302 |
3.56% |
double-strand break repair |
GO:0006591 |
3.55% |
ornithine metabolic process |
GO:0009743 |
3.55% |
response to carbohydrate |
GO:0022618 |
3.54% |
ribonucleoprotein complex assembly |
GO:0002682 |
3.54% |
regulation of immune system process |
GO:0010467 |
3.54% |
gene expression |
GO:0006633 |
3.54% |
fatty acid biosynthetic process |
GO:0007030 |
3.54% |
Golgi organization |
GO:0071826 |
3.54% |
ribonucleoprotein complex subunit organization |
GO:0032101 |
3.54% |
regulation of response to external stimulus |
GO:0033365 |
3.53% |
protein localization to organelle |
GO:0031347 |
3.53% |
regulation of defense response |
GO:0009082 |
3.53% |
branched-chain amino acid biosynthetic process |
GO:0042537 |
3.53% |
benzene-containing compound metabolic process |
GO:0000398 |
3.53% |
mRNA splicing, via spliceosome |
GO:0044764 |
3.53% |
multi-organism cellular process |
GO:0034637 |
3.53% |
cellular carbohydrate biosynthetic process |
GO:0046365 |
3.52% |
monosaccharide catabolic process |
GO:0051259 |
3.52% |
protein complex oligomerization |
GO:0008340 |
3.52% |
determination of adult lifespan |
GO:0006306 |
3.51% |
DNA methylation |
GO:0006304 |
3.51% |
DNA modification |
GO:0009069 |
3.51% |
serine family amino acid metabolic process |
GO:0061640 |
3.51% |
cytoskeleton-dependent cytokinesis |
GO:0016072 |
3.51% |
rRNA metabolic process |
GO:0042127 |
3.51% |
regulation of cell population proliferation |
GO:0009086 |
3.50% |
methionine biosynthetic process |
GO:0006364 |
3.50% |
rRNA processing |
GO:0018105 |
3.48% |
peptidyl-serine phosphorylation |
GO:0043900 |
3.48% |
regulation of multi-organism process |
GO:0034097 |
3.48% |
response to cytokine |
GO:1901701 |
3.48% |
cellular response to oxygen-containing compound |
GO:0043934 |
3.47% |
sporulation |
GO:0009698 |
3.47% |
phenylpropanoid metabolic process |
GO:0000097 |
3.47% |
sulfur amino acid biosynthetic process |
GO:0009396 |
3.47% |
folic acid-containing compound biosynthetic process |
GO:2001057 |
3.46% |
reactive nitrogen species metabolic process |
GO:0006586 |
3.46% |
indolalkylamine metabolic process |
GO:0048477 |
3.46% |
oogenesis |
GO:0019725 |
3.45% |
cellular homeostasis |
GO:0006305 |
3.45% |
DNA alkylation |
GO:0000302 |
3.45% |
response to reactive oxygen species |
GO:1902652 |
3.45% |
secondary alcohol metabolic process |
GO:0046034 |
3.44% |
ATP metabolic process |
GO:0043650 |
3.44% |
dicarboxylic acid biosynthetic process |
GO:1901293 |
3.44% |
nucleoside phosphate biosynthetic process |
GO:0060627 |
3.44% |
regulation of vesicle-mediated transport |
GO:0009165 |
3.43% |
nucleotide biosynthetic process |
GO:0009746 |
3.43% |
response to hexose |
GO:0006351 |
3.43% |
transcription, DNA-templated |
GO:2000241 |
3.43% |
regulation of reproductive process |
GO:0034284 |
3.42% |
response to monosaccharide |
GO:0048367 |
3.42% |
shoot system development |
GO:0006665 |
3.42% |
sphingolipid metabolic process |
GO:0006338 |
3.42% |
chromatin remodeling |
GO:0032990 |
3.42% |
cell part morphogenesis |
GO:0070482 |
3.41% |
response to oxygen levels |
GO:0046677 |
3.41% |
response to antibiotic |
GO:1903047 |
3.41% |
mitotic cell cycle process |
GO:0009100 |
3.41% |
glycoprotein metabolic process |
GO:0048729 |
3.41% |
tissue morphogenesis |
GO:0031175 |
3.41% |
neuron projection development |
GO:0051247 |
3.40% |
positive regulation of protein metabolic process |
GO:0008283 |
3.39% |
cell population proliferation |
GO:0060284 |
3.39% |
regulation of cell development |
GO:0009415 |
3.38% |
response to water |
GO:0010564 |
3.38% |
regulation of cell cycle process |
GO:0097659 |
3.37% |
nucleic acid-templated transcription |
GO:0009908 |
3.36% |
flower development |
GO:0034976 |
3.36% |
response to endoplasmic reticulum stress |
GO:0050776 |
3.36% |
regulation of immune response |
GO:0005984 |
3.36% |
disaccharide metabolic process |
GO:0010224 |
3.35% |
response to UV-B |
GO:0007420 |
3.35% |
brain development |
GO:0033013 |
3.35% |
tetrapyrrole metabolic process |
GO:0032270 |
3.35% |
positive regulation of cellular protein metabolic process |
GO:0030855 |
3.35% |
epithelial cell differentiation |
GO:0051028 |
3.35% |
mRNA transport |
GO:0016458 |
3.34% |
gene silencing |
GO:0071695 |
3.34% |
anatomical structure maturation |
GO:0006915 |
3.34% |
apoptotic process |
GO:0034728 |
3.34% |
nucleosome organization |
GO:0022610 |
3.34% |
biological adhesion |
GO:0043085 |
3.34% |
positive regulation of catalytic activity |
GO:0051960 |
3.33% |
regulation of nervous system development |
GO:0009267 |
3.33% |
cellular response to starvation |
GO:0046653 |
3.33% |
tetrahydrofolate metabolic process |
GO:2000765 |
3.33% |
regulation of cytoplasmic translation |
GO:0031047 |
3.32% |
gene silencing by RNA |
GO:0019321 |
3.32% |
pentose metabolic process |
GO:0009896 |
3.31% |
positive regulation of catabolic process |
GO:0048193 |
3.30% |
Golgi vesicle transport |
GO:1901657 |
3.30% |
glycosyl compound metabolic process |
GO:0090305 |
3.30% |
nucleic acid phosphodiester bond hydrolysis |
GO:0072657 |
3.30% |
protein localization to membrane |
GO:0050829 |
3.29% |
defense response to Gram-negative bacterium |
GO:0001701 |
3.29% |
in utero embryonic development |
GO:0051168 |
3.29% |
nuclear export |
GO:0010638 |
3.29% |
positive regulation of organelle organization |
GO:0006310 |
3.28% |
DNA recombination |
GO:0009753 |
3.28% |
response to jasmonic acid |
GO:0044703 |
3.28% |
multi-organism reproductive process |
GO:0051254 |
3.28% |
positive regulation of RNA metabolic process |
GO:0023056 |
3.28% |
positive regulation of signaling |
GO:0044728 |
3.27% |
DNA methylation or demethylation |
GO:0010647 |
3.27% |
positive regulation of cell communication |
GO:0006020 |
3.26% |
inositol metabolic process |
GO:0009310 |
3.26% |
amine catabolic process |
GO:0006886 |
3.26% |
intracellular protein transport |
GO:0097722 |
3.26% |
sperm motility |
GO:0051592 |
3.26% |
response to calcium ion |
GO:0034655 |
3.26% |
nucleobase-containing compound catabolic process |
GO:0002697 |
3.26% |
regulation of immune effector process |
GO:0051341 |
3.24% |
regulation of oxidoreductase activity |
GO:0015979 |
3.24% |
photosynthesis |
GO:0042435 |
3.24% |
indole-containing compound biosynthetic process |
GO:0007169 |
3.24% |
transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0007626 |
3.23% |
locomotory behavior |
GO:0007389 |
3.22% |
pattern specification process |
GO:0043009 |
3.22% |
chordate embryonic development |
GO:0070192 |
3.22% |
chromosome organization involved in meiotic cell cycle |
GO:0009850 |
3.22% |
auxin metabolic process |
GO:0071345 |
3.21% |
cellular response to cytokine stimulus |
GO:0090702 |
3.20% |
non-reproductive fruiting body development |
GO:0099536 |
3.20% |
synaptic signaling |
GO:0035999 |
3.19% |
tetrahydrofolate interconversion |
GO:0048585 |
3.19% |
negative regulation of response to stimulus |
GO:0010558 |
3.19% |
negative regulation of macromolecule biosynthetic process |
GO:0009312 |
3.19% |
oligosaccharide biosynthetic process |
GO:0052803 |
3.19% |
imidazole-containing compound metabolic process |
GO:0009247 |
3.19% |
glycolipid biosynthetic process |
GO:0007268 |
3.18% |
chemical synaptic transmission |
GO:0043687 |
3.18% |
post-translational protein modification |
GO:0019320 |
3.18% |
hexose catabolic process |
GO:0033044 |
3.18% |
regulation of chromosome organization |
GO:0018410 |
3.18% |
C-terminal protein amino acid modification |
GO:0009699 |
3.18% |
phenylpropanoid biosynthetic process |
GO:0001510 |
3.17% |
RNA methylation |
GO:0042402 |
3.17% |
cellular biogenic amine catabolic process |
GO:0006012 |
3.17% |
galactose metabolic process |
GO:0009410 |
3.17% |
response to xenobiotic stimulus |
GO:0006090 |
3.17% |
pyruvate metabolic process |
GO:0007411 |
3.17% |
axon guidance |
GO:0034227 |
3.16% |
tRNA thio-modification |
GO:0006471 |
3.16% |
protein ADP-ribosylation |
GO:0006163 |
3.16% |
purine nucleotide metabolic process |
GO:0007155 |
3.16% |
cell adhesion |
GO:0006734 |
3.16% |
NADH metabolic process |
GO:2000113 |
3.15% |
negative regulation of cellular macromolecule biosynthetic process |
GO:0009890 |
3.15% |
negative regulation of biosynthetic process |
GO:0008202 |
3.15% |
steroid metabolic process |
GO:0030317 |
3.14% |
flagellated sperm motility |
GO:0009749 |
3.14% |
response to glucose |
GO:0009414 |
3.14% |
response to water deprivation |
GO:0009250 |
3.14% |
glucan biosynthetic process |
GO:0031331 |
3.13% |
positive regulation of cellular catabolic process |
GO:0006972 |
3.13% |
hyperosmotic response |
GO:0098916 |
3.13% |
anterograde trans-synaptic signaling |
GO:0001666 |
3.13% |
response to hypoxia |
GO:0019693 |
3.13% |
ribose phosphate metabolic process |
GO:0046474 |
3.13% |
glycerophospholipid biosynthetic process |
GO:0099537 |
3.12% |
trans-synaptic signaling |
GO:0006577 |
3.12% |
amino-acid betaine metabolic process |
GO:0030587 |
3.12% |
sorocarp development |
GO:0045893 |
3.11% |
positive regulation of transcription, DNA-templated |
GO:0007568 |
3.11% |
aging |
GO:0051260 |
3.11% |
protein homooligomerization |
GO:0048580 |
3.11% |
regulation of post-embryonic development |
GO:0072524 |
3.11% |
pyridine-containing compound metabolic process |
GO:0051093 |
3.11% |
negative regulation of developmental process |
GO:0050890 |
3.11% |
cognition |
GO:0030097 |
3.11% |
hemopoiesis |
GO:0007600 |
3.10% |
sensory perception |
GO:0009411 |
3.10% |
response to UV |
GO:0045017 |
3.10% |
glycerolipid biosynthetic process |
GO:0006778 |
3.09% |
porphyrin-containing compound metabolic process |
GO:0006000 |
3.09% |
fructose metabolic process |
GO:2000243 |
3.09% |
positive regulation of reproductive process |
GO:0019220 |
3.09% |
regulation of phosphate metabolic process |
GO:0032870 |
3.09% |
cellular response to hormone stimulus |
GO:0006491 |
3.09% |
N-glycan processing |
GO:0043467 |
3.08% |
regulation of generation of precursor metabolites and energy |
GO:0007167 |
3.08% |
enzyme linked receptor protein signaling pathway |
GO:0051174 |
3.08% |
regulation of phosphorus metabolic process |
GO:0007584 |
3.07% |
response to nutrient |
GO:0097485 |
3.07% |
neuron projection guidance |
GO:0007611 |
3.07% |
learning or memory |
GO:1902679 |
3.07% |
negative regulation of RNA biosynthetic process |
GO:0019098 |
3.07% |
reproductive behavior |
GO:1903507 |
3.06% |
negative regulation of nucleic acid-templated transcription |
GO:0044093 |
3.06% |
positive regulation of molecular function |
GO:0045597 |
3.06% |
positive regulation of cell differentiation |
GO:0044085 |
3.06% |
cellular component biogenesis |
GO:0018126 |
3.05% |
protein hydroxylation |
GO:0042168 |
3.05% |
heme metabolic process |
GO:0009887 |
3.05% |
animal organ morphogenesis |
GO:0006406 |
3.05% |
mRNA export from nucleus |
GO:0043254 |
3.05% |
regulation of protein complex assembly |
GO:0031327 |
3.05% |
negative regulation of cellular biosynthetic process |
GO:0036293 |
3.04% |
response to decreased oxygen levels |
GO:0035239 |
3.04% |
tube morphogenesis |
GO:0006694 |
3.04% |
steroid biosynthetic process |
GO:0098754 |
3.04% |
detoxification |
GO:0009755 |
3.04% |
hormone-mediated signaling pathway |
GO:0071824 |
3.04% |
protein-DNA complex subunit organization |
GO:0044089 |
3.04% |
positive regulation of cellular component biogenesis |
GO:0007346 |
3.04% |
regulation of mitotic cell cycle |
GO:0002831 |
3.03% |
regulation of response to biotic stimulus |
GO:0002097 |
3.03% |
tRNA wobble base modification |
GO:0006402 |
3.03% |
mRNA catabolic process |
GO:0009060 |
3.03% |
aerobic respiration |
GO:0006261 |
3.03% |
DNA-dependent DNA replication |
GO:0032881 |
3.03% |
regulation of polysaccharide metabolic process |
GO:1902680 |
3.02% |
positive regulation of RNA biosynthetic process |
GO:0043434 |
3.02% |
response to peptide hormone |
GO:0043543 |
3.02% |
protein acylation |
GO:0006089 |
3.02% |
lactate metabolic process |
GO:1903508 |
3.02% |
positive regulation of nucleic acid-templated transcription |
GO:0022613 |
3.02% |
ribonucleoprotein complex biogenesis |
GO:0051050 |
3.01% |
positive regulation of transport |
GO:0045786 |
3.01% |
negative regulation of cell cycle |
GO:0001558 |
3.01% |
regulation of cell growth |
GO:0000003 |
3.01% |
reproduction |
GO:1901652 |
3.01% |
response to peptide |
GO:0050808 |
3.00% |
synapse organization |
GO:0044706 |
3.00% |
multi-multicellular organism process |
GO:0009070 |
3.00% |
serine family amino acid biosynthetic process |
GO:0051640 |
3.00% |
organelle localization |
GO:0046209 |
2.99% |
nitric oxide metabolic process |
GO:0002119 |
2.99% |
nematode larval development |
GO:0023014 |
2.98% |
signal transduction by protein phosphorylation |
GO:0031099 |
2.98% |
regeneration |
GO:0016226 |
2.98% |
iron-sulfur cluster assembly |
GO:0042128 |
2.98% |
nitrate assimilation |
GO:0099402 |
2.97% |
plant organ development |
GO:0008360 |
2.97% |
regulation of cell shape |
GO:0045892 |
2.97% |
negative regulation of transcription, DNA-templated |
GO:0009083 |
2.97% |
branched-chain amino acid catabolic process |
GO:0046189 |
2.97% |
phenol-containing compound biosynthetic process |
GO:0031503 |
2.97% |
protein-containing complex localization |
GO:0002009 |
2.97% |
morphogenesis of an epithelium |
GO:0090501 |
2.96% |
RNA phosphodiester bond hydrolysis |
GO:0050778 |
2.96% |
positive regulation of immune response |
GO:0023061 |
2.96% |
signal release |
GO:0045229 |
2.96% |
external encapsulating structure organization |
GO:0006111 |
2.95% |
regulation of gluconeogenesis |
GO:0006749 |
2.95% |
glutathione metabolic process |
GO:0000271 |
2.95% |
polysaccharide biosynthetic process |
GO:0006573 |
2.95% |
valine metabolic process |
GO:0016477 |
2.95% |
cell migration |
GO:0000278 |
2.94% |
mitotic cell cycle |
GO:0050801 |
2.94% |
ion homeostasis |
GO:1900864 |
2.94% |
mitochondrial RNA modification |
GO:0008344 |
2.94% |
adult locomotory behavior |
GO:0033692 |
2.94% |
cellular polysaccharide biosynthetic process |
GO:0034661 |
2.94% |
ncRNA catabolic process |
GO:0002098 |
2.93% |
tRNA wobble uridine modification |
GO:0009793 |
2.93% |
embryo development ending in seed dormancy |
GO:0071554 |
2.93% |
cell wall organization or biogenesis |
GO:0031163 |
2.92% |
metallo-sulfur cluster assembly |
GO:0071241 |
2.92% |
cellular response to inorganic substance |
GO:0071396 |
2.92% |
cellular response to lipid |
GO:0002164 |
2.91% |
larval development |
GO:0009658 |
2.91% |
chloroplast organization |
GO:0071229 |
2.91% |
cellular response to acid chemical |
GO:0009657 |
2.91% |
plastid organization |
GO:0090693 |
2.91% |
plant organ senescence |
GO:0042126 |
2.90% |
nitrate metabolic process |
GO:0009886 |
2.90% |
post-embryonic animal morphogenesis |
GO:0072525 |
2.90% |
pyridine-containing compound biosynthetic process |
GO:0016036 |
2.90% |
cellular response to phosphate starvation |
GO:0046885 |
2.90% |
regulation of hormone biosynthetic process |
GO:0048598 |
2.89% |
embryonic morphogenesis |
GO:0016032 |
2.89% |
viral process |
GO:0018212 |
2.89% |
peptidyl-tyrosine modification |
GO:0072347 |
2.89% |
response to anesthetic |
GO:0032922 |
2.88% |
circadian regulation of gene expression |
GO:0009733 |
2.88% |
response to auxin |
GO:0007417 |
2.88% |
central nervous system development |
GO:0030036 |
2.88% |
actin cytoskeleton organization |
GO:0007399 |
2.88% |
nervous system development |
GO:0045927 |
2.87% |
positive regulation of growth |
GO:0044403 |
2.87% |
symbiotic process |
GO:0031638 |
2.87% |
zymogen activation |
GO:0071555 |
2.86% |
cell wall organization |
GO:0031399 |
2.86% |
regulation of protein modification process |
GO:0008285 |
2.86% |
negative regulation of cell population proliferation |
GO:0042254 |
2.85% |
ribosome biogenesis |
GO:0006547 |
2.85% |
histidine metabolic process |
GO:0010506 |
2.85% |
regulation of autophagy |
GO:0043044 |
2.85% |
ATP-dependent chromatin remodeling |
GO:0031100 |
2.84% |
animal organ regeneration |
GO:0060341 |
2.84% |
regulation of cellular localization |
GO:0032880 |
2.84% |
regulation of protein localization |
GO:0070873 |
2.84% |
regulation of glycogen metabolic process |
GO:1990778 |
2.84% |
protein localization to cell periphery |
GO:0044782 |
2.84% |
cilium organization |
GO:1901659 |
2.84% |
glycosyl compound biosynthetic process |
GO:0043068 |
2.83% |
positive regulation of programmed cell death |
GO:0006913 |
2.83% |
nucleocytoplasmic transport |
GO:0051187 |
2.83% |
cofactor catabolic process |
GO:0042325 |
2.82% |
regulation of phosphorylation |
GO:1902115 |
2.82% |
regulation of organelle assembly |
GO:0051493 |
2.82% |
regulation of cytoskeleton organization |
GO:0046890 |
2.82% |
regulation of lipid biosynthetic process |
GO:0000165 |
2.82% |
MAPK cascade |
GO:0009259 |
2.82% |
ribonucleotide metabolic process |
GO:0001525 |
2.81% |
angiogenesis |
GO:0048831 |
2.81% |
regulation of shoot system development |
GO:0061061 |
2.81% |
muscle structure development |
GO:0001522 |
2.81% |
pseudouridine synthesis |
GO:0006473 |
2.81% |
protein acetylation |
GO:1902850 |
2.80% |
microtubule cytoskeleton organization involved in mitosis |
GO:0009967 |
2.80% |
positive regulation of signal transduction |
GO:0046500 |
2.80% |
S-adenosylmethionine metabolic process |
GO:0043069 |
2.79% |
negative regulation of programmed cell death |
GO:0007018 |
2.79% |
microtubule-based movement |
GO:0042330 |
2.79% |
taxis |
GO:0010565 |
2.79% |
regulation of cellular ketone metabolic process |
GO:0009914 |
2.79% |
hormone transport |
GO:0050767 |
2.79% |
regulation of neurogenesis |
GO:0034250 |
2.79% |
positive regulation of cellular amide metabolic process |
GO:0016125 |
2.78% |
sterol metabolic process |
GO:0006526 |
2.78% |
arginine biosynthetic process |
GO:0010150 |
2.78% |
leaf senescence |
GO:0030162 |
2.78% |
regulation of proteolysis |
GO:0019674 |
2.78% |
NAD metabolic process |
GO:0016126 |
2.77% |
sterol biosynthetic process |
GO:0008406 |
2.77% |
gonad development |
GO:0043486 |
2.77% |
histone exchange |
GO:0060548 |
2.77% |
negative regulation of cell death |
GO:0006664 |
2.77% |
glycolipid metabolic process |
GO:0000272 |
2.77% |
polysaccharide catabolic process |
GO:0006103 |
2.77% |
2-oxoglutarate metabolic process |
GO:0072594 |
2.76% |
establishment of protein localization to organelle |
GO:0000281 |
2.76% |
mitotic cytokinesis |
GO:0034754 |
2.76% |
cellular hormone metabolic process |
GO:0019216 |
2.76% |
regulation of lipid metabolic process |
GO:0055082 |
2.75% |
cellular chemical homeostasis |
GO:0006672 |
2.75% |
ceramide metabolic process |
GO:0055076 |
2.75% |
transition metal ion homeostasis |
GO:0051129 |
2.74% |
negative regulation of cellular component organization |
GO:0060271 |
2.74% |
cilium assembly |
GO:0009409 |
2.74% |
response to cold |
GO:0009615 |
2.73% |
response to virus |
GO:0043171 |
2.73% |
peptide catabolic process |
GO:0051169 |
2.73% |
nuclear transport |
GO:0043628 |
2.73% |
ncRNA 3'-end processing |
GO:0009566 |
2.72% |
fertilization |
GO:0005978 |
2.72% |
glycogen biosynthetic process |
GO:0007617 |
2.72% |
mating behavior |
GO:0048812 |
2.72% |
neuron projection morphogenesis |
GO:0009855 |
2.72% |
determination of bilateral symmetry |
GO:0071248 |
2.71% |
cellular response to metal ion |
GO:0009799 |
2.71% |
specification of symmetry |
GO:0016973 |
2.71% |
poly(A)+ mRNA export from nucleus |
GO:0032386 |
2.71% |
regulation of intracellular transport |
GO:0043066 |
2.71% |
negative regulation of apoptotic process |
GO:0032107 |
2.70% |
regulation of response to nutrient levels |
GO:0098771 |
2.70% |
inorganic ion homeostasis |
GO:0007052 |
2.70% |
mitotic spindle organization |
GO:0120039 |
2.70% |
plasma membrane bounded cell projection morphogenesis |
GO:0048534 |
2.69% |
hematopoietic or lymphoid organ development |
GO:0044092 |
2.69% |
negative regulation of molecular function |
GO:0048858 |
2.68% |
cell projection morphogenesis |
GO:0051241 |
2.68% |
negative regulation of multicellular organismal process |
GO:0072527 |
2.68% |
pyrimidine-containing compound metabolic process |
GO:0006811 |
2.68% |
ion transport |
GO:0044057 |
2.68% |
regulation of system process |
GO:0046655 |
2.67% |
folic acid metabolic process |
GO:0046364 |
2.67% |
monosaccharide biosynthetic process |
GO:0007349 |
2.67% |
cellularization |
GO:0033014 |
2.67% |
tetrapyrrole biosynthetic process |
GO:0007131 |
2.67% |
reciprocal meiotic recombination |
GO:0023057 |
2.66% |
negative regulation of signaling |
GO:0040029 |
2.66% |
regulation of gene expression, epigenetic |
GO:0018202 |
2.66% |
peptidyl-histidine modification |
GO:0044275 |
2.66% |
cellular carbohydrate catabolic process |
GO:0030182 |
2.66% |
neuron differentiation |
GO:0051649 |
2.66% |
establishment of localization in cell |
GO:0043065 |
2.65% |
positive regulation of apoptotic process |
GO:0090502 |
2.65% |
RNA phosphodiester bond hydrolysis, endonucleolytic |
GO:0006482 |
2.65% |
protein demethylation |
GO:1902369 |
2.65% |
negative regulation of RNA catabolic process |
GO:0072528 |
2.65% |
pyrimidine-containing compound biosynthetic process |
GO:0051235 |
2.64% |
maintenance of location |
GO:0035082 |
2.64% |
axoneme assembly |
GO:0048509 |
2.64% |
regulation of meristem development |
GO:0003012 |
2.64% |
muscle system process |
GO:0055072 |
2.64% |
iron ion homeostasis |
GO:0009150 |
2.63% |
purine ribonucleotide metabolic process |
GO:0010821 |
2.63% |
regulation of mitochondrion organization |
GO:0044419 |
2.63% |
interspecies interaction between organisms |
GO:0018394 |
2.63% |
peptidyl-lysine acetylation |
GO:0018196 |
2.63% |
peptidyl-asparagine modification |
GO:0007368 |
2.63% |
determination of left/right symmetry |
GO:0035825 |
2.63% |
homologous recombination |
GO:0071897 |
2.63% |
DNA biosynthetic process |
GO:0016101 |
2.63% |
diterpenoid metabolic process |
GO:0030148 |
2.63% |
sphingolipid biosynthetic process |
GO:0006360 |
2.62% |
transcription by RNA polymerase I |
GO:0070201 |
2.62% |
regulation of establishment of protein localization |
GO:0030534 |
2.62% |
adult behavior |
GO:1902653 |
2.62% |
secondary alcohol biosynthetic process |
GO:0005985 |
2.62% |
sucrose metabolic process |
GO:1901214 |
2.62% |
regulation of neuron death |
GO:0032350 |
2.62% |
regulation of hormone metabolic process |
GO:0002684 |
2.62% |
positive regulation of immune system process |
GO:0071495 |
2.61% |
cellular response to endogenous stimulus |
GO:0010648 |
2.61% |
negative regulation of cell communication |
GO:0009968 |
2.61% |
negative regulation of signal transduction |
GO:0030488 |
2.61% |
tRNA methylation |
GO:0071277 |
2.61% |
cellular response to calcium ion |
GO:0051189 |
2.60% |
prosthetic group metabolic process |
GO:0019362 |
2.60% |
pyridine nucleotide metabolic process |
GO:0043562 |
2.60% |
cellular response to nitrogen levels |
GO:0043112 |
2.60% |
receptor metabolic process |
GO:0009639 |
2.60% |
response to red or far red light |
GO:0055080 |
2.60% |
cation homeostasis |
GO:0032886 |
2.60% |
regulation of microtubule-based process |
GO:0030155 |
2.59% |
regulation of cell adhesion |
GO:0008214 |
2.59% |
protein dealkylation |
GO:0019720 |
2.59% |
Mo-molybdopterin cofactor metabolic process |
GO:0006030 |
2.59% |
chitin metabolic process |
GO:0001817 |
2.58% |
regulation of cytokine production |
GO:0006605 |
2.58% |
protein targeting |
GO:0030029 |
2.58% |
actin filament-based process |
GO:0017001 |
2.58% |
antibiotic catabolic process |
GO:0051262 |
2.58% |
protein tetramerization |
GO:1903509 |
2.58% |
liposaccharide metabolic process |
GO:0032984 |
2.58% |
protein-containing complex disassembly |
GO:0007616 |
2.57% |
long-term memory |
GO:0055065 |
2.57% |
metal ion homeostasis |
GO:0006476 |
2.57% |
protein deacetylation |
GO:0016143 |
2.57% |
S-glycoside metabolic process |
GO:0042176 |
2.57% |
regulation of protein catabolic process |
GO:0031365 |
2.57% |
N-terminal protein amino acid modification |
GO:0018208 |
2.57% |
peptidyl-proline modification |
GO:0051668 |
2.57% |
localization within membrane |
GO:0046390 |
2.56% |
ribose phosphate biosynthetic process |
GO:0044257 |
2.56% |
cellular protein catabolic process |
GO:0048582 |
2.56% |
positive regulation of post-embryonic development |
GO:0006415 |
2.56% |
translational termination |
GO:0001889 |
2.56% |
liver development |
GO:0046496 |
2.56% |
nicotinamide nucleotide metabolic process |
GO:0002066 |
2.56% |
columnar/cuboidal epithelial cell development |
GO:0120035 |
2.56% |
regulation of plasma membrane bounded cell projection organization |
GO:0000280 |
2.56% |
nuclear division |
GO:0043902 |
2.56% |
positive regulation of multi-organism process |
GO:0104004 |
2.55% |
cellular response to environmental stimulus |
GO:0010043 |
2.55% |
response to zinc ion |
GO:0001932 |
2.55% |
regulation of protein phosphorylation |
GO:0030031 |
2.55% |
cell projection assembly |
GO:0045727 |
2.55% |
positive regulation of translation |
GO:0007059 |
2.55% |
chromosome segregation |
GO:0051338 |
2.55% |
regulation of transferase activity |
GO:0018393 |
2.54% |
internal peptidyl-lysine acetylation |
GO:1903008 |
2.54% |
organelle disassembly |
GO:0050918 |
2.54% |
positive chemotaxis |
GO:0010676 |
2.54% |
positive regulation of cellular carbohydrate metabolic process |
GO:2000377 |
2.54% |
regulation of reactive oxygen species metabolic process |
GO:0042773 |
2.54% |
ATP synthesis coupled electron transport |
GO:0072522 |
2.54% |
purine-containing compound biosynthetic process |
GO:0060479 |
2.54% |
lung cell differentiation |
GO:0048545 |
2.53% |
response to steroid hormone |
GO:0007622 |
2.53% |
rhythmic behavior |
GO:0009723 |
2.53% |
response to ethylene |
GO:0045596 |
2.53% |
negative regulation of cell differentiation |
GO:0071214 |
2.53% |
cellular response to abiotic stimulus |
GO:0045664 |
2.53% |
regulation of neuron differentiation |
GO:0000729 |
2.53% |
DNA double-strand break processing |
GO:0007219 |
2.52% |
Notch signaling pathway |
GO:0046685 |
2.52% |
response to arsenic-containing substance |
GO:0061919 |
2.51% |
process utilizing autophagic mechanism |
GO:0050830 |
2.51% |
defense response to Gram-positive bacterium |
GO:0007033 |
2.51% |
vacuole organization |
GO:0042538 |
2.51% |
hyperosmotic salinity response |
GO:0031344 |
2.51% |
regulation of cell projection organization |
GO:0051291 |
2.51% |
protein heterooligomerization |
GO:0009068 |
2.51% |
aspartate family amino acid catabolic process |
GO:0009116 |
2.50% |
nucleoside metabolic process |
GO:0006914 |
2.50% |
autophagy |
GO:1902531 |
2.50% |
regulation of intracellular signal transduction |
GO:0045732 |
2.50% |
positive regulation of protein catabolic process |
GO:0006887 |
2.50% |
exocytosis |
GO:0006475 |
2.49% |
internal protein amino acid acetylation |
GO:0006777 |
2.49% |
Mo-molybdopterin cofactor biosynthetic process |
GO:0006549 |
2.49% |
isoleucine metabolic process |
GO:0009642 |
2.49% |
response to light intensity |
GO:0071852 |
2.49% |
fungal-type cell wall organization or biogenesis |
GO:0045787 |
2.48% |
positive regulation of cell cycle |
GO:0010975 |
2.48% |
regulation of neuron projection development |
GO:0009895 |
2.48% |
negative regulation of catabolic process |
GO:0032885 |
2.48% |
regulation of polysaccharide biosynthetic process |
GO:0099111 |
2.48% |
microtubule-based transport |
GO:0006783 |
2.48% |
heme biosynthetic process |
GO:0046434 |
2.47% |
organophosphate catabolic process |
GO:0043545 |
2.46% |
molybdopterin cofactor metabolic process |
GO:0007613 |
2.46% |
memory |
GO:0045995 |
2.46% |
regulation of embryonic development |
GO:0018904 |
2.46% |
ether metabolic process |
GO:0006022 |
2.46% |
aminoglycan metabolic process |
GO:1901570 |
2.46% |
fatty acid derivative biosynthetic process |
GO:0022406 |
2.46% |
membrane docking |
GO:0040014 |
2.46% |
regulation of multicellular organism growth |
GO:0009085 |
2.45% |
lysine biosynthetic process |
GO:0033206 |
2.45% |
meiotic cytokinesis |
GO:0051153 |
2.45% |
regulation of striated muscle cell differentiation |
GO:0006515 |
2.45% |
protein quality control for misfolded or incompletely synthesized proteins |
GO:0006954 |
2.45% |
inflammatory response |
GO:0043549 |
2.45% |
regulation of kinase activity |
GO:0051336 |
2.45% |
regulation of hydrolase activity |
GO:0006892 |
2.45% |
post-Golgi vesicle-mediated transport |
GO:0140029 |
2.45% |
exocytic process |
GO:0006448 |
2.44% |
regulation of translational elongation |
GO:0061245 |
2.44% |
establishment or maintenance of bipolar cell polarity |
GO:0006897 |
2.44% |
endocytosis |
GO:0008037 |
2.44% |
cell recognition |
GO:0098657 |
2.44% |
import into cell |
GO:0019344 |
2.44% |
cysteine biosynthetic process |
GO:0006779 |
2.43% |
porphyrin-containing compound biosynthetic process |
GO:0120031 |
2.43% |
plasma membrane bounded cell projection assembly |
GO:0048732 |
2.43% |
gland development |
GO:0009909 |
2.43% |
regulation of flower development |
GO:0031098 |
2.43% |
stress-activated protein kinase signaling cascade |
GO:0043624 |
2.43% |
cellular protein complex disassembly |
GO:0016575 |
2.43% |
histone deacetylation |
GO:0009742 |
2.43% |
brassinosteroid mediated signaling pathway |
GO:0062013 |
2.43% |
positive regulation of small molecule metabolic process |
GO:0040012 |
2.43% |
regulation of locomotion |
GO:0016050 |
2.43% |
vesicle organization |
GO:0090150 |
2.42% |
establishment of protein localization to membrane |
GO:0051783 |
2.42% |
regulation of nuclear division |
GO:0046473 |
2.42% |
phosphatidic acid metabolic process |
GO:0051147 |
2.41% |
regulation of muscle cell differentiation |
GO:0032104 |
2.41% |
regulation of response to extracellular stimulus |
GO:0006553 |
2.41% |
lysine metabolic process |
GO:0009132 |
2.41% |
nucleoside diphosphate metabolic process |
GO:0098732 |
2.41% |
macromolecule deacylation |
GO:0060537 |
2.40% |
muscle tissue development |
GO:0015914 |
2.40% |
phospholipid transport |
GO:0045913 |
2.40% |
positive regulation of carbohydrate metabolic process |
GO:0070525 |
2.40% |
tRNA threonylcarbamoyladenosine metabolic process |
GO:0002237 |
2.40% |
response to molecule of bacterial origin |
GO:1901654 |
2.40% |
response to ketone |
GO:0030437 |
2.40% |
ascospore formation |
GO:0000209 |
2.40% |
protein polyubiquitination |
GO:0065004 |
2.40% |
protein-DNA complex assembly |
GO:0071453 |
2.40% |
cellular response to oxygen levels |
GO:0045088 |
2.40% |
regulation of innate immune response |
GO:2001023 |
2.39% |
regulation of response to drug |
GO:0019760 |
2.39% |
glucosinolate metabolic process |
GO:0090066 |
2.39% |
regulation of anatomical structure size |
GO:0009101 |
2.39% |
glycoprotein biosynthetic process |
GO:0051223 |
2.39% |
regulation of protein transport |
GO:0016241 |
2.39% |
regulation of macroautophagy |
GO:0007034 |
2.39% |
vacuolar transport |
GO:0042752 |
2.38% |
regulation of circadian rhythm |
GO:0031647 |
2.38% |
regulation of protein stability |
GO:0006004 |
2.38% |
fucose metabolic process |
GO:0006935 |
2.38% |
chemotaxis |
GO:0007286 |
2.38% |
spermatid development |
GO:0046488 |
2.38% |
phosphatidylinositol metabolic process |
GO:0042135 |
2.38% |
neurotransmitter catabolic process |
GO:1903311 |
2.38% |
regulation of mRNA metabolic process |
GO:0007163 |
2.38% |
establishment or maintenance of cell polarity |
GO:0007528 |
2.38% |
neuromuscular junction development |
GO:0043523 |
2.37% |
regulation of neuron apoptotic process |
GO:0003002 |
2.37% |
regionalization |
GO:0010769 |
2.37% |
regulation of cell morphogenesis involved in differentiation |
GO:0051193 |
2.37% |
regulation of cofactor metabolic process |
GO:0044036 |
2.37% |
cell wall macromolecule metabolic process |
GO:0051923 |
2.37% |
sulfation |
GO:0045862 |
2.37% |
positive regulation of proteolysis |
GO:0006497 |
2.36% |
protein lipidation |
GO:0046939 |
2.36% |
nucleotide phosphorylation |
GO:0007619 |
2.36% |
courtship behavior |
GO:0051017 |
2.36% |
actin filament bundle assembly |
GO:0046501 |
2.36% |
protoporphyrinogen IX metabolic process |
GO:0140013 |
2.36% |
meiotic nuclear division |
GO:0009712 |
2.36% |
catechol-containing compound metabolic process |
GO:0019646 |
2.36% |
aerobic electron transport chain |
GO:1901861 |
2.35% |
regulation of muscle tissue development |
GO:0001578 |
2.35% |
microtubule bundle formation |
GO:0031167 |
2.35% |
rRNA methylation |
GO:0009738 |
2.35% |
abscisic acid-activated signaling pathway |
GO:0072659 |
2.35% |
protein localization to plasma membrane |
GO:0008284 |
2.34% |
positive regulation of cell population proliferation |
GO:0051705 |
2.34% |
multi-organism behavior |
GO:0048827 |
2.34% |
phyllome development |
GO:0002244 |
2.34% |
hematopoietic progenitor cell differentiation |
GO:0006517 |
2.34% |
protein deglycosylation |
GO:0009635 |
2.34% |
response to herbicide |
GO:0007127 |
2.34% |
meiosis I |
GO:0048639 |
2.33% |
positive regulation of developmental growth |
GO:0051353 |
2.33% |
positive regulation of oxidoreductase activity |
GO:0006566 |
2.33% |
threonine metabolic process |
GO:0006936 |
2.33% |
muscle contraction |
GO:0042436 |
2.33% |
indole-containing compound catabolic process |
GO:1901616 |
2.33% |
organic hydroxy compound catabolic process |
GO:0055001 |
2.33% |
muscle cell development |
GO:0016197 |
2.33% |
endosomal transport |
GO:0006893 |
2.33% |
Golgi to plasma membrane transport |
GO:1903312 |
2.33% |
negative regulation of mRNA metabolic process |
GO:0007517 |
2.32% |
muscle organ development |
GO:0016540 |
2.32% |
protein autoprocessing |
GO:0035592 |
2.32% |
establishment of protein localization to extracellular region |
GO:0051248 |
2.32% |
negative regulation of protein metabolic process |
GO:0051403 |
2.32% |
stress-activated MAPK cascade |
GO:1902275 |
2.32% |
regulation of chromatin organization |
GO:1903827 |
2.32% |
regulation of cellular protein localization |
GO:0043470 |
2.32% |
regulation of carbohydrate catabolic process |
GO:0016571 |
2.31% |
histone methylation |
GO:0043487 |
2.31% |
regulation of RNA stability |
GO:0060429 |
2.31% |
epithelium development |
GO:0002790 |
2.31% |
peptide secretion |
GO:0001678 |
2.31% |
cellular glucose homeostasis |
GO:0006352 |
2.31% |
DNA-templated transcription, initiation |
GO:0050807 |
2.31% |
regulation of synapse organization |
GO:0010720 |
2.31% |
positive regulation of cell development |
GO:2001252 |
2.31% |
positive regulation of chromosome organization |
GO:0048469 |
2.30% |
cell maturation |
GO:0006869 |
2.30% |
lipid transport |
GO:0090140 |
2.30% |
regulation of mitochondrial fission |
GO:0016102 |
2.30% |
diterpenoid biosynthetic process |
GO:0061512 |
2.30% |
protein localization to cilium |
GO:0045471 |
2.30% |
response to ethanol |
GO:0072665 |
2.29% |
protein localization to vacuole |
GO:0045926 |
2.29% |
negative regulation of growth |
GO:0098876 |
2.29% |
vesicle-mediated transport to the plasma membrane |
GO:0042753 |
2.29% |
positive regulation of circadian rhythm |
GO:0098609 |
2.29% |
cell-cell adhesion |
GO:0007015 |
2.29% |
actin filament organization |
GO:0051983 |
2.29% |
regulation of chromosome segregation |
GO:0034404 |
2.29% |
nucleobase-containing small molecule biosynthetic process |
GO:0046686 |
2.29% |
response to cadmium ion |
GO:0048520 |
2.29% |
positive regulation of behavior |
GO:0009112 |
2.29% |
nucleobase metabolic process |
GO:0051606 |
2.29% |
detection of stimulus |
GO:2001038 |
2.29% |
regulation of cellular response to drug |
GO:0048569 |
2.28% |
post-embryonic animal organ development |
GO:0000122 |
2.28% |
negative regulation of transcription by RNA polymerase II |
GO:0009141 |
2.28% |
nucleoside triphosphate metabolic process |
GO:0035418 |
2.28% |
protein localization to synapse |
GO:0035690 |
2.27% |
cellular response to drug |
GO:0046459 |
2.27% |
short-chain fatty acid metabolic process |
GO:0042816 |
2.27% |
vitamin B6 metabolic process |
GO:0071692 |
2.27% |
protein localization to extracellular region |
GO:0051046 |
2.27% |
regulation of secretion |
GO:0035601 |
2.27% |
protein deacylation |
GO:0002683 |
2.27% |
negative regulation of immune system process |
GO:2000145 |
2.27% |
regulation of cell motility |
GO:0034605 |
2.27% |
cellular response to heat |
GO:0018200 |
2.27% |
peptidyl-glutamic acid modification |
GO:0022008 |
2.26% |
neurogenesis |
GO:0001667 |
2.26% |
ameboidal-type cell migration |
GO:0042593 |
2.26% |
glucose homeostasis |
GO:0016577 |
2.26% |
histone demethylation |
GO:0006654 |
2.26% |
phosphatidic acid biosynthetic process |
GO:0033500 |
2.26% |
carbohydrate homeostasis |
GO:0031623 |
2.26% |
receptor internalization |
GO:0042219 |
2.26% |
cellular modified amino acid catabolic process |
GO:0097502 |
2.26% |
mannosylation |
GO:0009437 |
2.26% |
carnitine metabolic process |
GO:0019319 |
2.26% |
hexose biosynthetic process |
GO:0031960 |
2.26% |
response to corticosteroid |
GO:0046185 |
2.26% |
aldehyde catabolic process |
GO:0001764 |
2.26% |
neuron migration |
GO:0070475 |
2.25% |
rRNA base methylation |
GO:0043489 |
2.25% |
RNA stabilization |
GO:0048017 |
2.25% |
inositol lipid-mediated signaling |
GO:0009185 |
2.25% |
ribonucleoside diphosphate metabolic process |
GO:0051962 |
2.25% |
positive regulation of nervous system development |
GO:0048872 |
2.25% |
homeostasis of number of cells |
GO:0051384 |
2.25% |
response to glucocorticoid |
GO:0006888 |
2.25% |
endoplasmic reticulum to Golgi vesicle-mediated transport |
GO:0006164 |
2.25% |
purine nucleotide biosynthetic process |
GO:0090087 |
2.25% |
regulation of peptide transport |
GO:0016202 |
2.25% |
regulation of striated muscle tissue development |
GO:0055085 |
2.24% |
transmembrane transport |
GO:0030239 |
2.24% |
myofibril assembly |
GO:0043277 |
2.24% |
apoptotic cell clearance |
GO:0019359 |
2.24% |
nicotinamide nucleotide biosynthetic process |
GO:0032496 |
2.24% |
response to lipopolysaccharide |
GO:0051270 |
2.24% |
regulation of cellular component movement |
GO:0071103 |
2.24% |
DNA conformation change |
GO:1902883 |
2.24% |
negative regulation of response to oxidative stress |
GO:0051302 |
2.24% |
regulation of cell division |
GO:0018065 |
2.23% |
protein-cofactor linkage |
GO:0006584 |
2.23% |
catecholamine metabolic process |
GO:0006820 |
2.23% |
anion transport |
GO:0009867 |
2.23% |
jasmonic acid mediated signaling pathway |
GO:1990748 |
2.23% |
cellular detoxification |
GO:0031505 |
2.23% |
fungal-type cell wall organization |
GO:0019757 |
2.23% |
glycosinolate metabolic process |
GO:0018279 |
2.23% |
protein N-linked glycosylation via asparagine |
GO:0061025 |
2.22% |
membrane fusion |
GO:0046513 |
2.22% |
ceramide biosynthetic process |
GO:0006446 |
2.22% |
regulation of translational initiation |
GO:0006560 |
2.22% |
proline metabolic process |
GO:0070507 |
2.22% |
regulation of microtubule cytoskeleton organization |
GO:0036503 |
2.22% |
ERAD pathway |
GO:0019363 |
2.22% |
pyridine nucleotide biosynthetic process |
GO:0006094 |
2.22% |
gluconeogenesis |
GO:0007129 |
2.22% |
synapsis |
GO:0071456 |
2.22% |
cellular response to hypoxia |
GO:0043935 |
2.21% |
sexual sporulation resulting in formation of a cellular spore |
GO:0071265 |
2.21% |
L-methionine biosynthetic process |
GO:0006772 |
2.21% |
thiamine metabolic process |
GO:0050821 |
2.21% |
protein stabilization |
GO:0051100 |
2.21% |
negative regulation of binding |
GO:0000154 |
2.21% |
rRNA modification |
GO:0034614 |
2.21% |
cellular response to reactive oxygen species |
GO:0055081 |
2.21% |
anion homeostasis |
GO:0045682 |
2.21% |
regulation of epidermis development |
GO:0016128 |
2.21% |
phytosteroid metabolic process |
GO:0010562 |
2.20% |
positive regulation of phosphorus metabolic process |
GO:0002181 |
2.20% |
cytoplasmic translation |
GO:0000725 |
2.20% |
recombinational repair |
GO:0030111 |
2.20% |
regulation of Wnt signaling pathway |
GO:0022413 |
2.20% |
reproductive process in single-celled organism |
GO:0060918 |
2.20% |
auxin transport |
GO:0016573 |
2.20% |
histone acetylation |
GO:0043649 |
2.20% |
dicarboxylic acid catabolic process |
GO:0036294 |
2.20% |
cellular response to decreased oxygen levels |
GO:0051607 |
2.20% |
defense response to virus |
GO:0032535 |
2.20% |
regulation of cellular component size |
GO:0046470 |
2.20% |
phosphatidylcholine metabolic process |
GO:0070726 |
2.20% |
cell wall assembly |
GO:0008203 |
2.20% |
cholesterol metabolic process |
GO:0002252 |
2.20% |
immune effector process |
GO:0000387 |
2.19% |
spliceosomal snRNP assembly |
GO:0051289 |
2.19% |
protein homotetramerization |
GO:0005979 |
2.18% |
regulation of glycogen biosynthetic process |
GO:0048366 |
2.18% |
leaf development |
GO:0140056 |
2.18% |
organelle localization by membrane tethering |
GO:0048641 |
2.18% |
regulation of skeletal muscle tissue development |
GO:0032269 |
2.18% |
negative regulation of cellular protein metabolic process |
GO:0045912 |
2.18% |
negative regulation of carbohydrate metabolic process |
GO:0033875 |
2.17% |
ribonucleoside bisphosphate metabolic process |
GO:0060395 |
2.17% |
SMAD protein signal transduction |
GO:0061013 |
2.17% |
regulation of mRNA catabolic process |
GO:0042723 |
2.17% |
thiamine-containing compound metabolic process |
GO:1901136 |
2.17% |
carbohydrate derivative catabolic process |
GO:0000956 |
2.17% |
nuclear-transcribed mRNA catabolic process |
GO:0031589 |
2.17% |
cell-substrate adhesion |
GO:0043086 |
2.17% |
negative regulation of catalytic activity |
GO:0051098 |
2.17% |
regulation of binding |
GO:0097327 |
2.17% |
response to antineoplastic agent |
GO:0016482 |
2.17% |
cytosolic transport |
GO:0090598 |
2.17% |
male anatomical structure morphogenesis |
GO:0010508 |
2.17% |
positive regulation of autophagy |
GO:0006646 |
2.17% |
phosphatidylethanolamine biosynthetic process |
GO:0032506 |
2.17% |
cytokinetic process |
GO:0010948 |
2.16% |
negative regulation of cell cycle process |
GO:0006836 |
2.16% |
neurotransmitter transport |
GO:0006333 |
2.16% |
chromatin assembly or disassembly |
GO:0043401 |
2.16% |
steroid hormone mediated signaling pathway |
GO:0062014 |
2.16% |
negative regulation of small molecule metabolic process |
GO:0009306 |
2.16% |
protein secretion |
GO:0034032 |
2.16% |
purine nucleoside bisphosphate metabolic process |
GO:0033865 |
2.16% |
nucleoside bisphosphate metabolic process |
GO:0070646 |
2.16% |
protein modification by small protein removal |
GO:0048568 |
2.16% |
embryonic organ development |
GO:0035148 |
2.15% |
tube formation |
GO:0031348 |
2.15% |
negative regulation of defense response |
GO:0045116 |
2.15% |
protein neddylation |
GO:0009435 |
2.15% |
NAD biosynthetic process |
GO:0015748 |
2.15% |
organophosphate ester transport |
GO:0060415 |
2.15% |
muscle tissue morphogenesis |
GO:0043200 |
2.14% |
response to amino acid |
GO:0061572 |
2.14% |
actin filament bundle organization |
GO:0002700 |
2.14% |
regulation of production of molecular mediator of immune response |
GO:0007006 |
2.14% |
mitochondrial membrane organization |
GO:0031124 |
2.14% |
mRNA 3'-end processing |
GO:0045937 |
2.14% |
positive regulation of phosphate metabolic process |
GO:0048364 |
2.14% |
root development |
GO:0006023 |
2.14% |
aminoglycan biosynthetic process |
GO:0031146 |
2.14% |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO:0006873 |
2.14% |
cellular ion homeostasis |
GO:0050688 |
2.14% |
regulation of defense response to virus |
GO:0051345 |
2.14% |
positive regulation of hydrolase activity |
GO:0002833 |
2.13% |
positive regulation of response to biotic stimulus |
GO:0032868 |
2.13% |
response to insulin |
GO:1903530 |
2.13% |
regulation of secretion by cell |
GO:0008593 |
2.13% |
regulation of Notch signaling pathway |
GO:0030199 |
2.13% |
collagen fibril organization |
GO:0045834 |
2.13% |
positive regulation of lipid metabolic process |
GO:0014706 |
2.13% |
striated muscle tissue development |
GO:0042762 |
2.13% |
regulation of sulfur metabolic process |
GO:0060249 |
2.12% |
anatomical structure homeostasis |
GO:0001732 |
2.12% |
formation of cytoplasmic translation initiation complex |
GO:0055008 |
2.12% |
cardiac muscle tissue morphogenesis |
GO:0030705 |
2.12% |
cytoskeleton-dependent intracellular transport |
GO:0001763 |
2.12% |
morphogenesis of a branching structure |
GO:1903829 |
2.12% |
positive regulation of cellular protein localization |
GO:0071216 |
2.12% |
cellular response to biotic stimulus |
GO:0046889 |
2.12% |
positive regulation of lipid biosynthetic process |
GO:0031156 |
2.12% |
regulation of sorocarp development |
GO:0034063 |
2.12% |
stress granule assembly |
GO:0048634 |
2.12% |
regulation of muscle organ development |
GO:0060179 |
2.12% |
male mating behavior |
GO:0009071 |
2.11% |
serine family amino acid catabolic process |
GO:0097120 |
2.11% |
receptor localization to synapse |
GO:0070584 |
2.11% |
mitochondrion morphogenesis |
GO:0040028 |
2.11% |
regulation of vulval development |
GO:0035268 |
2.11% |
protein mannosylation |
GO:1905037 |
2.11% |
autophagosome organization |
GO:0030003 |
2.11% |
cellular cation homeostasis |
GO:0045661 |
2.11% |
regulation of myoblast differentiation |
GO:0070988 |
2.10% |
demethylation |
GO:1905952 |
2.10% |
regulation of lipid localization |
GO:0006383 |
2.10% |
transcription by RNA polymerase III |
GO:0043102 |
2.10% |
amino acid salvage |
GO:0007272 |
2.10% |
ensheathment of neurons |
GO:0032963 |
2.10% |
collagen metabolic process |
GO:0035295 |
2.10% |
tube development |
GO:0050795 |
2.10% |
regulation of behavior |
GO:0045785 |
2.10% |
positive regulation of cell adhesion |
GO:0040018 |
2.10% |
positive regulation of multicellular organism growth |
GO:0051347 |
2.10% |
positive regulation of transferase activity |
GO:0006334 |
2.09% |
nucleosome assembly |
GO:0007088 |
2.09% |
regulation of mitotic nuclear division |
GO:1900408 |
2.09% |
negative regulation of cellular response to oxidative stress |
GO:0009845 |
2.09% |
seed germination |
GO:0031401 |
2.09% |
positive regulation of protein modification process |
GO:0006995 |
2.09% |
cellular response to nitrogen starvation |
GO:0060359 |
2.09% |
response to ammonium ion |
GO:0040034 |
2.09% |
regulation of development, heterochronic |
GO:0043393 |
2.08% |
regulation of protein binding |
GO:0034587 |
2.08% |
piRNA metabolic process |
GO:0045944 |
2.08% |
positive regulation of transcription by RNA polymerase II |
GO:0006839 |
2.08% |
mitochondrial transport |
GO:0043903 |
2.08% |
regulation of symbiosis, encompassing mutualism through parasitism |
GO:0003341 |
2.08% |
cilium movement |
GO:0032102 |
2.08% |
negative regulation of response to external stimulus |
GO:0043248 |
2.08% |
proteasome assembly |
GO:0043001 |
2.08% |
Golgi to plasma membrane protein transport |
GO:0034285 |
2.07% |
response to disaccharide |
GO:0097064 |
2.07% |
ncRNA export from nucleus |
GO:0031670 |
2.07% |
cellular response to nutrient |
GO:0009135 |
2.07% |
purine nucleoside diphosphate metabolic process |
GO:0034311 |
2.07% |
diol metabolic process |
GO:0002250 |
2.07% |
adaptive immune response |
GO:0035264 |
2.07% |
multicellular organism growth |
GO:0010962 |
2.07% |
regulation of glucan biosynthetic process |
GO:0062125 |
2.07% |
regulation of mitochondrial gene expression |
GO:0009251 |
2.07% |
glucan catabolic process |
GO:0035914 |
2.07% |
skeletal muscle cell differentiation |
GO:0006301 |
2.07% |
postreplication repair |
GO:0007601 |
2.07% |
visual perception |
GO:0030865 |
2.07% |
cortical cytoskeleton organization |
GO:0007606 |
2.06% |
sensory perception of chemical stimulus |
GO:0009407 |
2.06% |
toxin catabolic process |
GO:0036230 |
2.06% |
granulocyte activation |
GO:0042178 |
2.06% |
xenobiotic catabolic process |
GO:0015711 |
2.06% |
organic anion transport |
GO:0010907 |
2.06% |
positive regulation of glucose metabolic process |
GO:1901990 |
2.06% |
regulation of mitotic cell cycle phase transition |
GO:0006206 |
2.06% |
pyrimidine nucleobase metabolic process |
GO:0002064 |
2.05% |
epithelial cell development |
GO:1901800 |
2.05% |
positive regulation of proteasomal protein catabolic process |
GO:1901419 |
2.05% |
regulation of response to alcohol |
GO:0043488 |
2.05% |
regulation of mRNA stability |
GO:0022616 |
2.05% |
DNA strand elongation |
GO:0050804 |
2.05% |
modulation of chemical synaptic transmission |
GO:0006308 |
2.05% |
DNA catabolic process |
GO:0006812 |
2.05% |
cation transport |
GO:0035269 |
2.05% |
protein O-linked mannosylation |
GO:0007416 |
2.05% |
synapse assembly |
GO:0042447 |
2.04% |
hormone catabolic process |
GO:0045930 |
2.04% |
negative regulation of mitotic cell cycle |
GO:0000160 |
2.04% |
phosphorelay signal transduction system |
GO:0043113 |
2.04% |
receptor clustering |
GO:0030307 |
2.04% |
positive regulation of cell growth |
GO:0051656 |
2.04% |
establishment of organelle localization |
GO:0042327 |
2.04% |
positive regulation of phosphorylation |
GO:0048311 |
2.04% |
mitochondrion distribution |
GO:0010639 |
2.04% |
negative regulation of organelle organization |
GO:0006782 |
2.04% |
protoporphyrinogen IX biosynthetic process |
GO:0000712 |
2.04% |
resolution of meiotic recombination intermediates |
GO:0032526 |
2.03% |
response to retinoic acid |
GO:0031349 |
2.03% |
positive regulation of defense response |
GO:0070828 |
2.03% |
heterochromatin organization |
GO:0006165 |
2.03% |
nucleoside diphosphate phosphorylation |
GO:0070589 |
2.03% |
cellular component macromolecule biosynthetic process |
GO:0030100 |
2.03% |
regulation of endocytosis |
GO:0048255 |
2.03% |
mRNA stabilization |
GO:0071478 |
2.03% |
cellular response to radiation |
GO:0043631 |
2.03% |
RNA polyadenylation |
GO:0016075 |
2.03% |
rRNA catabolic process |
GO:0017004 |
2.03% |
cytochrome complex assembly |
GO:0022404 |
2.02% |
molting cycle process |
GO:0034502 |
2.02% |
protein localization to chromosome |
GO:0006270 |
2.02% |
DNA replication initiation |
GO:0002253 |
2.02% |
activation of immune response |
GO:0000045 |
2.02% |
autophagosome assembly |
GO:0030072 |
2.02% |
peptide hormone secretion |
GO:0031334 |
2.02% |
positive regulation of protein complex assembly |
GO:0009260 |
2.02% |
ribonucleotide biosynthetic process |
GO:0006801 |
2.02% |
superoxide metabolic process |
GO:0042147 |
2.02% |
retrograde transport, endosome to Golgi |
GO:0009313 |
2.02% |
oligosaccharide catabolic process |
GO:0050832 |
2.02% |
defense response to fungus |
GO:1900407 |
2.02% |
regulation of cellular response to oxidative stress |
GO:0006691 |
2.02% |
leukotriene metabolic process |
GO:0061351 |
2.01% |
neural precursor cell proliferation |
GO:0010970 |
2.01% |
transport along microtubule |
GO:1902373 |
2.01% |
negative regulation of mRNA catabolic process |
GO:1901987 |
2.01% |
regulation of cell cycle phase transition |
GO:0006298 |
2.01% |
mismatch repair |
GO:0001573 |
2.01% |
ganglioside metabolic process |
GO:0033157 |
2.01% |
regulation of intracellular protein transport |
GO:0006875 |
2.01% |
cellular metal ion homeostasis |
GO:0042048 |
2.01% |
olfactory behavior |
GO:1902533 |
2.01% |
positive regulation of intracellular signal transduction |
GO:0071267 |
2.01% |
L-methionine salvage |
GO:0007062 |
2.01% |
sister chromatid cohesion |
GO:0009744 |
2.01% |
response to sucrose |
GO:0120161 |
2.00% |
regulation of cold-induced thermogenesis |
GO:0000731 |
2.00% |
DNA synthesis involved in DNA repair |
GO:0030099 |
2.00% |
myeloid cell differentiation |
GO:0043279 |
2.00% |
response to alkaloid |
GO:0045185 |
2.00% |
maintenance of protein location |
GO:0008366 |
2.00% |
axon ensheathment |
GO:0050953 |
2.00% |
sensory perception of light stimulus |
GO:0099177 |
2.00% |
regulation of trans-synaptic signaling |
GO:0006757 |
2.00% |
ATP generation from ADP |
GO:2000378 |
2.00% |
negative regulation of reactive oxygen species metabolic process |
GO:1901342 |
2.00% |
regulation of vasculature development |
GO:0010165 |
1.99% |
response to X-ray |
GO:1900424 |
1.99% |
regulation of defense response to bacterium |
GO:0090529 |
1.99% |
cell septum assembly |
GO:0034698 |
1.99% |
response to gonadotropin |
GO:0042417 |
1.99% |
dopamine metabolic process |
GO:0001649 |
1.99% |
osteoblast differentiation |
GO:0090257 |
1.99% |
regulation of muscle system process |
GO:0000726 |
1.99% |
non-recombinational repair |
GO:0030334 |
1.99% |
regulation of cell migration |
GO:0035966 |
1.99% |
response to topologically incorrect protein |
GO:0044038 |
1.99% |
cell wall macromolecule biosynthetic process |
GO:0006582 |
1.99% |
melanin metabolic process |
GO:0006303 |
1.99% |
double-strand break repair via nonhomologous end joining |
GO:0010677 |
1.98% |
negative regulation of cellular carbohydrate metabolic process |
GO:0042246 |
1.98% |
tissue regeneration |
GO:0000105 |
1.98% |
histidine biosynthetic process |
GO:0055010 |
1.98% |
ventricular cardiac muscle tissue morphogenesis |
GO:0070050 |
1.98% |
neuron cellular homeostasis |
GO:0048278 |
1.98% |
vesicle docking |
GO:0052548 |
1.98% |
regulation of endopeptidase activity |
GO:0019953 |
1.97% |
sexual reproduction |
GO:0006688 |
1.97% |
glycosphingolipid biosynthetic process |
GO:0072666 |
1.97% |
establishment of protein localization to vacuole |
GO:0019218 |
1.97% |
regulation of steroid metabolic process |
GO:1902532 |
1.97% |
negative regulation of intracellular signal transduction |
GO:0032103 |
1.97% |
positive regulation of response to external stimulus |
GO:0016579 |
1.97% |
protein deubiquitination |
GO:0006997 |
1.97% |
nucleus organization |
GO:0000422 |
1.96% |
autophagy of mitochondrion |
GO:0006221 |
1.96% |
pyrimidine nucleotide biosynthetic process |
GO:0016236 |
1.96% |
macroautophagy |
GO:0051273 |
1.96% |
beta-glucan metabolic process |
GO:0061726 |
1.96% |
mitochondrion disassembly |
GO:0032436 |
1.96% |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:1901699 |
1.96% |
cellular response to nitrogen compound |
GO:0006662 |
1.96% |
glycerol ether metabolic process |
GO:0034312 |
1.96% |
diol biosynthetic process |
GO:0070897 |
1.96% |
transcription preinitiation complex assembly |
GO:0006904 |
1.96% |
vesicle docking involved in exocytosis |
GO:0031330 |
1.96% |
negative regulation of cellular catabolic process |
GO:0050878 |
1.96% |
regulation of body fluid levels |
GO:0048284 |
1.95% |
organelle fusion |
GO:0021766 |
1.95% |
hippocampus development |
GO:0009156 |
1.95% |
ribonucleoside monophosphate biosynthetic process |
GO:0003007 |
1.95% |
heart morphogenesis |
GO:0030433 |
1.95% |
ubiquitin-dependent ERAD pathway |
GO:0034293 |
1.95% |
sexual sporulation |
GO:1901215 |
1.95% |
negative regulation of neuron death |
GO:0046031 |
1.95% |
ADP metabolic process |
GO:0051591 |
1.95% |
response to cAMP |
GO:0050708 |
1.95% |
regulation of protein secretion |
GO:0001822 |
1.95% |
kidney development |
GO:0006637 |
1.95% |
acyl-CoA metabolic process |
GO:0044247 |
1.95% |
cellular polysaccharide catabolic process |
GO:0044786 |
1.95% |
cell cycle DNA replication |
GO:0009787 |
1.95% |
regulation of abscisic acid-activated signaling pathway |
GO:0009648 |
1.94% |
photoperiodism |
GO:0007140 |
1.94% |
male meiotic nuclear division |
GO:0009179 |
1.94% |
purine ribonucleoside diphosphate metabolic process |
GO:0008585 |
1.94% |
female gonad development |
GO:1903202 |
1.94% |
negative regulation of oxidative stress-induced cell death |
GO:0000266 |
1.94% |
mitochondrial fission |
GO:0052547 |
1.94% |
regulation of peptidase activity |
GO:0051701 |
1.94% |
interaction with host |
GO:0071482 |
1.94% |
cellular response to light stimulus |
GO:0051445 |
1.94% |
regulation of meiotic cell cycle |
GO:0098781 |
1.94% |
ncRNA transcription |
GO:0006378 |
1.93% |
mRNA polyadenylation |
GO:0045197 |
1.93% |
establishment or maintenance of epithelial cell apical/basal polarity |
GO:0006096 |
1.93% |
glycolytic process |
GO:0060968 |
1.93% |
regulation of gene silencing |
GO:0033280 |
1.93% |
response to vitamin D |
GO:0046879 |
1.93% |
hormone secretion |
GO:0072655 |
1.93% |
establishment of protein localization to mitochondrion |
GO:0048813 |
1.93% |
dendrite morphogenesis |
GO:0061951 |
1.93% |
establishment of protein localization to plasma membrane |
GO:0110154 |
1.93% |
RNA decapping |
GO:0046519 |
1.93% |
sphingoid metabolic process |
GO:0035383 |
1.93% |
thioester metabolic process |
GO:0045089 |
1.93% |
positive regulation of innate immune response |
GO:0034308 |
1.93% |
primary alcohol metabolic process |
GO:0051881 |
1.93% |
regulation of mitochondrial membrane potential |
GO:0050769 |
1.93% |
positive regulation of neurogenesis |
GO:0010824 |
1.93% |
regulation of centrosome duplication |
GO:0009734 |
1.93% |
auxin-activated signaling pathway |
GO:0009626 |
1.93% |
plant-type hypersensitive response |
GO:0006323 |
1.93% |
DNA packaging |
GO:0000724 |
1.92% |
double-strand break repair via homologous recombination |
GO:0051646 |
1.92% |
mitochondrion localization |
GO:0030308 |
1.92% |
negative regulation of cell growth |
GO:0016358 |
1.92% |
dendrite development |
GO:1901160 |
1.92% |
primary amino compound metabolic process |
GO:0045070 |
1.92% |
positive regulation of viral genome replication |
GO:0042391 |
1.92% |
regulation of membrane potential |
GO:0006623 |
1.92% |
protein targeting to vacuole |
GO:0033674 |
1.92% |
positive regulation of kinase activity |
GO:1900140 |
1.92% |
regulation of seedling development |
GO:0007565 |
1.92% |
female pregnancy |
GO:0097421 |
1.92% |
liver regeneration |
GO:0045879 |
1.92% |
negative regulation of smoothened signaling pathway |
GO:0010029 |
1.91% |
regulation of seed germination |
GO:0046683 |
1.91% |
response to organophosphorus |
GO:0006140 |
1.91% |
regulation of nucleotide metabolic process |
GO:1903052 |
1.91% |
positive regulation of proteolysis involved in cellular protein catabolic process |
GO:0061062 |
1.91% |
regulation of nematode larval development |
GO:0033273 |
1.91% |
response to vitamin |
GO:0006144 |
1.90% |
purine nucleobase metabolic process |
GO:0006638 |
1.90% |
neutral lipid metabolic process |
GO:0045187 |
1.90% |
regulation of circadian sleep/wake cycle, sleep |
GO:0070585 |
1.90% |
protein localization to mitochondrion |
GO:0000413 |
1.90% |
protein peptidyl-prolyl isomerization |
GO:0000462 |
1.90% |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:1903902 |
1.90% |
positive regulation of viral life cycle |
GO:0043087 |
1.90% |
regulation of GTPase activity |
GO:0018108 |
1.90% |
peptidyl-tyrosine phosphorylation |
GO:0031122 |
1.90% |
cytoplasmic microtubule organization |
GO:1905954 |
1.90% |
positive regulation of lipid localization |
GO:1904951 |
1.90% |
positive regulation of establishment of protein localization |
GO:0120162 |
1.90% |
positive regulation of cold-induced thermogenesis |
GO:1901031 |
1.90% |
regulation of response to reactive oxygen species |
GO:0006271 |
1.90% |
DNA strand elongation involved in DNA replication |
GO:0043901 |
1.90% |
negative regulation of multi-organism process |
GO:2000024 |
1.90% |
regulation of leaf development |
GO:0046839 |
1.90% |
phospholipid dephosphorylation |
GO:0035088 |
1.90% |
establishment or maintenance of apical/basal cell polarity |
GO:0098813 |
1.90% |
nuclear chromosome segregation |
GO:0000966 |
1.90% |
RNA 5'-end processing |
GO:0007160 |
1.89% |
cell-matrix adhesion |
GO:0099643 |
1.89% |
signal release from synapse |
GO:0001819 |
1.89% |
positive regulation of cytokine production |
GO:0009124 |
1.89% |
nucleoside monophosphate biosynthetic process |
GO:0046466 |
1.89% |
membrane lipid catabolic process |
GO:0045684 |
1.89% |
positive regulation of epidermis development |
GO:0007040 |
1.89% |
lysosome organization |
GO:0046626 |
1.89% |
regulation of insulin receptor signaling pathway |
GO:0000917 |
1.88% |
division septum assembly |
GO:0033045 |
1.88% |
regulation of sister chromatid segregation |
GO:0010883 |
1.88% |
regulation of lipid storage |
GO:0046348 |
1.88% |
amino sugar catabolic process |
GO:0010830 |
1.88% |
regulation of myotube differentiation |
GO:0003013 |
1.88% |
circulatory system process |
GO:1903201 |
1.88% |
regulation of oxidative stress-induced cell death |
GO:0045604 |
1.88% |
regulation of epidermal cell differentiation |
GO:0006656 |
1.87% |
phosphatidylcholine biosynthetic process |
GO:0010228 |
1.87% |
vegetative to reproductive phase transition of meristem |
GO:0006937 |
1.87% |
regulation of muscle contraction |
GO:0007409 |
1.87% |
axonogenesis |
GO:0098727 |
1.87% |
maintenance of cell number |
GO:0048666 |
1.87% |
neuron development |
GO:0044770 |
1.87% |
cell cycle phase transition |
GO:0045055 |
1.87% |
regulated exocytosis |
GO:0031400 |
1.87% |
negative regulation of protein modification process |
GO:0051963 |
1.87% |
regulation of synapse assembly |
GO:0033363 |
1.87% |
secretory granule organization |
GO:0006563 |
1.86% |
L-serine metabolic process |
GO:0045444 |
1.86% |
fat cell differentiation |
GO:0010822 |
1.86% |
positive regulation of mitochondrion organization |
GO:0009751 |
1.86% |
response to salicylic acid |
GO:0010042 |
1.86% |
response to manganese ion |
GO:0046184 |
1.86% |
aldehyde biosynthetic process |
GO:0031060 |
1.86% |
regulation of histone methylation |
GO:0097190 |
1.86% |
apoptotic signaling pathway |
GO:1904396 |
1.86% |
regulation of neuromuscular junction development |
GO:0110156 |
1.86% |
methylguanosine-cap decapping |
GO:0048581 |
1.86% |
negative regulation of post-embryonic development |
GO:0007130 |
1.86% |
synaptonemal complex assembly |
GO:0042255 |
1.86% |
ribosome assembly |
GO:0051651 |
1.86% |
maintenance of location in cell |
GO:0008361 |
1.86% |
regulation of cell size |
GO:0019400 |
1.86% |
alditol metabolic process |
GO:0008582 |
1.86% |
regulation of synaptic growth at neuromuscular junction |
GO:0046688 |
1.86% |
response to copper ion |
GO:0008584 |
1.86% |
male gonad development |
GO:0016055 |
1.85% |
Wnt signaling pathway |
GO:0006220 |
1.85% |
pyrimidine nucleotide metabolic process |
GO:0031056 |
1.85% |
regulation of histone modification |
GO:0009713 |
1.85% |
catechol-containing compound biosynthetic process |
GO:0010212 |
1.85% |
response to ionizing radiation |
GO:0006639 |
1.85% |
acylglycerol metabolic process |
GO:0000245 |
1.85% |
spliceosomal complex assembly |
GO:0070076 |
1.85% |
histone lysine demethylation |
GO:0019221 |
1.85% |
cytokine-mediated signaling pathway |
GO:0042542 |
1.85% |
response to hydrogen peroxide |
GO:0048871 |
1.85% |
multicellular organismal homeostasis |
GO:0019932 |
1.85% |
second-messenger-mediated signaling |
GO:0022407 |
1.85% |
regulation of cell-cell adhesion |
GO:1905957 |
1.85% |
regulation of cellular response to alcohol |
GO:0032507 |
1.85% |
maintenance of protein location in cell |
GO:0045814 |
1.85% |
negative regulation of gene expression, epigenetic |
GO:0045765 |
1.84% |
regulation of angiogenesis |
GO:0019915 |
1.84% |
lipid storage |
GO:0006354 |
1.84% |
DNA-templated transcription, elongation |
GO:0072523 |
1.84% |
purine-containing compound catabolic process |
GO:0031929 |
1.84% |
TOR signaling |
GO:0032091 |
1.84% |
negative regulation of protein binding |
GO:0008589 |
1.84% |
regulation of smoothened signaling pathway |
GO:0042157 |
1.84% |
lipoprotein metabolic process |
GO:0045859 |
1.84% |
regulation of protein kinase activity |
GO:0003351 |
1.84% |
epithelial cilium movement involved in extracellular fluid movement |
GO:0099118 |
1.84% |
microtubule-based protein transport |
GO:0046337 |
1.84% |
phosphatidylethanolamine metabolic process |
GO:0071407 |
1.84% |
cellular response to organic cyclic compound |
GO:0007519 |
1.84% |
skeletal muscle tissue development |
GO:0048015 |
1.84% |
phosphatidylinositol-mediated signaling |
GO:0045005 |
1.84% |
DNA-dependent DNA replication maintenance of fidelity |
GO:0031507 |
1.83% |
heterochromatin assembly |
GO:0007297 |
1.83% |
ovarian follicle cell migration |
GO:0042749 |
1.83% |
regulation of circadian sleep/wake cycle |
GO:0007141 |
1.83% |
male meiosis I |
GO:0021885 |
1.83% |
forebrain cell migration |
GO:0032434 |
1.83% |
regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:0002702 |
1.83% |
positive regulation of production of molecular mediator of immune response |
GO:2000060 |
1.83% |
positive regulation of ubiquitin-dependent protein catabolic process |
GO:0046113 |
1.83% |
nucleobase catabolic process |
GO:0099003 |
1.83% |
vesicle-mediated transport in synapse |
GO:0051225 |
1.83% |
spindle assembly |
GO:0019184 |
1.82% |
nonribosomal peptide biosynthetic process |
GO:0042552 |
1.82% |
myelination |
GO:0046605 |
1.82% |
regulation of centrosome cycle |
GO:0009163 |
1.82% |
nucleoside biosynthetic process |
GO:0050905 |
1.82% |
neuromuscular process |
GO:1905114 |
1.82% |
cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0051149 |
1.82% |
positive regulation of muscle cell differentiation |
GO:0006342 |
1.82% |
chromatin silencing |
GO:0051354 |
1.82% |
negative regulation of oxidoreductase activity |
GO:0010529 |
1.82% |
negative regulation of transposition |
GO:0051274 |
1.82% |
beta-glucan biosynthetic process |
GO:0009612 |
1.82% |
response to mechanical stimulus |
GO:1903146 |
1.82% |
regulation of autophagy of mitochondrion |
GO:1990928 |
1.82% |
response to amino acid starvation |
GO:0009142 |
1.81% |
nucleoside triphosphate biosynthetic process |
GO:0046834 |
1.81% |
lipid phosphorylation |
GO:0009119 |
1.81% |
ribonucleoside metabolic process |
GO:0030490 |
1.81% |
maturation of SSU-rRNA |
GO:0009161 |
1.81% |
ribonucleoside monophosphate metabolic process |
GO:0002699 |
1.81% |
positive regulation of immune effector process |
GO:0042182 |
1.81% |
ketone catabolic process |
GO:0098693 |
1.81% |
regulation of synaptic vesicle cycle |
GO:0006123 |
1.81% |
mitochondrial electron transport, cytochrome c to oxygen |
GO:0006695 |
1.81% |
cholesterol biosynthetic process |
GO:0002791 |
1.81% |
regulation of peptide secretion |
GO:0035112 |
1.81% |
genitalia morphogenesis |
GO:0002040 |
1.81% |
sprouting angiogenesis |
GO:0009581 |
1.80% |
detection of external stimulus |
GO:0032956 |
1.80% |
regulation of actin cytoskeleton organization |
GO:0000002 |
1.80% |
mitochondrial genome maintenance |
GO:0010476 |
1.80% |
gibberellin mediated signaling pathway |
GO:0031509 |
1.80% |
telomeric heterochromatin assembly |
GO:0016556 |
1.80% |
mRNA modification |
GO:0055002 |
1.80% |
striated muscle cell development |
GO:0043455 |
1.80% |
regulation of secondary metabolic process |
GO:0045454 |
1.80% |
cell redox homeostasis |
GO:0070129 |
1.79% |
regulation of mitochondrial translation |
GO:0006687 |
1.79% |
glycosphingolipid metabolic process |
GO:0006879 |
1.79% |
cellular iron ion homeostasis |
GO:0007605 |
1.79% |
sensory perception of sound |
GO:0042073 |
1.79% |
intraciliary transport |
GO:0006275 |
1.79% |
regulation of DNA replication |
GO:0050792 |
1.79% |
regulation of viral process |
GO:0019985 |
1.79% |
translesion synthesis |
GO:0051047 |
1.79% |
positive regulation of secretion |
GO:1903364 |
1.78% |
positive regulation of cellular protein catabolic process |
GO:0018210 |
1.78% |
peptidyl-threonine modification |
GO:0045931 |
1.78% |
positive regulation of mitotic cell cycle |
GO:0050777 |
1.78% |
negative regulation of immune response |
GO:0048524 |
1.78% |
positive regulation of viral process |
GO:0006858 |
1.78% |
extracellular transport |
GO:0051495 |
1.78% |
positive regulation of cytoskeleton organization |
GO:0007635 |
1.78% |
chemosensory behavior |
GO:0061136 |
1.78% |
regulation of proteasomal protein catabolic process |
GO:0043123 |
1.78% |
positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:1903539 |
1.78% |
protein localization to postsynaptic membrane |
GO:1902903 |
1.78% |
regulation of supramolecular fiber organization |
GO:0009123 |
1.78% |
nucleoside monophosphate metabolic process |
GO:0048514 |
1.78% |
blood vessel morphogenesis |
GO:0046822 |
1.78% |
regulation of nucleocytoplasmic transport |
GO:0050810 |
1.77% |
regulation of steroid biosynthetic process |
GO:0006284 |
1.77% |
base-excision repair |
GO:0048512 |
1.77% |
circadian behavior |
GO:0007586 |
1.77% |
digestion |
GO:0000291 |
1.77% |
nuclear-transcribed mRNA catabolic process, exonucleolytic |
GO:0007288 |
1.77% |
sperm axoneme assembly |
GO:0018198 |
1.77% |
peptidyl-cysteine modification |
GO:0022405 |
1.77% |
hair cycle process |
GO:1902117 |
1.77% |
positive regulation of organelle assembly |
GO:0051782 |
1.77% |
negative regulation of cell division |
GO:1900542 |
1.76% |
regulation of purine nucleotide metabolic process |
GO:0009873 |
1.76% |
ethylene-activated signaling pathway |
GO:0032970 |
1.76% |
regulation of actin filament-based process |
GO:0046916 |
1.76% |
cellular transition metal ion homeostasis |
GO:0009644 |
1.76% |
response to high light intensity |
GO:0046856 |
1.76% |
phosphatidylinositol dephosphorylation |
GO:0001541 |
1.76% |
ovarian follicle development |
GO:0048705 |
1.76% |
skeletal system morphogenesis |
GO:1900076 |
1.75% |
regulation of cellular response to insulin stimulus |
GO:1901216 |
1.75% |
positive regulation of neuron death |
GO:0042278 |
1.75% |
purine nucleoside metabolic process |
GO:0033047 |
1.75% |
regulation of mitotic sister chromatid segregation |
GO:0010087 |
1.75% |
phloem or xylem histogenesis |
GO:0030203 |
1.75% |
glycosaminoglycan metabolic process |
GO:0071417 |
1.75% |
cellular response to organonitrogen compound |
GO:1901292 |
1.75% |
nucleoside phosphate catabolic process |
GO:0007031 |
1.75% |
peroxisome organization |
GO:0034401 |
1.74% |
chromatin organization involved in regulation of transcription |
GO:0002886 |
1.74% |
regulation of myeloid leukocyte mediated immunity |
GO:0006612 |
1.74% |
protein targeting to membrane |
GO:0043122 |
1.74% |
regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0080171 |
1.74% |
lytic vacuole organization |
GO:0003208 |
1.74% |
cardiac ventricle morphogenesis |
GO:0007178 |
1.74% |
transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0045214 |
1.74% |
sarcomere organization |
GO:1902749 |
1.74% |
regulation of cell cycle G2/M phase transition |
GO:0061515 |
1.74% |
myeloid cell development |
GO:0032479 |
1.74% |
regulation of type I interferon production |
GO:0046456 |
1.74% |
icosanoid biosynthetic process |
GO:0032392 |
1.74% |
DNA geometric change |
GO:0010721 |
1.74% |
negative regulation of cell development |
GO:1902170 |
1.74% |
cellular response to reactive nitrogen species |
GO:0044772 |
1.74% |
mitotic cell cycle phase transition |
GO:0000075 |
1.74% |
cell cycle checkpoint |
GO:0034471 |
1.74% |
ncRNA 5'-end processing |
GO:0019827 |
1.74% |
stem cell population maintenance |
GO:1903533 |
1.73% |
regulation of protein targeting |
GO:0008637 |
1.73% |
apoptotic mitochondrial changes |
GO:0034198 |
1.73% |
cellular response to amino acid starvation |
GO:0014074 |
1.73% |
response to purine-containing compound |
GO:0000184 |
1.73% |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO:0097549 |
1.73% |
chromatin organization involved in negative regulation of transcription |
GO:0097366 |
1.73% |
response to bronchodilator |
GO:0031497 |
1.73% |
chromatin assembly |
GO:0009303 |
1.73% |
rRNA transcription |
GO:0031333 |
1.73% |
negative regulation of protein complex assembly |
GO:0098840 |
1.73% |
protein transport along microtubule |
GO:0010119 |
1.73% |
regulation of stomatal movement |
GO:0010528 |
1.73% |
regulation of transposition |
GO:0010842 |
1.73% |
retina layer formation |
GO:0016441 |
1.73% |
posttranscriptional gene silencing |
GO:0007032 |
1.73% |
endosome organization |
GO:0071806 |
1.73% |
protein transmembrane transport |
GO:1903205 |
1.72% |
regulation of hydrogen peroxide-induced cell death |
GO:0034050 |
1.72% |
host programmed cell death induced by symbiont |
GO:0030001 |
1.72% |
metal ion transport |
GO:0033962 |
1.72% |
cytoplasmic mRNA processing body assembly |
GO:0042060 |
1.72% |
wound healing |
GO:0035456 |
1.72% |
response to interferon-beta |
GO:0007507 |
1.72% |
heart development |
GO:0032508 |
1.72% |
DNA duplex unwinding |
GO:0009220 |
1.72% |
pyrimidine ribonucleotide biosynthetic process |
GO:0070193 |
1.71% |
synaptonemal complex organization |
GO:0060828 |
1.71% |
regulation of canonical Wnt signaling pathway |
GO:0017038 |
1.71% |
protein import |
GO:0010389 |
1.71% |
regulation of G2/M transition of mitotic cell cycle |
GO:0009218 |
1.71% |
pyrimidine ribonucleotide metabolic process |
GO:0009798 |
1.71% |
axis specification |
GO:0007498 |
1.71% |
mesoderm development |
GO:0007224 |
1.71% |
smoothened signaling pathway |
GO:0002759 |
1.71% |
regulation of antimicrobial humoral response |
GO:0034762 |
1.71% |
regulation of transmembrane transport |
GO:0008209 |
1.71% |
androgen metabolic process |
GO:0044088 |
1.71% |
regulation of vacuole organization |
GO:0050764 |
1.71% |
regulation of phagocytosis |
GO:0042455 |
1.71% |
ribonucleoside biosynthetic process |
GO:0050994 |
1.71% |
regulation of lipid catabolic process |
GO:0071470 |
1.71% |
cellular response to osmotic stress |
GO:1900426 |
1.71% |
positive regulation of defense response to bacterium |
GO:0006119 |
1.70% |
oxidative phosphorylation |
GO:0046164 |
1.70% |
alcohol catabolic process |
GO:0050727 |
1.70% |
regulation of inflammatory response |
GO:0042545 |
1.70% |
cell wall modification |
GO:0009166 |
1.70% |
nucleotide catabolic process |
GO:0090101 |
1.70% |
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0007269 |
1.70% |
neurotransmitter secretion |
GO:0009583 |
1.70% |
detection of light stimulus |
GO:0098586 |
1.70% |
cellular response to virus |
GO:0006986 |
1.70% |
response to unfolded protein |
GO:0007156 |
1.70% |
homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0031032 |
1.70% |
actomyosin structure organization |
GO:0009152 |
1.70% |
purine ribonucleotide biosynthetic process |
GO:0043244 |
1.70% |
regulation of protein complex disassembly |
GO:0003014 |
1.70% |
renal system process |
GO:0097193 |
1.70% |
intrinsic apoptotic signaling pathway |
GO:0006959 |
1.70% |
humoral immune response |
GO:0030216 |
1.69% |
keratinocyte differentiation |
GO:0010810 |
1.69% |
regulation of cell-substrate adhesion |
GO:0046174 |
1.69% |
polyol catabolic process |
GO:0009593 |
1.69% |
detection of chemical stimulus |
GO:0031214 |
1.69% |
biomineral tissue development |
GO:0051052 |
1.69% |
regulation of DNA metabolic process |
GO:0051222 |
1.69% |
positive regulation of protein transport |
GO:0099072 |
1.69% |
regulation of postsynaptic membrane neurotransmitter receptor levels |
GO:1903510 |
1.69% |
mucopolysaccharide metabolic process |
GO:0051155 |
1.69% |
positive regulation of striated muscle cell differentiation |
GO:0090068 |
1.69% |
positive regulation of cell cycle process |
GO:0010383 |
1.68% |
cell wall polysaccharide metabolic process |
GO:0043269 |
1.68% |
regulation of ion transport |
GO:0002920 |
1.68% |
regulation of humoral immune response |
GO:1902905 |
1.68% |
positive regulation of supramolecular fiber organization |
GO:0006898 |
1.68% |
receptor-mediated endocytosis |
GO:0045069 |
1.68% |
regulation of viral genome replication |
GO:0043392 |
1.68% |
negative regulation of DNA binding |
GO:0009395 |
1.68% |
phospholipid catabolic process |
GO:0043473 |
1.68% |
pigmentation |
GO:0008217 |
1.67% |
regulation of blood pressure |
GO:1990542 |
1.67% |
mitochondrial transmembrane transport |
GO:0016242 |
1.67% |
negative regulation of macroautophagy |
GO:0035330 |
1.67% |
regulation of hippo signaling |
GO:0001934 |
1.67% |
positive regulation of protein phosphorylation |
GO:0007029 |
1.67% |
endoplasmic reticulum organization |
GO:2000785 |
1.67% |
regulation of autophagosome assembly |
GO:0006670 |
1.67% |
sphingosine metabolic process |
GO:0019236 |
1.67% |
response to pheromone |
GO:0000338 |
1.67% |
protein deneddylation |
GO:0009582 |
1.67% |
detection of abiotic stimulus |
GO:0032388 |
1.66% |
positive regulation of intracellular transport |
GO:0046503 |
1.66% |
glycerolipid catabolic process |
GO:0070555 |
1.66% |
response to interleukin-1 |
GO:0006356 |
1.66% |
regulation of transcription by RNA polymerase I |
GO:0051056 |
1.66% |
regulation of small GTPase mediated signal transduction |
GO:0046530 |
1.66% |
photoreceptor cell differentiation |
GO:2001025 |
1.66% |
positive regulation of response to drug |
GO:0032784 |
1.66% |
regulation of DNA-templated transcription, elongation |
GO:0042423 |
1.66% |
catecholamine biosynthetic process |
GO:0015698 |
1.66% |
inorganic anion transport |
GO:0001890 |
1.66% |
placenta development |
GO:1903900 |
1.66% |
regulation of viral life cycle |
GO:0042335 |
1.66% |
cuticle development |
GO:0006636 |
1.65% |
unsaturated fatty acid biosynthetic process |
GO:0030149 |
1.65% |
sphingolipid catabolic process |
GO:0110020 |
1.65% |
regulation of actomyosin structure organization |
GO:0009740 |
1.65% |
gibberellic acid mediated signaling pathway |
GO:0046471 |
1.65% |
phosphatidylglycerol metabolic process |
GO:1903050 |
1.65% |
regulation of proteolysis involved in cellular protein catabolic process |
GO:0060562 |
1.65% |
epithelial tube morphogenesis |
GO:0050691 |
1.65% |
regulation of defense response to virus by host |
GO:0006942 |
1.65% |
regulation of striated muscle contraction |
GO:0050954 |
1.65% |
sensory perception of mechanical stimulus |
GO:0002028 |
1.65% |
regulation of sodium ion transport |
GO:0002832 |
1.65% |
negative regulation of response to biotic stimulus |
GO:0006458 |
1.65% |
'de novo' protein folding |
GO:0007612 |
1.65% |
learning |
GO:0110148 |
1.65% |
biomineralization |
GO:0043966 |
1.65% |
histone H3 acetylation |
GO:0001503 |
1.64% |
ossification |
GO:0006366 |
1.64% |
transcription by RNA polymerase II |
GO:2001020 |
1.64% |
regulation of response to DNA damage stimulus |
GO:0000469 |
1.64% |
cleavage involved in rRNA processing |
GO:0001570 |
1.64% |
vasculogenesis |
GO:2000242 |
1.64% |
negative regulation of reproductive process |
GO:0022029 |
1.64% |
telencephalon cell migration |
GO:0097306 |
1.64% |
cellular response to alcohol |
GO:0006084 |
1.64% |
acetyl-CoA metabolic process |
GO:0098742 |
1.64% |
cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0035459 |
1.63% |
vesicle cargo loading |
GO:0034644 |
1.63% |
cellular response to UV |
GO:0032648 |
1.63% |
regulation of interferon-beta production |
GO:0019954 |
1.63% |
asexual reproduction |
GO:0034389 |
1.63% |
lipid droplet organization |
GO:0071219 |
1.63% |
cellular response to molecule of bacterial origin |
GO:0070536 |
1.63% |
protein K63-linked deubiquitination |
GO:0046716 |
1.63% |
muscle cell cellular homeostasis |
GO:0034724 |
1.62% |
DNA replication-independent nucleosome organization |
GO:0061138 |
1.62% |
morphogenesis of a branching epithelium |
GO:0002526 |
1.62% |
acute inflammatory response |
GO:0045861 |
1.62% |
negative regulation of proteolysis |
GO:0019217 |
1.62% |
regulation of fatty acid metabolic process |
GO:0043524 |
1.62% |
negative regulation of neuron apoptotic process |
GO:2000027 |
1.62% |
regulation of animal organ morphogenesis |
GO:0040013 |
1.62% |
negative regulation of locomotion |
GO:0048857 |
1.62% |
neural nucleus development |
GO:0060348 |
1.62% |
bone development |
GO:0008306 |
1.62% |
associative learning |
GO:0030178 |
1.62% |
negative regulation of Wnt signaling pathway |
GO:0017157 |
1.61% |
regulation of exocytosis |
GO:0018149 |
1.61% |
peptide cross-linking |
GO:0046578 |
1.61% |
regulation of Ras protein signal transduction |
GO:2001251 |
1.61% |
negative regulation of chromosome organization |
GO:0051271 |
1.61% |
negative regulation of cellular component movement |
GO:0016180 |
1.61% |
snRNA processing |
GO:2000058 |
1.61% |
regulation of ubiquitin-dependent protein catabolic process |
GO:0048532 |
1.61% |
anatomical structure arrangement |
GO:0140253 |
1.61% |
cell-cell fusion |
GO:0030218 |
1.61% |
erythrocyte differentiation |
GO:0002218 |
1.61% |
activation of innate immune response |
GO:0018107 |
1.61% |
peptidyl-threonine phosphorylation |
GO:0050773 |
1.61% |
regulation of dendrite development |
GO:0007264 |
1.60% |
small GTPase mediated signal transduction |
GO:0008643 |
1.60% |
carbohydrate transport |
GO:0048544 |
1.60% |
recognition of pollen |
GO:0046128 |
1.60% |
purine ribonucleoside metabolic process |
GO:0050817 |
1.60% |
coagulation |
GO:0030010 |
1.60% |
establishment of cell polarity |
GO:0051216 |
1.60% |
cartilage development |
GO:0071375 |
1.60% |
cellular response to peptide hormone stimulus |
GO:0042462 |
1.60% |
eye photoreceptor cell development |
GO:0018022 |
1.60% |
peptidyl-lysine methylation |
GO:0010662 |
1.60% |
regulation of striated muscle cell apoptotic process |
GO:0035458 |
1.60% |
cellular response to interferon-beta |
GO:0016239 |
1.60% |
positive regulation of macroautophagy |
GO:0002251 |
1.60% |
organ or tissue specific immune response |
GO:0007608 |
1.60% |
sensory perception of smell |
GO:0050865 |
1.60% |
regulation of cell activation |
GO:0045216 |
1.60% |
cell-cell junction organization |
GO:0045132 |
1.60% |
meiotic chromosome segregation |
GO:0010226 |
1.60% |
response to lithium ion |
GO:0002784 |
1.60% |
regulation of antimicrobial peptide production |
GO:0007093 |
1.60% |
mitotic cell cycle checkpoint |
GO:0042149 |
1.60% |
cellular response to glucose starvation |
GO:0030968 |
1.60% |
endoplasmic reticulum unfolded protein response |
GO:0045666 |
1.59% |
positive regulation of neuron differentiation |
GO:0046883 |
1.59% |
regulation of hormone secretion |
GO:0072595 |
1.59% |
maintenance of protein localization in organelle |
GO:0010823 |
1.59% |
negative regulation of mitochondrion organization |
GO:0031644 |
1.59% |
regulation of nervous system process |
GO:0034629 |
1.59% |
cellular protein-containing complex localization |
GO:0048754 |
1.59% |
branching morphogenesis of an epithelial tube |
GO:0043331 |
1.59% |
response to dsRNA |
GO:0007602 |
1.59% |
phototransduction |
GO:0046854 |
1.59% |
phosphatidylinositol phosphorylation |
GO:0007009 |
1.59% |
plasma membrane organization |
GO:0042326 |
1.59% |
negative regulation of phosphorylation |
GO:0000289 |
1.58% |
nuclear-transcribed mRNA poly(A) tail shortening |
GO:0048738 |
1.58% |
cardiac muscle tissue development |
GO:0071426 |
1.58% |
ribonucleoprotein complex export from nucleus |
GO:0042546 |
1.58% |
cell wall biogenesis |
GO:0006289 |
1.58% |
nucleotide-excision repair |
GO:0006544 |
1.58% |
glycine metabolic process |
GO:0045598 |
1.58% |
regulation of fat cell differentiation |
GO:0040017 |
1.58% |
positive regulation of locomotion |
GO:0010171 |
1.58% |
body morphogenesis |
GO:1904018 |
1.58% |
positive regulation of vasculature development |
GO:0045721 |
1.58% |
negative regulation of gluconeogenesis |
GO:1903828 |
1.58% |
negative regulation of cellular protein localization |
GO:0040020 |
1.58% |
regulation of meiotic nuclear division |
GO:0050806 |
1.58% |
positive regulation of synaptic transmission |
GO:0000083 |
1.58% |
regulation of transcription involved in G1/S transition of mitotic cell cycle |
GO:0008038 |
1.58% |
neuron recognition |
GO:0031023 |
1.58% |
microtubule organizing center organization |
GO:0034330 |
1.57% |
cell junction organization |
GO:0120032 |
1.57% |
regulation of plasma membrane bounded cell projection assembly |
GO:0000479 |
1.57% |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0000027 |
1.57% |
ribosomal large subunit assembly |
GO:0090287 |
1.57% |
regulation of cellular response to growth factor stimulus |
GO:0010631 |
1.57% |
epithelial cell migration |
GO:1903706 |
1.57% |
regulation of hemopoiesis |
GO:1901991 |
1.57% |
negative regulation of mitotic cell cycle phase transition |
GO:0061564 |
1.57% |
axon development |
GO:0006641 |
1.57% |
triglyceride metabolic process |
GO:0000478 |
1.57% |
endonucleolytic cleavage involved in rRNA processing |
GO:1905392 |
1.57% |
plant organ morphogenesis |
GO:0009913 |
1.56% |
epidermal cell differentiation |
GO:0010632 |
1.56% |
regulation of epithelial cell migration |
GO:2000280 |
1.56% |
regulation of root development |
GO:0051084 |
1.56% |
'de novo' posttranslational protein folding |
GO:0030522 |
1.56% |
intracellular receptor signaling pathway |
GO:1903320 |
1.56% |
regulation of protein modification by small protein conjugation or removal |
GO:0071514 |
1.56% |
genetic imprinting |
GO:0015672 |
1.56% |
monovalent inorganic cation transport |
GO:0009268 |
1.56% |
response to pH |
GO:0034220 |
1.56% |
ion transmembrane transport |
GO:0043174 |
1.56% |
nucleoside salvage |
GO:1900180 |
1.56% |
regulation of protein localization to nucleus |
GO:0097009 |
1.55% |
energy homeostasis |
GO:0051090 |
1.55% |
regulation of DNA-binding transcription factor activity |
GO:0042044 |
1.55% |
fluid transport |
GO:0002239 |
1.55% |
response to oomycetes |
GO:0098534 |
1.55% |
centriole assembly |
GO:1901989 |
1.55% |
positive regulation of cell cycle phase transition |
GO:0045936 |
1.55% |
negative regulation of phosphate metabolic process |
GO:0002229 |
1.55% |
defense response to oomycetes |
GO:0001818 |
1.55% |
negative regulation of cytokine production |
GO:0043457 |
1.55% |
regulation of cellular respiration |
GO:0006071 |
1.55% |
glycerol metabolic process |
GO:0002698 |
1.55% |
negative regulation of immune effector process |
GO:0007596 |
1.55% |
blood coagulation |
GO:0007599 |
1.55% |
hemostasis |
GO:0009880 |
1.55% |
embryonic pattern specification |
GO:0001501 |
1.55% |
skeletal system development |
GO:0007254 |
1.55% |
JNK cascade |
GO:0080154 |
1.55% |
regulation of fertilization |
GO:0071230 |
1.55% |
cellular response to amino acid stimulus |
GO:0007164 |
1.55% |
establishment of tissue polarity |
GO:0032878 |
1.55% |
regulation of establishment or maintenance of cell polarity |
GO:1905818 |
1.55% |
regulation of chromosome separation |
GO:0030728 |
1.54% |
ovulation |
GO:0021795 |
1.54% |
cerebral cortex cell migration |
GO:0042744 |
1.54% |
hydrogen peroxide catabolic process |
GO:0031152 |
1.54% |
aggregation involved in sorocarp development |
GO:0000737 |
1.54% |
DNA catabolic process, endonucleolytic |
GO:0007179 |
1.54% |
transforming growth factor beta receptor signaling pathway |
GO:1902099 |
1.54% |
regulation of metaphase/anaphase transition of cell cycle |
GO:0009584 |
1.54% |
detection of visible light |
GO:0006359 |
1.54% |
regulation of transcription by RNA polymerase III |
GO:0050000 |
1.54% |
chromosome localization |
GO:0046339 |
1.54% |
diacylglycerol metabolic process |
GO:0003206 |
1.54% |
cardiac chamber morphogenesis |
GO:2000146 |
1.54% |
negative regulation of cell motility |
GO:0007229 |
1.54% |
integrin-mediated signaling pathway |
GO:0007631 |
1.54% |
feeding behavior |
GO:0008045 |
1.54% |
motor neuron axon guidance |
GO:0010972 |
1.54% |
negative regulation of G2/M transition of mitotic cell cycle |
GO:0034394 |
1.53% |
protein localization to cell surface |
GO:0007444 |
1.53% |
imaginal disc development |
GO:0071545 |
1.53% |
inositol phosphate catabolic process |
GO:0016073 |
1.53% |
snRNA metabolic process |
GO:0030278 |
1.53% |
regulation of ossification |
GO:0010563 |
1.53% |
negative regulation of phosphorus metabolic process |
GO:0042439 |
1.53% |
ethanolamine-containing compound metabolic process |
GO:0090316 |
1.53% |
positive regulation of intracellular protein transport |
GO:0046999 |
1.53% |
regulation of conjugation |
GO:1903362 |
1.52% |
regulation of cellular protein catabolic process |
GO:0007186 |
1.52% |
G protein-coupled receptor signaling pathway |
GO:0045488 |
1.52% |
pectin metabolic process |
GO:0030166 |
1.52% |
proteoglycan biosynthetic process |
GO:0030336 |
1.52% |
negative regulation of cell migration |
GO:0042461 |
1.52% |
photoreceptor cell development |
GO:0022612 |
1.52% |
gland morphogenesis |
GO:0006024 |
1.52% |
glycosaminoglycan biosynthetic process |
GO:0120178 |
1.52% |
steroid hormone biosynthetic process |
GO:1903317 |
1.52% |
regulation of protein maturation |
GO:0033046 |
1.52% |
negative regulation of sister chromatid segregation |
GO:0022409 |
1.52% |
positive regulation of cell-cell adhesion |
GO:0048259 |
1.52% |
regulation of receptor-mediated endocytosis |
GO:0030856 |
1.52% |
regulation of epithelial cell differentiation |
GO:0051170 |
1.52% |
import into nucleus |
GO:0014072 |
1.52% |
response to isoquinoline alkaloid |
GO:0045292 |
1.52% |
mRNA cis splicing, via spliceosome |
GO:0044458 |
1.52% |
motile cilium assembly |
GO:0032944 |
1.52% |
regulation of mononuclear cell proliferation |
GO:1901988 |
1.52% |
negative regulation of cell cycle phase transition |
GO:0045663 |
1.51% |
positive regulation of myoblast differentiation |
GO:0045494 |
1.51% |
photoreceptor cell maintenance |
GO:1903522 |
1.51% |
regulation of blood circulation |
GO:0032456 |
1.51% |
endocytic recycling |
GO:0006353 |
1.51% |
DNA-templated transcription, termination |
GO:1903421 |
1.51% |
regulation of synaptic vesicle recycling |
GO:0043462 |
1.51% |
regulation of ATPase activity |
GO:0034504 |
1.51% |
protein localization to nucleus |
GO:0030866 |
1.51% |
cortical actin cytoskeleton organization |
GO:0046838 |
1.51% |
phosphorylated carbohydrate dephosphorylation |
GO:0006379 |
1.51% |
mRNA cleavage |
GO:0006450 |
1.51% |
regulation of translational fidelity |
GO:0010453 |
1.51% |
regulation of cell fate commitment |
GO:1905477 |
1.51% |
positive regulation of protein localization to membrane |
GO:0051784 |
1.51% |
negative regulation of nuclear division |
GO:0030073 |
1.50% |
insulin secretion |
GO:0031346 |
1.50% |
positive regulation of cell projection organization |
GO:1903725 |
1.50% |
regulation of phospholipid metabolic process |
GO:0006611 |
1.50% |
protein export from nucleus |
GO:0043484 |
1.50% |
regulation of RNA splicing |
GO:0044839 |
1.50% |
cell cycle G2/M phase transition |
GO:0006029 |
1.50% |
proteoglycan metabolic process |
GO:0007423 |
1.50% |
sensory organ development |
GO:0030858 |
1.50% |
positive regulation of epithelial cell differentiation |
GO:0032069 |
1.50% |
regulation of nuclease activity |
GO:0070663 |
1.50% |
regulation of leukocyte proliferation |
GO:0007007 |
1.50% |
inner mitochondrial membrane organization |
GO:0014823 |
1.50% |
response to activity |
GO:0070303 |
1.50% |
negative regulation of stress-activated protein kinase signaling cascade |
GO:0060047 |
1.50% |
heart contraction |
GO:0070592 |
1.50% |
cell wall polysaccharide biosynthetic process |
GO:0014075 |
1.50% |
response to amine |
GO:0043627 |
1.50% |
response to estrogen |
GO:0006007 |
1.50% |
glucose catabolic process |
GO:0060674 |
1.49% |
placenta blood vessel development |
GO:0051985 |
1.49% |
negative regulation of chromosome segregation |
GO:0002385 |
1.49% |
mucosal immune response |
GO:0043547 |
1.49% |
positive regulation of GTPase activity |
GO:0016578 |
1.49% |
histone deubiquitination |
GO:0050678 |
1.49% |
regulation of epithelial cell proliferation |
GO:2000106 |
1.49% |
regulation of leukocyte apoptotic process |
GO:0010665 |
1.49% |
regulation of cardiac muscle cell apoptotic process |
GO:0044804 |
1.49% |
autophagy of nucleus |
GO:0006941 |
1.49% |
striated muscle contraction |
GO:0051653 |
1.49% |
spindle localization |
GO:0050770 |
1.49% |
regulation of axonogenesis |
GO:0007043 |
1.49% |
cell-cell junction assembly |
GO:0030260 |
1.49% |
entry into host cell |
GO:0007143 |
1.49% |
female meiotic nuclear division |
GO:0010286 |
1.49% |
heat acclimation |
GO:0070286 |
1.48% |
axonemal dynein complex assembly |
GO:0021987 |
1.48% |
cerebral cortex development |
GO:0006775 |
1.48% |
fat-soluble vitamin metabolic process |
GO:0002757 |
1.48% |
immune response-activating signal transduction |
GO:0033048 |
1.48% |
negative regulation of mitotic sister chromatid segregation |
GO:0006906 |
1.48% |
vesicle fusion |
GO:0031570 |
1.48% |
DNA integrity checkpoint |
GO:0098660 |
1.48% |
inorganic ion transmembrane transport |
GO:0043408 |
1.48% |
regulation of MAPK cascade |
GO:0010965 |
1.48% |
regulation of mitotic sister chromatid separation |
GO:0070328 |
1.48% |
triglyceride homeostasis |
GO:0042659 |
1.48% |
regulation of cell fate specification |
GO:0010324 |
1.48% |
membrane invagination |
GO:1904029 |
1.48% |
regulation of cyclin-dependent protein kinase activity |
GO:1902074 |
1.48% |
response to salt |
GO:0015850 |
1.48% |
organic hydroxy compound transport |
GO:0032786 |
1.48% |
positive regulation of DNA-templated transcription, elongation |
GO:0007041 |
1.48% |
lysosomal transport |
GO:0032873 |
1.48% |
negative regulation of stress-activated MAPK cascade |
GO:0051961 |
1.47% |
negative regulation of nervous system development |
GO:0048771 |
1.47% |
tissue remodeling |
GO:0000054 |
1.47% |
ribosomal subunit export from nucleus |
GO:0048704 |
1.47% |
embryonic skeletal system morphogenesis |
GO:0001775 |
1.47% |
cell activation |
GO:0035176 |
1.47% |
social behavior |
GO:0021915 |
1.47% |
neural tube development |
GO:0018298 |
1.47% |
protein-chromophore linkage |
GO:1900024 |
1.47% |
regulation of substrate adhesion-dependent cell spreading |
GO:0060541 |
1.47% |
respiratory system development |
GO:1900182 |
1.47% |
positive regulation of protein localization to nucleus |
GO:2001039 |
1.47% |
negative regulation of cellular response to drug |
GO:0051865 |
1.47% |
protein autoubiquitination |
GO:0008016 |
1.47% |
regulation of heart contraction |
GO:0090162 |
1.47% |
establishment of epithelial cell polarity |
GO:0032370 |
1.47% |
positive regulation of lipid transport |
GO:0006661 |
1.47% |
phosphatidylinositol biosynthetic process |
GO:0006891 |
1.47% |
intra-Golgi vesicle-mediated transport |
GO:1902750 |
1.47% |
negative regulation of cell cycle G2/M phase transition |
GO:1901992 |
1.47% |
positive regulation of mitotic cell cycle phase transition |
GO:1905475 |
1.46% |
regulation of protein localization to membrane |
GO:0071222 |
1.46% |
cellular response to lipopolysaccharide |
GO:0055083 |
1.46% |
monovalent inorganic anion homeostasis |
GO:0042451 |
1.46% |
purine nucleoside biosynthetic process |
GO:0097191 |
1.46% |
extrinsic apoptotic signaling pathway |
GO:0071322 |
1.46% |
cellular response to carbohydrate stimulus |
GO:0010507 |
1.46% |
negative regulation of autophagy |
GO:0016237 |
1.46% |
lysosomal microautophagy |
GO:0033866 |
1.46% |
nucleoside bisphosphate biosynthetic process |
GO:0045637 |
1.46% |
regulation of myeloid cell differentiation |
GO:0009103 |
1.46% |
lipopolysaccharide biosynthetic process |
GO:0071331 |
1.46% |
cellular response to hexose stimulus |
GO:0006521 |
1.46% |
regulation of cellular amino acid metabolic process |
GO:0030091 |
1.46% |
protein repair |
GO:0010288 |
1.46% |
response to lead ion |
GO:0051051 |
1.46% |
negative regulation of transport |
GO:0035150 |
1.46% |
regulation of tube size |
GO:0051781 |
1.46% |
positive regulation of cell division |
GO:0002573 |
1.46% |
myeloid leukocyte differentiation |
GO:0016553 |
1.46% |
base conversion or substitution editing |
GO:0071300 |
1.46% |
cellular response to retinoic acid |
GO:0055090 |
1.46% |
acylglycerol homeostasis |
GO:0032271 |
1.46% |
regulation of protein polymerization |
GO:0001894 |
1.46% |
tissue homeostasis |
GO:0031396 |
1.45% |
regulation of protein ubiquitination |
GO:0044409 |
1.45% |
entry into host |
GO:1902930 |
1.45% |
regulation of alcohol biosynthetic process |
GO:0008298 |
1.45% |
intracellular mRNA localization |
GO:1905819 |
1.45% |
negative regulation of chromosome separation |
GO:0008286 |
1.45% |
insulin receptor signaling pathway |
GO:0002703 |
1.45% |
regulation of leukocyte mediated immunity |
GO:0022602 |
1.45% |
ovulation cycle process |
GO:0032374 |
1.45% |
regulation of cholesterol transport |
GO:0010410 |
1.45% |
hemicellulose metabolic process |
GO:0043954 |
1.45% |
cellular component maintenance |
GO:1903055 |
1.45% |
positive regulation of extracellular matrix organization |
GO:0001933 |
1.45% |
negative regulation of protein phosphorylation |
GO:2000116 |
1.45% |
regulation of cysteine-type endopeptidase activity |
GO:0060606 |
1.45% |
tube closure |
GO:0061077 |
1.45% |
chaperone-mediated protein folding |
GO:0010811 |
1.45% |
positive regulation of cell-substrate adhesion |
GO:0032869 |
1.45% |
cellular response to insulin stimulus |
GO:0006368 |
1.45% |
transcription elongation from RNA polymerase II promoter |
GO:0030201 |
1.44% |
heparan sulfate proteoglycan metabolic process |
GO:0001843 |
1.44% |
neural tube closure |
GO:0051054 |
1.44% |
positive regulation of DNA metabolic process |
GO:0007638 |
1.44% |
mechanosensory behavior |
GO:0035437 |
1.44% |
maintenance of protein localization in endoplasmic reticulum |
GO:0046855 |
1.44% |
inositol phosphate dephosphorylation |
GO:0006376 |
1.44% |
mRNA splice site selection |
GO:0016525 |
1.44% |
negative regulation of angiogenesis |
GO:1905897 |
1.44% |
regulation of response to endoplasmic reticulum stress |
GO:0002694 |
1.44% |
regulation of leukocyte activation |
GO:2000181 |
1.44% |
negative regulation of blood vessel morphogenesis |
GO:0048863 |
1.44% |
stem cell differentiation |
GO:0007020 |
1.44% |
microtubule nucleation |
GO:0046718 |
1.44% |
viral entry into host cell |
GO:0000079 |
1.44% |
regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0090276 |
1.44% |
regulation of peptide hormone secretion |
GO:1902410 |
1.44% |
mitotic cytokinetic process |
GO:0032481 |
1.44% |
positive regulation of type I interferon production |
GO:1901072 |
1.43% |
glucosamine-containing compound catabolic process |
GO:0061912 |
1.43% |
selective autophagy |
GO:0030574 |
1.43% |
collagen catabolic process |
GO:1905269 |
1.43% |
positive regulation of chromatin organization |
GO:0010393 |
1.43% |
galacturonan metabolic process |
GO:1901343 |
1.43% |
negative regulation of vasculature development |
GO:0006336 |
1.43% |
DNA replication-independent nucleosome assembly |
GO:0006403 |
1.43% |
RNA localization |
GO:0008156 |
1.43% |
negative regulation of DNA replication |
GO:0048563 |
1.43% |
post-embryonic animal organ morphogenesis |
GO:0001707 |
1.43% |
mesoderm formation |
GO:0030204 |
1.43% |
chondroitin sulfate metabolic process |
GO:0071071 |
1.43% |
regulation of phospholipid biosynthetic process |
GO:0000460 |
1.43% |
maturation of 5.8S rRNA |
GO:0034243 |
1.43% |
regulation of transcription elongation from RNA polymerase II promoter |
GO:0051447 |
1.43% |
negative regulation of meiotic cell cycle |
GO:0008630 |
1.43% |
intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0050796 |
1.43% |
regulation of insulin secretion |
GO:1901653 |
1.43% |
cellular response to peptide |
GO:2000816 |
1.43% |
negative regulation of mitotic sister chromatid separation |
GO:2000142 |
1.43% |
regulation of DNA-templated transcription, initiation |
GO:0042026 |
1.42% |
protein refolding |
GO:1901655 |
1.42% |
cellular response to ketone |
GO:0043967 |
1.42% |
histone H4 acetylation |
GO:0031137 |
1.42% |
regulation of conjugation with cellular fusion |
GO:0034030 |
1.42% |
ribonucleoside bisphosphate biosynthetic process |
GO:1900046 |
1.42% |
regulation of hemostasis |
GO:1905515 |
1.42% |
non-motile cilium assembly |
GO:0001708 |
1.42% |
cell fate specification |
GO:0032094 |
1.42% |
response to food |
GO:0051785 |
1.42% |
positive regulation of nuclear division |
GO:0009401 |
1.42% |
phosphoenolpyruvate-dependent sugar phosphotransferase system |
GO:0098630 |
1.42% |
aggregation of unicellular organisms |
GO:0060148 |
1.42% |
positive regulation of posttranscriptional gene silencing |
GO:0051346 |
1.42% |
negative regulation of hydrolase activity |
GO:0050768 |
1.42% |
negative regulation of neurogenesis |
GO:0098662 |
1.42% |
inorganic cation transmembrane transport |
GO:0042403 |
1.42% |
thyroid hormone metabolic process |
GO:0098655 |
1.42% |
cation transmembrane transport |
GO:0007476 |
1.42% |
imaginal disc-derived wing morphogenesis |
GO:0043330 |
1.42% |
response to exogenous dsRNA |
GO:0046129 |
1.42% |
purine ribonucleoside biosynthetic process |
GO:0035194 |
1.41% |
posttranscriptional gene silencing by RNA |
GO:0033750 |
1.41% |
ribosome localization |
GO:0060021 |
1.41% |
roof of mouth development |
GO:0007099 |
1.41% |
centriole replication |
GO:0048640 |
1.41% |
negative regulation of developmental growth |
GO:0071731 |
1.41% |
response to nitric oxide |
GO:1901998 |
1.41% |
toxin transport |
GO:0070542 |
1.41% |
response to fatty acid |
GO:0006278 |
1.41% |
RNA-dependent DNA biosynthetic process |
GO:0034033 |
1.41% |
purine nucleoside bisphosphate biosynthetic process |
GO:0030243 |
1.41% |
cellulose metabolic process |
GO:0042119 |
1.41% |
neutrophil activation |
GO:0045665 |
1.40% |
negative regulation of neuron differentiation |
GO:0030071 |
1.40% |
regulation of mitotic metaphase/anaphase transition |
GO:0070997 |
1.40% |
neuron death |
GO:0002062 |
1.40% |
chondrocyte differentiation |
GO:0010976 |
1.40% |
positive regulation of neuron projection development |
GO:0048741 |
1.40% |
skeletal muscle fiber development |
GO:0045948 |
1.40% |
positive regulation of translational initiation |
GO:0034329 |
1.40% |
cell junction assembly |
GO:0006282 |
1.40% |
regulation of DNA repair |
GO:0010765 |
1.40% |
positive regulation of sodium ion transport |
GO:1905393 |
1.40% |
plant organ formation |
GO:0032368 |
1.40% |
regulation of lipid transport |
GO:0048821 |
1.40% |
erythrocyte development |
GO:0060966 |
1.40% |
regulation of gene silencing by RNA |
GO:0099024 |
1.40% |
plasma membrane invagination |
GO:0000082 |
1.40% |
G1/S transition of mitotic cell cycle |
GO:0034472 |
1.40% |
snRNA 3'-end processing |
GO:0015936 |
1.40% |
coenzyme A metabolic process |
GO:0000768 |
1.40% |
syncytium formation by plasma membrane fusion |
GO:0021954 |
1.40% |
central nervous system neuron development |
GO:2001238 |
1.40% |
positive regulation of extrinsic apoptotic signaling pathway |
GO:0032480 |
1.40% |
negative regulation of type I interferon production |
GO:0010667 |
1.40% |
negative regulation of cardiac muscle cell apoptotic process |
GO:0070613 |
1.40% |
regulation of protein processing |
GO:0070570 |
1.40% |
regulation of neuron projection regeneration |
GO:1903053 |
1.40% |
regulation of extracellular matrix organization |
GO:0010594 |
1.39% |
regulation of endothelial cell migration |
GO:0046112 |
1.39% |
nucleobase biosynthetic process |
GO:0006626 |
1.39% |
protein targeting to mitochondrion |
GO:0048747 |
1.39% |
muscle fiber development |
GO:0090313 |
1.39% |
regulation of protein targeting to membrane |
GO:0030301 |
1.39% |
cholesterol transport |
GO:0048008 |
1.39% |
platelet-derived growth factor receptor signaling pathway |
GO:0060491 |
1.39% |
regulation of cell projection assembly |
GO:0010717 |
1.39% |
regulation of epithelial to mesenchymal transition |
GO:0003143 |
1.39% |
embryonic heart tube morphogenesis |
GO:0007338 |
1.39% |
single fertilization |
GO:0090092 |
1.39% |
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0051650 |
1.39% |
establishment of vesicle localization |
GO:0002429 |
1.39% |
immune response-activating cell surface receptor signaling pathway |
GO:0035967 |
1.39% |
cellular response to topologically incorrect protein |
GO:0010884 |
1.39% |
positive regulation of lipid storage |
GO:0030500 |
1.39% |
regulation of bone mineralization |
GO:0006968 |
1.39% |
cellular defense response |
GO:2001024 |
1.39% |
negative regulation of response to drug |
GO:0002764 |
1.39% |
immune response-regulating signaling pathway |
GO:1903034 |
1.39% |
regulation of response to wounding |
GO:0038127 |
1.38% |
ERBB signaling pathway |
GO:0042177 |
1.38% |
negative regulation of protein catabolic process |
GO:0006110 |
1.38% |
regulation of glycolytic process |
GO:0050851 |
1.38% |
antigen receptor-mediated signaling pathway |
GO:0032371 |
1.38% |
regulation of sterol transport |
GO:0008088 |
1.38% |
axo-dendritic transport |
GO:0032465 |
1.38% |
regulation of cytokinesis |
GO:0071459 |
1.38% |
protein localization to chromosome, centromeric region |
GO:0009637 |
1.38% |
response to blue light |
GO:0042273 |
1.38% |
ribosomal large subunit biogenesis |
GO:0050909 |
1.38% |
sensory perception of taste |
GO:0098743 |
1.38% |
cell aggregation |
GO:0002027 |
1.38% |
regulation of heart rate |
GO:0097237 |
1.38% |
cellular response to toxic substance |
GO:0030261 |
1.38% |
chromosome condensation |
GO:0043101 |
1.38% |
purine-containing compound salvage |
GO:0010950 |
1.38% |
positive regulation of endopeptidase activity |
GO:1903532 |
1.38% |
positive regulation of secretion by cell |
GO:0007628 |
1.37% |
adult walking behavior |
GO:0051648 |
1.37% |
vesicle localization |
GO:0051965 |
1.37% |
positive regulation of synapse assembly |
GO:0007435 |
1.37% |
salivary gland morphogenesis |
GO:0071333 |
1.37% |
cellular response to glucose stimulus |
GO:0090181 |
1.37% |
regulation of cholesterol metabolic process |
GO:0007632 |
1.37% |
visual behavior |
GO:0035337 |
1.37% |
fatty-acyl-CoA metabolic process |
GO:0034968 |
1.37% |
histone lysine methylation |
GO:0090174 |
1.37% |
organelle membrane fusion |
GO:0030244 |
1.37% |
cellulose biosynthetic process |
GO:0006890 |
1.37% |
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
GO:0043278 |
1.37% |
response to morphine |
GO:0043173 |
1.37% |
nucleotide salvage |
GO:0032728 |
1.37% |
positive regulation of interferon-beta production |
GO:0000018 |
1.37% |
regulation of DNA recombination |
GO:0006953 |
1.37% |
acute-phase response |
GO:0072529 |
1.37% |
pyrimidine-containing compound catabolic process |
GO:1901222 |
1.37% |
regulation of NIK/NF-kappaB signaling |
GO:0001824 |
1.37% |
blastocyst development |
GO:0051101 |
1.37% |
regulation of DNA binding |
GO:0003018 |
1.37% |
vascular process in circulatory system |
GO:1903845 |
1.37% |
negative regulation of cellular response to transforming growth factor beta stimulus |
GO:0048709 |
1.37% |
oligodendrocyte differentiation |
GO:0070167 |
1.37% |
regulation of biomineral tissue development |
GO:0019856 |
1.36% |
pyrimidine nucleobase biosynthetic process |
GO:0007595 |
1.36% |
lactation |
GO:0008544 |
1.36% |
epidermis development |
GO:0007162 |
1.36% |
negative regulation of cell adhesion |
GO:0017156 |
1.36% |
calcium-ion regulated exocytosis |
GO:0071326 |
1.36% |
cellular response to monosaccharide stimulus |
GO:0051446 |
1.36% |
positive regulation of meiotic cell cycle |
GO:1990138 |
1.36% |
neuron projection extension |
GO:0017148 |
1.36% |
negative regulation of translation |
GO:0008356 |
1.36% |
asymmetric cell division |
GO:0032781 |
1.36% |
positive regulation of ATPase activity |
GO:0017145 |
1.36% |
stem cell division |
GO:0070071 |
1.36% |
proton-transporting two-sector ATPase complex assembly |
GO:0000819 |
1.36% |
sister chromatid segregation |
GO:0045943 |
1.36% |
positive regulation of transcription by RNA polymerase I |
GO:0036075 |
1.36% |
replacement ossification |
GO:0051339 |
1.36% |
regulation of lyase activity |
GO:0050906 |
1.35% |
detection of stimulus involved in sensory perception |
GO:0007588 |
1.35% |
excretion |
GO:0000463 |
1.35% |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0060325 |
1.35% |
face morphogenesis |
GO:0002274 |
1.35% |
myeloid leukocyte activation |
GO:0009649 |
1.35% |
entrainment of circadian clock |
GO:0071363 |
1.35% |
cellular response to growth factor stimulus |
GO:0017085 |
1.35% |
response to insecticide |
GO:0085029 |
1.35% |
extracellular matrix assembly |
GO:0010977 |
1.35% |
negative regulation of neuron projection development |
GO:0071025 |
1.35% |
RNA surveillance |
GO:0050714 |
1.35% |
positive regulation of protein secretion |
GO:0009262 |
1.35% |
deoxyribonucleotide metabolic process |
GO:0035336 |
1.35% |
long-chain fatty-acyl-CoA metabolic process |
GO:0050805 |
1.35% |
negative regulation of synaptic transmission |
GO:0046902 |
1.35% |
regulation of mitochondrial membrane permeability |
GO:0034249 |
1.34% |
negative regulation of cellular amide metabolic process |
GO:0006998 |
1.34% |
nuclear envelope organization |
GO:0007369 |
1.34% |
gastrulation |
GO:0045472 |
1.34% |
response to ether |
GO:0050435 |
1.34% |
amyloid-beta metabolic process |
GO:0090503 |
1.34% |
RNA phosphodiester bond hydrolysis, exonucleolytic |
GO:0010001 |
1.34% |
glial cell differentiation |
GO:0051348 |
1.34% |
negative regulation of transferase activity |
GO:0034764 |
1.34% |
positive regulation of transmembrane transport |
GO:1901658 |
1.34% |
glycosyl compound catabolic process |
GO:0010039 |
1.34% |
response to iron ion |
GO:0065005 |
1.34% |
protein-lipid complex assembly |
GO:0050852 |
1.34% |
T cell receptor signaling pathway |
GO:0071548 |
1.34% |
response to dexamethasone |
GO:0050684 |
1.34% |
regulation of mRNA processing |
GO:0001654 |
1.33% |
eye development |
GO:0046825 |
1.33% |
regulation of protein export from nucleus |
GO:2000177 |
1.33% |
regulation of neural precursor cell proliferation |
GO:0140238 |
1.33% |
presynaptic endocytosis |
GO:0035902 |
1.33% |
response to immobilization stress |
GO:0031288 |
1.33% |
sorocarp morphogenesis |
GO:0000086 |
1.33% |
G2/M transition of mitotic cell cycle |
GO:0010660 |
1.33% |
regulation of muscle cell apoptotic process |
GO:0001947 |
1.33% |
heart looping |
GO:0016331 |
1.33% |
morphogenesis of embryonic epithelium |
GO:1902019 |
1.33% |
regulation of cilium-dependent cell motility |
GO:0071900 |
1.33% |
regulation of protein serine/threonine kinase activity |
GO:0001958 |
1.33% |
endochondral ossification |
GO:0007520 |
1.33% |
myoblast fusion |
GO:0048167 |
1.33% |
regulation of synaptic plasticity |
GO:0046320 |
1.33% |
regulation of fatty acid oxidation |
GO:0001672 |
1.33% |
regulation of chromatin assembly or disassembly |
GO:0021953 |
1.33% |
central nervous system neuron differentiation |
GO:0071371 |
1.33% |
cellular response to gonadotropin stimulus |
GO:0030833 |
1.33% |
regulation of actin filament polymerization |
GO:0061387 |
1.33% |
regulation of extent of cell growth |
GO:0032365 |
1.33% |
intracellular lipid transport |
GO:0044843 |
1.32% |
cell cycle G1/S phase transition |
GO:0007098 |
1.32% |
centrosome cycle |
GO:0048562 |
1.32% |
embryonic organ morphogenesis |
GO:0051272 |
1.32% |
positive regulation of cellular component movement |
GO:0046928 |
1.32% |
regulation of neurotransmitter secretion |
GO:0050686 |
1.32% |
negative regulation of mRNA processing |
GO:0031058 |
1.32% |
positive regulation of histone modification |
GO:0001838 |
1.32% |
embryonic epithelial tube formation |
GO:2000147 |
1.32% |
positive regulation of cell motility |
GO:0016925 |
1.32% |
protein sumoylation |
GO:0048103 |
1.32% |
somatic stem cell division |
GO:0032200 |
1.32% |
telomere organization |
GO:0002275 |
1.32% |
myeloid cell activation involved in immune response |
GO:1903578 |
1.32% |
regulation of ATP metabolic process |
GO:0002263 |
1.32% |
cell activation involved in immune response |
GO:0031397 |
1.32% |
negative regulation of protein ubiquitination |
GO:0072348 |
1.32% |
sulfur compound transport |
GO:0002230 |
1.32% |
positive regulation of defense response to virus by host |
GO:0006166 |
1.32% |
purine ribonucleoside salvage |
GO:1902100 |
1.32% |
negative regulation of metaphase/anaphase transition of cell cycle |
GO:0110149 |
1.32% |
regulation of biomineralization |
GO:0051303 |
1.32% |
establishment of chromosome localization |
GO:0042129 |
1.32% |
regulation of T cell proliferation |
GO:0090329 |
1.31% |
regulation of DNA-dependent DNA replication |
GO:0043525 |
1.31% |
positive regulation of neuron apoptotic process |
GO:0000270 |
1.31% |
peptidoglycan metabolic process |
GO:0010951 |
1.31% |
negative regulation of endopeptidase activity |
GO:0006241 |
1.31% |
CTP biosynthetic process |
GO:0008535 |
1.31% |
respiratory chain complex IV assembly |
GO:0019722 |
1.31% |
calcium-mediated signaling |
GO:0021533 |
1.31% |
cell differentiation in hindbrain |
GO:0045109 |
1.31% |
intermediate filament organization |
GO:0015074 |
1.31% |
DNA integration |
GO:0090322 |
1.31% |
regulation of superoxide metabolic process |
GO:0006207 |
1.31% |
'de novo' pyrimidine nucleobase biosynthetic process |
GO:0071428 |
1.31% |
rRNA-containing ribonucleoprotein complex export from nucleus |
GO:0055067 |
1.31% |
monovalent inorganic cation homeostasis |
GO:0009199 |
1.31% |
ribonucleoside triphosphate metabolic process |
GO:0008653 |
1.31% |
lipopolysaccharide metabolic process |
GO:0035094 |
1.31% |
response to nicotine |
GO:0043620 |
1.31% |
regulation of DNA-templated transcription in response to stress |
GO:0002768 |
1.31% |
immune response-regulating cell surface receptor signaling pathway |
GO:0048679 |
1.31% |
regulation of axon regeneration |
GO:0055074 |
1.31% |
calcium ion homeostasis |
GO:0050670 |
1.31% |
regulation of lymphocyte proliferation |
GO:0045766 |
1.31% |
positive regulation of angiogenesis |
GO:0035114 |
1.30% |
imaginal disc-derived appendage morphogenesis |
GO:0018027 |
1.30% |
peptidyl-lysine dimethylation |
GO:0042634 |
1.30% |
regulation of hair cycle |
GO:0035296 |
1.30% |
regulation of tube diameter |
GO:0051091 |
1.30% |
positive regulation of DNA-binding transcription factor activity |
GO:0000076 |
1.30% |
DNA replication checkpoint |
GO:0030282 |
1.30% |
bone mineralization |
GO:0030177 |
1.30% |
positive regulation of Wnt signaling pathway |
GO:0050996 |
1.30% |
positive regulation of lipid catabolic process |
GO:0030512 |
1.30% |
negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0006465 |
1.30% |
signal peptide processing |
GO:0048525 |
1.30% |
negative regulation of viral process |
GO:0006911 |
1.30% |
phagocytosis, engulfment |
GO:0034332 |
1.30% |
adherens junction organization |
GO:0032048 |
1.30% |
cardiolipin metabolic process |
GO:0009953 |
1.30% |
dorsal/ventral pattern formation |
GO:0010959 |
1.30% |
regulation of metal ion transport |
GO:0002437 |
1.30% |
inflammatory response to antigenic stimulus |
GO:0014904 |
1.29% |
myotube cell development |
GO:0032006 |
1.29% |
regulation of TOR signaling |
GO:0019369 |
1.29% |
arachidonic acid metabolic process |
GO:0051131 |
1.29% |
chaperone-mediated protein complex assembly |
GO:0045841 |
1.29% |
negative regulation of mitotic metaphase/anaphase transition |
GO:0044743 |
1.29% |
protein transmembrane import into intracellular organelle |
GO:0034497 |
1.29% |
protein localization to phagophore assembly site |
GO:0007589 |
1.29% |
body fluid secretion |
GO:0031139 |
1.29% |
positive regulation of conjugation with cellular fusion |
GO:0032007 |
1.29% |
negative regulation of TOR signaling |
GO:0035120 |
1.29% |
post-embryonic appendage morphogenesis |
GO:0009174 |
1.29% |
pyrimidine ribonucleoside monophosphate biosynthetic process |
GO:2000736 |
1.29% |
regulation of stem cell differentiation |
GO:0051249 |
1.29% |
regulation of lymphocyte activation |
GO:0030832 |
1.29% |
regulation of actin filament length |
GO:0032376 |
1.29% |
positive regulation of cholesterol transport |
GO:0046460 |
1.29% |
neutral lipid biosynthetic process |
GO:0090659 |
1.29% |
walking behavior |
GO:0034109 |
1.29% |
homotypic cell-cell adhesion |
GO:0008333 |
1.29% |
endosome to lysosome transport |
GO:0010952 |
1.29% |
positive regulation of peptidase activity |
GO:0001709 |
1.29% |
cell fate determination |
GO:0033032 |
1.29% |
regulation of myeloid cell apoptotic process |
GO:0090208 |
1.29% |
positive regulation of triglyceride metabolic process |
GO:0065002 |
1.29% |
intracellular protein transmembrane transport |
GO:0070848 |
1.28% |
response to growth factor |
GO:2000045 |
1.28% |
regulation of G1/S transition of mitotic cell cycle |
GO:0010466 |
1.28% |
negative regulation of peptidase activity |
GO:0051293 |
1.28% |
establishment of spindle localization |
GO:2001056 |
1.28% |
positive regulation of cysteine-type endopeptidase activity |
GO:0048240 |
1.28% |
sperm capacitation |
GO:0051092 |
1.28% |
positive regulation of NF-kappaB transcription factor activity |
GO:0009832 |
1.28% |
plant-type cell wall biogenesis |
GO:0006874 |
1.28% |
cellular calcium ion homeostasis |
GO:0001523 |
1.28% |
retinoid metabolic process |
GO:0009147 |
1.28% |
pyrimidine nucleoside triphosphate metabolic process |
GO:0045321 |
1.28% |
leukocyte activation |
GO:1903844 |
1.28% |
regulation of cellular response to transforming growth factor beta stimulus |
GO:0030004 |
1.28% |
cellular monovalent inorganic cation homeostasis |
GO:0051966 |
1.28% |
regulation of synaptic transmission, glutamatergic |
GO:1903305 |
1.28% |
regulation of regulated secretory pathway |
GO:0003015 |
1.28% |
heart process |
GO:2000104 |
1.28% |
negative regulation of DNA-dependent DNA replication |
GO:2000756 |
1.28% |
regulation of peptidyl-lysine acetylation |
GO:0009126 |
1.28% |
purine nucleoside monophosphate metabolic process |
GO:0031345 |
1.28% |
negative regulation of cell projection organization |
GO:0090314 |
1.27% |
positive regulation of protein targeting to membrane |
GO:0016137 |
1.27% |
glycoside metabolic process |
GO:0009208 |
1.27% |
pyrimidine ribonucleoside triphosphate metabolic process |
GO:0048488 |
1.27% |
synaptic vesicle endocytosis |
GO:1902751 |
1.27% |
positive regulation of cell cycle G2/M phase transition |
GO:0046627 |
1.27% |
negative regulation of insulin receptor signaling pathway |
GO:0002521 |
1.27% |
leukocyte differentiation |
GO:0051148 |
1.27% |
negative regulation of muscle cell differentiation |
GO:0009129 |
1.27% |
pyrimidine nucleoside monophosphate metabolic process |
GO:0032872 |
1.27% |
regulation of stress-activated MAPK cascade |
GO:0032354 |
1.27% |
response to follicle-stimulating hormone |
GO:0001776 |
1.27% |
leukocyte homeostasis |
GO:0017015 |
1.27% |
regulation of transforming growth factor beta receptor signaling pathway |
GO:0030518 |
1.27% |
intracellular steroid hormone receptor signaling pathway |
GO:0045880 |
1.27% |
positive regulation of smoothened signaling pathway |
GO:0036297 |
1.27% |
interstrand cross-link repair |
GO:0032467 |
1.27% |
positive regulation of cytokinesis |
GO:0010664 |
1.27% |
negative regulation of striated muscle cell apoptotic process |
GO:0045907 |
1.27% |
positive regulation of vasoconstriction |
GO:0006814 |
1.27% |
sodium ion transport |
GO:0009952 |
1.27% |
anterior/posterior pattern specification |
GO:0007614 |
1.27% |
short-term memory |
GO:0043281 |
1.27% |
regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0000212 |
1.27% |
meiotic spindle organization |
GO:0071825 |
1.27% |
protein-lipid complex subunit organization |
GO:0022617 |
1.27% |
extracellular matrix disassembly |
GO:0030900 |
1.27% |
forebrain development |
GO:0021549 |
1.27% |
cerebellum development |
GO:0048844 |
1.27% |
artery morphogenesis |
GO:0050728 |
1.26% |
negative regulation of inflammatory response |
GO:0000077 |
1.26% |
DNA damage checkpoint |
GO:0061448 |
1.26% |
connective tissue development |
GO:0048873 |
1.26% |
homeostasis of number of cells within a tissue |
GO:0002861 |
1.26% |
regulation of inflammatory response to antigenic stimulus |
GO:0045807 |
1.26% |
positive regulation of endocytosis |
GO:0051294 |
1.26% |
establishment of spindle orientation |
GO:0009629 |
1.26% |
response to gravity |
GO:0009606 |
1.26% |
tropism |
GO:1904375 |
1.26% |
regulation of protein localization to cell periphery |
GO:0072384 |
1.26% |
organelle transport along microtubule |
GO:0051952 |
1.26% |
regulation of amine transport |
GO:0007530 |
1.26% |
sex determination |
GO:0046464 |
1.26% |
acylglycerol catabolic process |
GO:0043029 |
1.25% |
T cell homeostasis |
GO:0009950 |
1.25% |
dorsal/ventral axis specification |
GO:0018023 |
1.25% |
peptidyl-lysine trimethylation |
GO:0008543 |
1.25% |
fibroblast growth factor receptor signaling pathway |
GO:0045047 |
1.25% |
protein targeting to ER |
GO:0050766 |
1.25% |
positive regulation of phagocytosis |
GO:0030516 |
1.25% |
regulation of axon extension |
GO:0031577 |
1.25% |
spindle checkpoint |
GO:0042759 |
1.25% |
long-chain fatty acid biosynthetic process |
GO:0002922 |
1.25% |
positive regulation of humoral immune response |
GO:0014013 |
1.25% |
regulation of gliogenesis |
GO:0009127 |
1.25% |
purine nucleoside monophosphate biosynthetic process |
GO:0051875 |
1.25% |
pigment granule localization |
GO:0072507 |
1.25% |
divalent inorganic cation homeostasis |
GO:0071174 |
1.25% |
mitotic spindle checkpoint |
GO:0031136 |
1.25% |
positive regulation of conjugation |
GO:0050673 |
1.25% |
epithelial cell proliferation |
GO:0006474 |
1.25% |
N-terminal protein amino acid acetylation |
GO:0070633 |
1.25% |
transepithelial transport |
GO:0055021 |
1.25% |
regulation of cardiac muscle tissue growth |
GO:0000727 |
1.25% |
double-strand break repair via break-induced replication |
GO:0042220 |
1.25% |
response to cocaine |
GO:0010971 |
1.25% |
positive regulation of G2/M transition of mitotic cell cycle |
GO:0000746 |
1.25% |
conjugation |
GO:0019882 |
1.25% |
antigen processing and presentation |
GO:1903321 |
1.25% |
negative regulation of protein modification by small protein conjugation or removal |
GO:0071347 |
1.25% |
cellular response to interleukin-1 |
GO:0006606 |
1.25% |
protein import into nucleus |
GO:0045600 |
1.25% |
positive regulation of fat cell differentiation |
GO:0045839 |
1.25% |
negative regulation of mitotic nuclear division |
GO:0060147 |
1.25% |
regulation of posttranscriptional gene silencing |
GO:0051123 |
1.24% |
RNA polymerase II preinitiation complex assembly |
GO:1900181 |
1.24% |
negative regulation of protein localization to nucleus |
GO:0043270 |
1.24% |
positive regulation of ion transport |
GO:0043280 |
1.24% |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0071669 |
1.24% |
plant-type cell wall organization or biogenesis |
GO:0001959 |
1.24% |
regulation of cytokine-mediated signaling pathway |
GO:0002366 |
1.24% |
leukocyte activation involved in immune response |
GO:0051570 |
1.24% |
regulation of histone H3-K9 methylation |
GO:0002793 |
1.24% |
positive regulation of peptide secretion |
GO:0051647 |
1.24% |
nucleus localization |
GO:0048678 |
1.24% |
response to axon injury |
GO:0009130 |
1.24% |
pyrimidine nucleoside monophosphate biosynthetic process |
GO:0090698 |
1.24% |
post-embryonic plant morphogenesis |
GO:0031062 |
1.24% |
positive regulation of histone methylation |
GO:0009144 |
1.24% |
purine nucleoside triphosphate metabolic process |
GO:0031338 |
1.24% |
regulation of vesicle fusion |
GO:0051402 |
1.24% |
neuron apoptotic process |
GO:0046328 |
1.24% |
regulation of JNK cascade |
GO:0046475 |
1.24% |
glycerophospholipid catabolic process |
GO:0032946 |
1.24% |
positive regulation of mononuclear cell proliferation |
GO:1901983 |
1.24% |
regulation of protein acetylation |
GO:0046461 |
1.24% |
neutral lipid catabolic process |
GO:0000028 |
1.24% |
ribosomal small subunit assembly |
GO:0006949 |
1.24% |
syncytium formation |
GO:0045835 |
1.24% |
negative regulation of meiotic nuclear division |
GO:0090342 |
1.23% |
regulation of cell aging |
GO:0001837 |
1.23% |
epithelial to mesenchymal transition |
GO:1903901 |
1.23% |
negative regulation of viral life cycle |
GO:0006817 |
1.23% |
phosphate ion transport |
GO:0045746 |
1.23% |
negative regulation of Notch signaling pathway |
GO:0045124 |
1.23% |
regulation of bone resorption |
GO:1902806 |
1.23% |
regulation of cell cycle G1/S phase transition |
GO:0006706 |
1.23% |
steroid catabolic process |
GO:1900087 |
1.23% |
positive regulation of G1/S transition of mitotic cell cycle |
GO:0030335 |
1.23% |
positive regulation of cell migration |
GO:1990845 |
1.23% |
adaptive thermogenesis |
GO:0000723 |
1.23% |
telomere maintenance |
GO:0046620 |
1.23% |
regulation of organ growth |
GO:1902600 |
1.23% |
proton transmembrane transport |
GO:0006513 |
1.23% |
protein monoubiquitination |
GO:0007094 |
1.23% |
mitotic spindle assembly checkpoint |
GO:0000041 |
1.23% |
transition metal ion transport |
GO:0044774 |
1.23% |
mitotic DNA integrity checkpoint |
GO:1903649 |
1.23% |
regulation of cytoplasmic transport |
GO:0035162 |
1.23% |
embryonic hemopoiesis |
GO:0032409 |
1.23% |
regulation of transporter activity |
GO:0045836 |
1.23% |
positive regulation of meiotic nuclear division |
GO:0050873 |
1.22% |
brown fat cell differentiation |
GO:0051588 |
1.22% |
regulation of neurotransmitter transport |
GO:0009201 |
1.22% |
ribonucleoside triphosphate biosynthetic process |
GO:0050679 |
1.22% |
positive regulation of epithelial cell proliferation |
GO:0046463 |
1.22% |
acylglycerol biosynthetic process |
GO:0006896 |
1.22% |
Golgi to vacuole transport |
GO:0002090 |
1.22% |
regulation of receptor internalization |
GO:0051154 |
1.22% |
negative regulation of striated muscle cell differentiation |
GO:0071236 |
1.22% |
cellular response to antibiotic |
GO:1905268 |
1.22% |
negative regulation of chromatin organization |
GO:0046033 |
1.22% |
AMP metabolic process |
GO:0006027 |
1.22% |
glycosaminoglycan catabolic process |
GO:0009168 |
1.22% |
purine ribonucleoside monophosphate biosynthetic process |
GO:0006222 |
1.22% |
UMP biosynthetic process |
GO:0009209 |
1.22% |
pyrimidine ribonucleoside triphosphate biosynthetic process |
GO:0009109 |
1.22% |
coenzyme catabolic process |
GO:0080182 |
1.22% |
histone H3-K4 trimethylation |
GO:0021510 |
1.22% |
spinal cord development |
GO:0032373 |
1.22% |
positive regulation of sterol transport |
GO:0043500 |
1.21% |
muscle adaptation |
GO:1901888 |
1.21% |
regulation of cell junction assembly |
GO:2001233 |
1.21% |
regulation of apoptotic signaling pathway |
GO:0047484 |
1.21% |
regulation of response to osmotic stress |
GO:0060628 |
1.21% |
regulation of ER to Golgi vesicle-mediated transport |
GO:0071466 |
1.21% |
cellular response to xenobiotic stimulus |
GO:0043570 |
1.21% |
maintenance of DNA repeat elements |
GO:0032387 |
1.21% |
negative regulation of intracellular transport |
GO:0000070 |
1.20% |
mitotic sister chromatid segregation |
GO:0050870 |
1.20% |
positive regulation of T cell activation |
GO:0009173 |
1.20% |
pyrimidine ribonucleoside monophosphate metabolic process |
GO:0071709 |
1.20% |
membrane assembly |
GO:0002065 |
1.20% |
columnar/cuboidal epithelial cell differentiation |
GO:0031297 |
1.20% |
replication fork processing |
GO:0009263 |
1.20% |
deoxyribonucleotide biosynthetic process |
GO:0001736 |
1.20% |
establishment of planar polarity |
GO:0006885 |
1.20% |
regulation of pH |
GO:0019731 |
1.20% |
antibacterial humoral response |
GO:0008608 |
1.20% |
attachment of spindle microtubules to kinetochore |
GO:0019432 |
1.20% |
triglyceride biosynthetic process |
GO:0051954 |
1.20% |
positive regulation of amine transport |
GO:0051055 |
1.20% |
negative regulation of lipid biosynthetic process |
GO:0051058 |
1.20% |
negative regulation of small GTPase mediated signal transduction |
GO:0033574 |
1.20% |
response to testosterone |
GO:0033006 |
1.19% |
regulation of mast cell activation involved in immune response |
GO:0010874 |
1.19% |
regulation of cholesterol efflux |
GO:0110053 |
1.19% |
regulation of actin filament organization |
GO:1900006 |
1.19% |
positive regulation of dendrite development |
GO:0010656 |
1.19% |
negative regulation of muscle cell apoptotic process |
GO:0045833 |
1.19% |
negative regulation of lipid metabolic process |
GO:0000470 |
1.19% |
maturation of LSU-rRNA |
GO:0042761 |
1.19% |
very long-chain fatty acid biosynthetic process |
GO:0070374 |
1.19% |
positive regulation of ERK1 and ERK2 cascade |
GO:0046850 |
1.19% |
regulation of bone remodeling |
GO:0008064 |
1.19% |
regulation of actin polymerization or depolymerization |
GO:2001235 |
1.19% |
positive regulation of apoptotic signaling pathway |
GO:0043153 |
1.19% |
entrainment of circadian clock by photoperiod |
GO:0070302 |
1.19% |
regulation of stress-activated protein kinase signaling cascade |
GO:2000278 |
1.19% |
regulation of DNA biosynthetic process |
GO:0033003 |
1.19% |
regulation of mast cell activation |
GO:0097746 |
1.19% |
regulation of blood vessel diameter |
GO:0090559 |
1.19% |
regulation of membrane permeability |
GO:0006085 |
1.19% |
acetyl-CoA biosynthetic process |
GO:0015849 |
1.19% |
organic acid transport |
GO:0030279 |
1.18% |
negative regulation of ossification |
GO:0055024 |
1.18% |
regulation of cardiac muscle tissue development |
GO:0032273 |
1.18% |
positive regulation of protein polymerization |
GO:0009167 |
1.18% |
purine ribonucleoside monophosphate metabolic process |
GO:0051251 |
1.18% |
positive regulation of lymphocyte activation |
GO:0070527 |
1.18% |
platelet aggregation |
GO:0090090 |
1.18% |
negative regulation of canonical Wnt signaling pathway |
GO:0048762 |
1.18% |
mesenchymal cell differentiation |
GO:0071173 |
1.18% |
spindle assembly checkpoint |
GO:0031057 |
1.18% |
negative regulation of histone modification |
GO:0019233 |
1.18% |
sensory perception of pain |
GO:0032352 |
1.18% |
positive regulation of hormone metabolic process |
GO:1904950 |
1.18% |
negative regulation of establishment of protein localization |
GO:0034765 |
1.18% |
regulation of ion transmembrane transport |
GO:0002761 |
1.18% |
regulation of myeloid leukocyte differentiation |
GO:1905330 |
1.17% |
regulation of morphogenesis of an epithelium |
GO:0043588 |
1.17% |
skin development |
GO:1901797 |
1.17% |
negative regulation of signal transduction by p53 class mediator |
GO:0006268 |
1.17% |
DNA unwinding involved in DNA replication |
GO:0045844 |
1.17% |
positive regulation of striated muscle tissue development |
GO:0048701 |
1.17% |
embryonic cranial skeleton morphogenesis |
GO:2000107 |
1.17% |
negative regulation of leukocyte apoptotic process |
GO:0015918 |
1.17% |
sterol transport |
GO:0019692 |
1.17% |
deoxyribose phosphate metabolic process |
GO:0014015 |
1.17% |
positive regulation of gliogenesis |
GO:0010770 |
1.17% |
positive regulation of cell morphogenesis involved in differentiation |
GO:0033617 |
1.17% |
mitochondrial respiratory chain complex IV assembly |
GO:0031061 |
1.17% |
negative regulation of histone methylation |
GO:0045793 |
1.17% |
positive regulation of cell size |
GO:0060631 |
1.17% |
regulation of meiosis I |
GO:0099518 |
1.17% |
vesicle cytoskeletal trafficking |
GO:0035107 |
1.17% |
appendage morphogenesis |
GO:0006026 |
1.17% |
aminoglycan catabolic process |
GO:0002718 |
1.17% |
regulation of cytokine production involved in immune response |
GO:0051984 |
1.16% |
positive regulation of chromosome segregation |
GO:2001234 |
1.16% |
negative regulation of apoptotic signaling pathway |
GO:0035065 |
1.16% |
regulation of histone acetylation |
GO:0001731 |
1.16% |
formation of translation preinitiation complex |
GO:0008655 |
1.16% |
pyrimidine-containing compound salvage |
GO:0046049 |
1.16% |
UMP metabolic process |
GO:0032954 |
1.16% |
regulation of cytokinetic process |
GO:0051569 |
1.16% |
regulation of histone H3-K4 methylation |
GO:0022898 |
1.16% |
regulation of transmembrane transporter activity |
GO:0060612 |
1.16% |
adipose tissue development |
GO:0010669 |
1.16% |
epithelial structure maintenance |
GO:0034121 |
1.16% |
regulation of toll-like receptor signaling pathway |
GO:2001021 |
1.16% |
negative regulation of response to DNA damage stimulus |
GO:1901863 |
1.16% |
positive regulation of muscle tissue development |
GO:0033238 |
1.16% |
regulation of cellular amine metabolic process |
GO:2001239 |
1.16% |
regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0036314 |
1.16% |
response to sterol |
GO:1903426 |
1.16% |
regulation of reactive oxygen species biosynthetic process |
GO:0034341 |
1.16% |
response to interferon-gamma |
GO:0090207 |
1.16% |
regulation of triglyceride metabolic process |
GO:0050867 |
1.16% |
positive regulation of cell activation |
GO:0061687 |
1.15% |
detoxification of inorganic compound |
GO:0042274 |
1.15% |
ribosomal small subunit biogenesis |
GO:0030497 |
1.15% |
fatty acid elongation |
GO:0097588 |
1.15% |
archaeal or bacterial-type flagellum-dependent cell motility |
GO:0060688 |
1.15% |
regulation of morphogenesis of a branching structure |
GO:0071108 |
1.15% |
protein K48-linked deubiquitination |
GO:0007004 |
1.15% |
telomere maintenance via telomerase |
GO:0061339 |
1.15% |
establishment or maintenance of monopolar cell polarity |
GO:1903727 |
1.15% |
positive regulation of phospholipid metabolic process |
GO:0046622 |
1.15% |
positive regulation of organ growth |
GO:0070372 |
1.15% |
regulation of ERK1 and ERK2 cascade |
GO:0062033 |
1.14% |
positive regulation of mitotic sister chromatid segregation |
GO:0090288 |
1.14% |
negative regulation of cellular response to growth factor stimulus |
GO:1903319 |
1.14% |
positive regulation of protein maturation |
GO:0030447 |
1.14% |
filamentous growth |
GO:0045824 |
1.14% |
negative regulation of innate immune response |
GO:0042102 |
1.14% |
positive regulation of T cell proliferation |
GO:0034310 |
1.14% |
primary alcohol catabolic process |
GO:0001954 |
1.14% |
positive regulation of cell-matrix adhesion |
GO:0009394 |
1.14% |
2'-deoxyribonucleotide metabolic process |
GO:2000379 |
1.14% |
positive regulation of reactive oxygen species metabolic process |
GO:0046040 |
1.14% |
IMP metabolic process |
GO:0002696 |
1.14% |
positive regulation of leukocyte activation |
GO:0071869 |
1.14% |
response to catecholamine |
GO:1902116 |
1.14% |
negative regulation of organelle assembly |
GO:0072503 |
1.14% |
cellular divalent inorganic cation homeostasis |
GO:0043433 |
1.14% |
negative regulation of DNA-binding transcription factor activity |
GO:0034103 |
1.14% |
regulation of tissue remodeling |
GO:0060420 |
1.14% |
regulation of heart growth |
GO:0035640 |
1.13% |
exploration behavior |
GO:1990089 |
1.13% |
response to nerve growth factor |
GO:0007064 |
1.13% |
mitotic sister chromatid cohesion |
GO:0090596 |
1.13% |
sensory organ morphogenesis |
GO:0046036 |
1.13% |
CTP metabolic process |
GO:0009148 |
1.13% |
pyrimidine nucleoside triphosphate biosynthetic process |
GO:0032196 |
1.13% |
transposition |
GO:0001975 |
1.13% |
response to amphetamine |
GO:0042551 |
1.13% |
neuron maturation |
GO:0090151 |
1.13% |
establishment of protein localization to mitochondrial membrane |
GO:0070269 |
1.13% |
pyroptosis |
GO:0071398 |
1.13% |
cellular response to fatty acid |
GO:0007585 |
1.13% |
respiratory gaseous exchange by respiratory system |
GO:0032986 |
1.13% |
protein-DNA complex disassembly |
GO:0042074 |
1.13% |
cell migration involved in gastrulation |
GO:0072331 |
1.13% |
signal transduction by p53 class mediator |
GO:0030641 |
1.13% |
regulation of cellular pH |
GO:1905879 |
1.13% |
regulation of oogenesis |
GO:0050892 |
1.13% |
intestinal absorption |
GO:0007379 |
1.13% |
segment specification |
GO:0033673 |
1.13% |
negative regulation of kinase activity |
GO:0060122 |
1.13% |
inner ear receptor cell stereocilium organization |
GO:0051099 |
1.13% |
positive regulation of binding |
GO:0048706 |
1.13% |
embryonic skeletal system development |
GO:0008210 |
1.12% |
estrogen metabolic process |
GO:0070059 |
1.12% |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO:0045599 |
1.12% |
negative regulation of fat cell differentiation |
GO:0042304 |
1.12% |
regulation of fatty acid biosynthetic process |
GO:0032206 |
1.12% |
positive regulation of telomere maintenance |
GO:0021782 |
1.12% |
glial cell development |
GO:0060759 |
1.12% |
regulation of response to cytokine stimulus |
GO:0006613 |
1.12% |
cotranslational protein targeting to membrane |
GO:0090224 |
1.12% |
regulation of spindle organization |
GO:1903115 |
1.12% |
regulation of actin filament-based movement |
GO:0090263 |
1.12% |
positive regulation of canonical Wnt signaling pathway |
GO:0010623 |
1.12% |
programmed cell death involved in cell development |
GO:0015696 |
1.12% |
ammonium transport |
GO:0072175 |
1.12% |
epithelial tube formation |
GO:0009252 |
1.12% |
peptidoglycan biosynthetic process |
GO:0051224 |
1.12% |
negative regulation of protein transport |
GO:0034501 |
1.12% |
protein localization to kinetochore |
GO:0098815 |
1.12% |
modulation of excitatory postsynaptic potential |
GO:0046942 |
1.12% |
carboxylic acid transport |
GO:0099174 |
1.12% |
regulation of presynapse organization |
GO:0031110 |
1.12% |
regulation of microtubule polymerization or depolymerization |
GO:1900027 |
1.12% |
regulation of ruffle assembly |
GO:0048636 |
1.12% |
positive regulation of muscle organ development |
GO:0060048 |
1.12% |
cardiac muscle contraction |
GO:1903859 |
1.12% |
regulation of dendrite extension |
GO:0045910 |
1.11% |
negative regulation of DNA recombination |
GO:0046580 |
1.11% |
negative regulation of Ras protein signal transduction |
GO:0010833 |
1.11% |
telomere maintenance via telomere lengthening |
GO:0072663 |
1.11% |
establishment of protein localization to peroxisome |
GO:1903338 |
1.11% |
regulation of cell wall organization or biogenesis |
GO:1903039 |
1.11% |
positive regulation of leukocyte cell-cell adhesion |
GO:0032570 |
1.11% |
response to progesterone |
GO:0060281 |
1.11% |
regulation of oocyte development |
GO:0009264 |
1.11% |
deoxyribonucleotide catabolic process |
GO:0050885 |
1.11% |
neuromuscular process controlling balance |
GO:0060041 |
1.11% |
retina development in camera-type eye |
GO:0007569 |
1.11% |
cell aging |
GO:0031554 |
1.11% |
regulation of DNA-templated transcription, termination |
GO:0002262 |
1.11% |
myeloid cell homeostasis |
GO:0099175 |
1.11% |
regulation of postsynapse organization |
GO:0009954 |
1.11% |
proximal/distal pattern formation |
GO:0001895 |
1.11% |
retina homeostasis |
GO:0001936 |
1.11% |
regulation of endothelial cell proliferation |
GO:1904377 |
1.10% |
positive regulation of protein localization to cell periphery |
GO:2000573 |
1.10% |
positive regulation of DNA biosynthetic process |
GO:0060326 |
1.10% |
cell chemotaxis |
GO:0001568 |
1.10% |
blood vessel development |
GO:0030514 |
1.10% |
negative regulation of BMP signaling pathway |
GO:1902101 |
1.10% |
positive regulation of metaphase/anaphase transition of cell cycle |
GO:1902412 |
1.10% |
regulation of mitotic cytokinesis |
GO:0010633 |
1.10% |
negative regulation of epithelial cell migration |
GO:0031125 |
1.10% |
rRNA 3'-end processing |
GO:1903322 |
1.10% |
positive regulation of protein modification by small protein conjugation or removal |
GO:0008207 |
1.10% |
C21-steroid hormone metabolic process |
GO:0045740 |
1.10% |
positive regulation of DNA replication |
GO:0120163 |
1.10% |
negative regulation of cold-induced thermogenesis |
GO:0051048 |
1.10% |
negative regulation of secretion |
GO:0032968 |
1.10% |
positive regulation of transcription elongation from RNA polymerase II promoter |
GO:0031646 |
1.10% |
positive regulation of nervous system process |
GO:0002088 |
1.09% |
lens development in camera-type eye |
GO:0045165 |
1.09% |
cell fate commitment |
GO:0032642 |
1.09% |
regulation of chemokine production |
GO:0009948 |
1.09% |
anterior/posterior axis specification |
GO:0006884 |
1.09% |
cell volume homeostasis |
GO:0006367 |
1.09% |
transcription initiation from RNA polymerase II promoter |
GO:0051204 |
1.09% |
protein insertion into mitochondrial membrane |
GO:0048146 |
1.09% |
positive regulation of fibroblast proliferation |
GO:0070723 |
1.09% |
response to cholesterol |
GO:0051205 |
1.09% |
protein insertion into membrane |
GO:0030002 |
1.09% |
cellular anion homeostasis |
GO:1903429 |
1.09% |
regulation of cell maturation |
GO:1902808 |
1.09% |
positive regulation of cell cycle G1/S phase transition |
GO:1901068 |
1.09% |
guanosine-containing compound metabolic process |
GO:0048736 |
1.09% |
appendage development |
GO:0061162 |
1.09% |
establishment of monopolar cell polarity |
GO:0046887 |
1.09% |
positive regulation of hormone secretion |
GO:0070918 |
1.09% |
production of small RNA involved in gene silencing by RNA |
GO:0019405 |
1.09% |
alditol catabolic process |
GO:0045687 |
1.09% |
positive regulation of glial cell differentiation |
GO:0051085 |
1.09% |
chaperone cofactor-dependent protein refolding |
GO:0098930 |
1.09% |
axonal transport |
GO:1901224 |
1.09% |
positive regulation of NIK/NF-kappaB signaling |
GO:0006188 |
1.09% |
IMP biosynthetic process |
GO:0071479 |
1.08% |
cellular response to ionizing radiation |
GO:0001961 |
1.08% |
positive regulation of cytokine-mediated signaling pathway |
GO:1903708 |
1.08% |
positive regulation of hemopoiesis |
GO:0045667 |
1.08% |
regulation of osteoblast differentiation |
GO:0060135 |
1.08% |
maternal process involved in female pregnancy |
GO:2000677 |
1.08% |
regulation of transcription regulatory region DNA binding |
GO:0007339 |
1.08% |
binding of sperm to zona pellucida |
GO:0030808 |
1.08% |
regulation of nucleotide biosynthetic process |
GO:0009219 |
1.08% |
pyrimidine deoxyribonucleotide metabolic process |
GO:0043010 |
1.08% |
camera-type eye development |
GO:0060390 |
1.08% |
regulation of SMAD protein signal transduction |
GO:0051568 |
1.08% |
histone H3-K4 methylation |
GO:0032731 |
1.08% |
positive regulation of interleukin-1 beta production |
GO:0031532 |
1.08% |
actin cytoskeleton reorganization |
GO:0044773 |
1.08% |
mitotic DNA damage checkpoint |
GO:0042476 |
1.08% |
odontogenesis |
GO:0035510 |
1.08% |
DNA dealkylation |
GO:0006213 |
1.08% |
pyrimidine nucleoside metabolic process |
GO:0009630 |
1.08% |
gravitropism |
GO:0051438 |
1.08% |
regulation of ubiquitin-protein transferase activity |
GO:0007422 |
1.08% |
peripheral nervous system development |
GO:0010447 |
1.08% |
response to acidic pH |
GO:0009265 |
1.08% |
2'-deoxyribonucleotide biosynthetic process |
GO:0050920 |
1.08% |
regulation of chemotaxis |
GO:0046847 |
1.08% |
filopodium assembly |
GO:0035384 |
1.08% |
thioester biosynthetic process |
GO:0010470 |
1.07% |
regulation of gastrulation |
GO:0001556 |
1.07% |
oocyte maturation |
GO:0061178 |
1.07% |
regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:2001032 |
1.07% |
regulation of double-strand break repair via nonhomologous end joining |
GO:0098900 |
1.07% |
regulation of action potential |
GO:0032355 |
1.07% |
response to estradiol |
GO:0010893 |
1.07% |
positive regulation of steroid biosynthetic process |
GO:0042755 |
1.07% |
eating behavior |
GO:0001778 |
1.07% |
plasma membrane repair |
GO:0000578 |
1.07% |
embryonic axis specification |
GO:0034453 |
1.07% |
microtubule anchoring |
GO:0044070 |
1.07% |
regulation of anion transport |
GO:0010155 |
1.07% |
regulation of proton transport |
GO:1905476 |
1.07% |
negative regulation of protein localization to membrane |
GO:1903035 |
1.07% |
negative regulation of response to wounding |
GO:0048013 |
1.07% |
ephrin receptor signaling pathway |
GO:1903779 |
1.07% |
regulation of cardiac conduction |
GO:0071867 |
1.07% |
response to monoamine |
GO:0071276 |
1.07% |
cellular response to cadmium ion |
GO:0031118 |
1.07% |
rRNA pseudouridine synthesis |
GO:0071827 |
1.06% |
plasma lipoprotein particle organization |
GO:0060632 |
1.06% |
regulation of microtubule-based movement |
GO:0072511 |
1.06% |
divalent inorganic cation transport |
GO:1903531 |
1.06% |
negative regulation of secretion by cell |
GO:0051590 |
1.06% |
positive regulation of neurotransmitter transport |
GO:0071616 |
1.06% |
acyl-CoA biosynthetic process |
GO:0006625 |
1.06% |
protein targeting to peroxisome |
GO:0048854 |
1.06% |
brain morphogenesis |
GO:0031102 |
1.06% |
neuron projection regeneration |
GO:0002758 |
1.06% |
innate immune response-activating signal transduction |
GO:0061462 |
1.06% |
protein localization to lysosome |
GO:0055013 |
1.06% |
cardiac muscle cell development |
GO:0052126 |
1.06% |
movement in host environment |
GO:0046649 |
1.06% |
lymphocyte activation |
GO:0045773 |
1.06% |
positive regulation of axon extension |
GO:0031050 |
1.06% |
dsRNA processing |
GO:1900376 |
1.06% |
regulation of secondary metabolite biosynthetic process |
GO:0022600 |
1.06% |
digestive system process |
GO:0042475 |
1.06% |
odontogenesis of dentin-containing tooth |
GO:0007548 |
1.06% |
sex differentiation |
GO:0050919 |
1.06% |
negative chemotaxis |
GO:0048565 |
1.06% |
digestive tract development |
GO:0042733 |
1.06% |
embryonic digit morphogenesis |
GO:0072599 |
1.06% |
establishment of protein localization to endoplasmic reticulum |
GO:1903037 |
1.06% |
regulation of leukocyte cell-cell adhesion |
GO:0034122 |
1.06% |
negative regulation of toll-like receptor signaling pathway |
GO:0098787 |
1.06% |
mRNA cleavage involved in mRNA processing |
GO:0009113 |
1.06% |
purine nucleobase biosynthetic process |
GO:0034367 |
1.06% |
protein-containing complex remodeling |
GO:0106027 |
1.05% |
neuron projection organization |
GO:0033143 |
1.05% |
regulation of intracellular steroid hormone receptor signaling pathway |
GO:1990090 |
1.05% |
cellular response to nerve growth factor stimulus |
GO:0050818 |
1.05% |
regulation of coagulation |
GO:0007265 |
1.05% |
Ras protein signal transduction |
GO:0060236 |
1.05% |
regulation of mitotic spindle organization |
GO:0002221 |
1.05% |
pattern recognition receptor signaling pathway |
GO:0003009 |
1.05% |
skeletal muscle contraction |
GO:0032197 |
1.05% |
transposition, RNA-mediated |
GO:0042771 |
1.05% |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO:0050680 |
1.05% |
negative regulation of epithelial cell proliferation |
GO:0034620 |
1.05% |
cellular response to unfolded protein |
GO:1904591 |
1.05% |
positive regulation of protein import |
GO:1905820 |
1.05% |
positive regulation of chromosome separation |
GO:0070665 |
1.05% |
positive regulation of leukocyte proliferation |
GO:0030011 |
1.05% |
maintenance of cell polarity |
GO:0034656 |
1.04% |
nucleobase-containing small molecule catabolic process |
GO:0044030 |
1.04% |
regulation of DNA methylation |
GO:0032509 |
1.04% |
endosome transport via multivesicular body sorting pathway |
GO:0034612 |
1.04% |
response to tumor necrosis factor |
GO:0035821 |
1.04% |
modification of morphology or physiology of other organism |
GO:0034446 |
1.04% |
substrate adhesion-dependent cell spreading |
GO:0048041 |
1.04% |
focal adhesion assembly |
GO:0031103 |
1.04% |
axon regeneration |
GO:0008154 |
1.04% |
actin polymerization or depolymerization |
GO:0032210 |
1.04% |
regulation of telomere maintenance via telomerase |
GO:0045742 |
1.04% |
positive regulation of epidermal growth factor receptor signaling pathway |
GO:0072662 |
1.04% |
protein localization to peroxisome |
GO:0045616 |
1.04% |
regulation of keratinocyte differentiation |
GO:0019730 |
1.04% |
antimicrobial humoral response |
GO:1903203 |
1.04% |
regulation of oxidative stress-induced neuron death |
GO:0043409 |
1.04% |
negative regulation of MAPK cascade |
GO:0072332 |
1.04% |
intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0034727 |
1.04% |
piecemeal microautophagy of the nucleus |
GO:0044818 |
1.04% |
mitotic G2/M transition checkpoint |
GO:0007045 |
1.04% |
cell-substrate adherens junction assembly |
GO:0051702 |
1.04% |
interaction with symbiont |
GO:0035303 |
1.04% |
regulation of dephosphorylation |
GO:0006865 |
1.04% |
amino acid transport |
GO:2000725 |
1.04% |
regulation of cardiac muscle cell differentiation |
GO:0006265 |
1.04% |
DNA topological change |
GO:0006821 |
1.03% |
chloride transport |
GO:0051896 |
1.03% |
regulation of protein kinase B signaling |
GO:0043304 |
1.03% |
regulation of mast cell degranulation |
GO:1903747 |
1.03% |
regulation of establishment of protein localization to mitochondrion |
GO:0014743 |
1.03% |
regulation of muscle hypertrophy |
GO:0106030 |
1.03% |
neuron projection fasciculation |
GO:0051851 |
1.03% |
modification by host of symbiont morphology or physiology |
GO:0060760 |
1.03% |
positive regulation of response to cytokine stimulus |
GO:1903076 |
1.03% |
regulation of protein localization to plasma membrane |
GO:0071985 |
1.03% |
multivesicular body sorting pathway |
GO:1905898 |
1.03% |
positive regulation of response to endoplasmic reticulum stress |
GO:0045453 |
1.03% |
bone resorption |
GO:0070838 |
1.03% |
divalent metal ion transport |
GO:1903670 |
1.03% |
regulation of sprouting angiogenesis |
GO:0097756 |
1.03% |
negative regulation of blood vessel diameter |
GO:0031398 |
1.03% |
positive regulation of protein ubiquitination |
GO:0045860 |
1.03% |
positive regulation of protein kinase activity |
GO:0043242 |
1.03% |
negative regulation of protein complex disassembly |
GO:2000758 |
1.03% |
positive regulation of peptidyl-lysine acetylation |
GO:1903432 |
1.03% |
regulation of TORC1 signaling |
GO:0090311 |
1.03% |
regulation of protein deacetylation |
GO:1901976 |
1.03% |
regulation of cell cycle checkpoint |
GO:2000144 |
1.03% |
positive regulation of DNA-templated transcription, initiation |
GO:0003073 |
1.02% |
regulation of systemic arterial blood pressure |
GO:1901186 |
1.02% |
positive regulation of ERBB signaling pathway |
GO:0043410 |
1.02% |
positive regulation of MAPK cascade |
GO:0070417 |
1.02% |
cellular response to cold |
GO:0051642 |
1.02% |
centrosome localization |
GO:0007097 |
1.02% |
nuclear migration |
GO:1903524 |
1.02% |
positive regulation of blood circulation |
GO:0000447 |
1.02% |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0015695 |
1.02% |
organic cation transport |
GO:1904589 |
1.02% |
regulation of protein import |
GO:0032435 |
1.02% |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO:0035051 |
1.02% |
cardiocyte differentiation |
GO:0050863 |
1.02% |
regulation of T cell activation |
GO:0007173 |
1.02% |
epidermal growth factor receptor signaling pathway |
GO:0050819 |
1.02% |
negative regulation of coagulation |
GO:0044182 |
1.02% |
filamentous growth of a population of unicellular organisms |
GO:0099515 |
1.02% |
actin filament-based transport |
GO:1904705 |
1.02% |
regulation of vascular smooth muscle cell proliferation |
GO:0042310 |
1.02% |
vasoconstriction |
GO:0050848 |
1.02% |
regulation of calcium-mediated signaling |
GO:0055006 |
1.02% |
cardiac cell development |
GO:1901796 |
1.02% |
regulation of signal transduction by p53 class mediator |
GO:0030509 |
1.02% |
BMP signaling pathway |
GO:0002260 |
1.02% |
lymphocyte homeostasis |
GO:0045851 |
1.02% |
pH reduction |
GO:1904356 |
1.02% |
regulation of telomere maintenance via telomere lengthening |
GO:1901184 |
1.02% |
regulation of ERBB signaling pathway |
GO:0098661 |
1.02% |
inorganic anion transmembrane transport |
GO:2000772 |
1.02% |
regulation of cellular senescence |
GO:0042303 |
1.02% |
molting cycle |
GO:0032651 |
1.02% |
regulation of interleukin-1 beta production |
GO:0006505 |
1.02% |
GPI anchor metabolic process |
GO:1905207 |
1.02% |
regulation of cardiocyte differentiation |
GO:0043574 |
1.01% |
peroxisomal transport |
GO:1903861 |
1.01% |
positive regulation of dendrite extension |
GO:0007035 |
1.01% |
vacuolar acidification |
GO:0006826 |
1.01% |
iron ion transport |
GO:1902105 |
1.01% |
regulation of leukocyte differentiation |
GO:0016486 |
1.01% |
peptide hormone processing |
GO:0060411 |
1.01% |
cardiac septum morphogenesis |
GO:0046385 |
1.01% |
deoxyribose phosphate biosynthetic process |
GO:1904062 |
1.01% |
regulation of cation transmembrane transport |
GO:0045842 |
1.01% |
positive regulation of mitotic metaphase/anaphase transition |
GO:0051817 |
1.01% |
modification of morphology or physiology of other organism involved in symbiotic interaction |
GO:0043516 |
1.01% |
regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0042454 |
1.01% |
ribonucleoside catabolic process |
GO:0048635 |
1.01% |
negative regulation of muscle organ development |
GO:1901532 |
1.01% |
regulation of hematopoietic progenitor cell differentiation |
GO:0070301 |
1.01% |
cellular response to hydrogen peroxide |
GO:0046824 |
1.01% |
positive regulation of nucleocytoplasmic transport |
GO:0035036 |
1.01% |
sperm-egg recognition |
GO:0060260 |
1.01% |
regulation of transcription initiation from RNA polymerase II promoter |
GO:1902305 |
1.01% |
regulation of sodium ion transmembrane transport |
GO:0045071 |
1.01% |
negative regulation of viral genome replication |
GO:0010743 |
1.01% |
regulation of macrophage derived foam cell differentiation |
GO:0072089 |
1.01% |
stem cell proliferation |
GO:0044380 |
1.00% |
protein localization to cytoskeleton |
GO:0051315 |
1.00% |
attachment of mitotic spindle microtubules to kinetochore |
GO:0033146 |
1.00% |
regulation of intracellular estrogen receptor signaling pathway |
GO:0045670 |
1.00% |
regulation of osteoclast differentiation |
GO:0010939 |
1.00% |
regulation of necrotic cell death |
GO:1900077 |
1.00% |
negative regulation of cellular response to insulin stimulus |
GO:0030431 |
1.00% |
sleep |
GO:1901070 |
1.00% |
guanosine-containing compound biosynthetic process |
GO:1900271 |
1.00% |
regulation of long-term synaptic potentiation |
GO:0051053 |
1.00% |
negative regulation of DNA metabolic process |